
<html lang="en"     class="pb-page"  data-request-id="20705ad7-1ba8-420c-9521-812f1f7ec9ca"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm100714c;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2010.53.issue-23"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of 1-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (GSK163090), a Potent, Selective, and Orally Active 5-HT1A/B/D Receptor Antagonist" /></meta><meta name="dc.Creator" content="Colin P.  Leslie" /></meta><meta name="dc.Creator" content="Matteo  Biagetti" /></meta><meta name="dc.Creator" content="Silvia  Bison" /></meta><meta name="dc.Creator" content="Steven M.  Bromidge" /></meta><meta name="dc.Creator" content="Romano  Di Fabio" /></meta><meta name="dc.Creator" content="Daniele  Donati" /></meta><meta name="dc.Creator" content="Alessandro  Falchi" /></meta><meta name="dc.Creator" content="Martine J.  Garnier" /></meta><meta name="dc.Creator" content="Albert  Jaxa-Chamiec" /></meta><meta name="dc.Creator" content="Gary  Manchee" /></meta><meta name="dc.Creator" content="Giancarlo  Merlo" /></meta><meta name="dc.Creator" content="Domenica A.  Pizzi" /></meta><meta name="dc.Creator" content="Luigi P.  Stasi" /></meta><meta name="dc.Creator" content="Jessica  Tibasco" /></meta><meta name="dc.Creator" content="Antonio  Vong" /></meta><meta name="dc.Creator" content="Simon E.  Ward" /></meta><meta name="dc.Creator" content="Laura  Zonzini" /></meta><meta name="dc.Description" content="In an effort to identify selective drug like pan-antagonists of the 5-HT1 autoreceptors, studies were conducted to elaborate a previously reported dual acting 5-HT1 antagonist/SSRI structure. A nov..." /></meta><meta name="Description" content="In an effort to identify selective drug like pan-antagonists of the 5-HT1 autoreceptors, studies were conducted to elaborate a previously reported dual acting 5-HT1 antagonist/SSRI structure. A nov..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 5, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm100714c" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm100714c" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm100714c" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm100714c" /></link>
        
    
    

<title>Discovery of 1-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (GSK163090), a Potent, Selective, and Orally Active 5-HT1A/B/D Receptor Antagonist | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm100714c" /></meta><meta property="og:title" content="Discovery of 1-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (GSK163090), a Potent, Selective, and Orally Active 5-HT1A/B/D Receptor Antagonist" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-23/jm100714c/production/images/large/jm-2010-00714c_0003.jpeg" /></meta><meta property="og:description" content="In an effort to identify selective drug like pan-antagonists of the 5-HT1 autoreceptors, studies were conducted to elaborate a previously reported dual acting 5-HT1 antagonist/SSRI structure. A novel series of compounds was identified showing low intrinsic activities and potent affinities across the 5-HT1A, 5-HT1B, and 5-HT1D receptors as well as high selectivity against the serotonin transporter. From among these compounds, 1-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (36) was found to combine potent in vivo activity with a strong preclinical developability profile, and on this basis it was selected as a drug candidate with the aim of assessing its potential as a fast-onset antidepressant/anxiolytic." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm100714c"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm100714c">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm100714c&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm100714c&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm100714c&amp;href=/doi/10.1021/jm100714c" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 8228-8240</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm100836m" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm100957a" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of 1-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (GSK163090), a Potent, Selective, and Orally Active 5-HT<sub>1A/B/D</sub> Receptor Antagonist</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Colin+P.++Leslie">Colin P. Leslie</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matteo++Biagetti">Matteo Biagetti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Silvia++Bison">Silvia Bison</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+M.++Bromidge">Steven M. Bromidge</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Romano++Di+Fabio">Romano Di Fabio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniele++Donati">Daniele Donati</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alessandro++Falchi">Alessandro Falchi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martine+J.++Garnier">Martine J. Garnier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Albert++Jaxa-Chamiec">Albert Jaxa-Chamiec</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gary++Manchee">Gary Manchee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giancarlo++Merlo">Giancarlo Merlo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Domenica+A.++Pizzi">Domenica A. Pizzi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luigi+P.++Stasi">Luigi P. Stasi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>▽</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jessica++Tibasco">Jessica Tibasco</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Antonio++Vong">Antonio Vong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simon+E.++Ward">Simon E. Ward</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Zonzini">Laura Zonzini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline SpA, Medicines Research Centre, Via A. Fleming 4, 37135 Verona, Italy</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, United Kingdom</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +39 045 8218546. Fax: +39 045 8218196. E-mail: <a href="/cdn-cgi/l/email-protection#debdb1b2b7b0f0b2bbadb2b7bb9ebfaeaaabb7aaf0bdb1b3"><span class="__cf_email__" data-cfemail="72111d1e1b1c5c1e17011e1b1732130206071b065c111d1f">[email protected]</span></a></div><div class="corresp-fn" id="fn1">§Present address: Nerviano Medical Sciences Srl, Via Pasteur 10, 20014 Nerviano, Milan, Italy.</div><div class="corresp-fn" id="fn2">∥Present address: Chiesi Farmaceutici, Via Palermo 26/A, 43122 Parma, Italy.</div><div class="corresp-fn" id="fn3">⊥Present address: Imperial College, London, SW7 2AZ, United Kingdom.</div><div class="corresp-fn" id="fn4">#Present address: Pharmidex, 72 New Bond Street, Mayfair, London W1S 1RR, United Kingdom.</div><div class="corresp-fn" id="fn5">▽Present address: Rottapharm, Via Valosa di Sopra 9, 20052 Monza, Italy.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm100714c&amp;href=/doi/10.1021%2Fjm100714c" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 8228–8240</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 5, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 June 2010</li><li><span class="item_label"><b>Published</b> online</span>5 November 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 December 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm100714c" title="DOI URL">https://doi.org/10.1021/jm100714c</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8228%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DColin%2BP.%2BLeslie%252C%2BMatteo%2BBiagetti%252C%2BSilvia%2BBison%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D23%26contentID%3Djm100714c%26title%3DDiscovery%2Bof%2B1-%25283-%257B2-%255B4-%25282-Methyl-5-quinolinyl%2529-1-piperazinyl%255Dethyl%257Dphenyl%2529-2-imidazolidinone%2B%2528GSK163090%2529%252C%2Ba%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BActive%2B5-HT1A%252FB%252FD%2BReceptor%2BAntagonist%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8240%26publicationDate%3DDecember%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm100714c"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1949</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">9</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm100714c" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of 1-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (GSK163090), a Potent, Selective, and Orally Active 5-HT1A/B/D Receptor Antagonist&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Colin&quot;,&quot;last_name&quot;:&quot;P. Leslie&quot;},{&quot;first_name&quot;:&quot;Matteo&quot;,&quot;last_name&quot;:&quot;Biagetti&quot;},{&quot;first_name&quot;:&quot;Silvia&quot;,&quot;last_name&quot;:&quot;Bison&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;M. Bromidge&quot;},{&quot;first_name&quot;:&quot;Romano&quot;,&quot;last_name&quot;:&quot;Di Fabio&quot;},{&quot;first_name&quot;:&quot;Daniele&quot;,&quot;last_name&quot;:&quot;Donati&quot;},{&quot;first_name&quot;:&quot;Alessandro&quot;,&quot;last_name&quot;:&quot;Falchi&quot;},{&quot;first_name&quot;:&quot;Martine&quot;,&quot;last_name&quot;:&quot;J. Garnier&quot;},{&quot;first_name&quot;:&quot;Albert&quot;,&quot;last_name&quot;:&quot;Jaxa-Chamiec&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;Manchee&quot;},{&quot;first_name&quot;:&quot;Giancarlo&quot;,&quot;last_name&quot;:&quot;Merlo&quot;},{&quot;first_name&quot;:&quot;Domenica&quot;,&quot;last_name&quot;:&quot;A. Pizzi&quot;},{&quot;first_name&quot;:&quot;Luigi&quot;,&quot;last_name&quot;:&quot;P. Stasi&quot;},{&quot;first_name&quot;:&quot;Jessica&quot;,&quot;last_name&quot;:&quot;Tibasco&quot;},{&quot;first_name&quot;:&quot;Antonio&quot;,&quot;last_name&quot;:&quot;Vong&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;E. Ward&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Zonzini&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;8228-8240&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm100714c&quot;},&quot;abstract&quot;:&quot;In an effort to identify selective drug like pan-antagonists of the 5-HT1 autoreceptors, studies were conducted to elaborate a previously reported dual acting 5-HT1 antagonist/SSRI structure. A novel series of compounds was identified showing low intrinsic activities and potent affinities across the 5-HT1A, 5-HT1B, and 5-HT1D receptors as well as high selectivity against the serotonin transporter. From among these compounds, 1-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (36) was found to combine potent in vivo activity with a strong preclinical developability profile, and on this basis it was selected as a drug candidate with the aim of assessing its potential as a fast-onset antidepressant/anxiolytic.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100714c&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100714c" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100714c&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100714c" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100714c&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100714c" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm100714c&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100714c&amp;href=/doi/10.1021/jm100714c" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm100714c" /></input><a href="/doi/pdf/10.1021/jm100714c" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (896 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm100714c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm100714c%26sid%3Dliteratum%253Aachs%26pmid%3D21053897%26genre%3Darticle%26aulast%3DLeslie%26date%3D2010%26atitle%3DDiscovery%2Bof%2B1-%25283-%257B2-%255B4-%25282-Methyl-5-quinolinyl%2529-1-piperazinyl%255Dethyl%257Dphenyl%2529-2-imidazolidinone%2B%2528GSK163090%2529%252C%2Ba%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BActive%2B5-HT1A%252FB%252FD%2BReceptor%2BAntagonist%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D23%26spage%3D8228%26epage%3D8240%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-23/jmcmar.2010.53.issue-23/production/jmcmar.2010.53.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-23/jm100714c/production/images/medium/jm-2010-00714c_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-23/jm100714c/production/images/large/jm-2010-00714c_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100714c&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In an effort to identify selective drug like pan-antagonists of the 5-HT<sub>1</sub> autoreceptors, studies were conducted to elaborate a previously reported dual acting 5-HT<sub>1</sub> antagonist/SSRI structure. A novel series of compounds was identified showing low intrinsic activities and potent affinities across the 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, and 5-HT<sub>1D</sub> receptors as well as high selectivity against the serotonin transporter. From among these compounds, 1-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (<b>36</b>) was found to combine potent in vivo activity with a strong preclinical developability profile, and on this basis it was selected as a drug candidate with the aim of assessing its potential as a fast-onset antidepressant/anxiolytic.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61048" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61048" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Much preclinical and clinical evidence highlights the involvement of the serotonergic system in the regulation of mood.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Of particular clinical importance are the selective serotonin reuptake inhibitors (SSRIs<a class="ref internalNav" href="#fn6" aria-label="a">a</a><div class="NLM_fn" id="fn6">a<p class="last">Abbreviations: SSRI, selective serotonin reuptake inhibitor; 5-HT, 5-hydroxytyptamine; SerT, serotonin transporter; SAR, structure−activity relationship; GTPγS, guanosine 5′-<i>O</i>-[γ-thio]triphosphate; DMPK, drug metabolism and pharmacokinetics; CYP450, cytochrome P450; hERG, human ether-a-go-go-related-gene; CNS, central nervous system; PD, pharmacodynamic; 8-OH-DPAT, 8-hydroxy-<i>N</i>,<i>N</i>-dipropyl-2-aminotetralin; hLMA, hyperlocomotor activity; DDI, drug−drug interactions; P-gp, P-glycoprotein; MDCK, Madin−Darby canine kidney; hMDR1, human multidrug resistance 1 protein; BA, basolateral-to-apical; AB, apical-to-basolateral; IA, intrinsic activity; ND, value not determined; inv, inverse agonist; NMR, nuclear magnetic resonance; LCMS, liquid chromatography/mass sprectroscopy; Cl<sub>int</sub>, intrinsic clearance; compd, compound; clogP, calculated octanol/water partition coefficient; Cl<sub>b</sub>, blood clearance; <i>t</i><sub>1/2</sub>, half-life; <i>F</i><sub>po</sub>, oral bioavailability; <i>C</i><sub>max</sub>, maximum concentration.</p></div>), which represent the first choice for the treatment of depression. The SSRIs are believed to owe their efficacy to increased serotonergic neurotransmission brought about through the elevation of synaptic 5-hydroxytyptamine (5-HT) levels. Despite their popularity, the SSRIs are associated with a number of undesirable characteristics including the latency to therapeutic onset, which typically requires several weeks of SSRI treatment. It has been hypothesized that this delay in therapeutic onset is attributable to the time required for the desensitization of the 5-HT<sub>1A</sub> receptors, allowing increased 5-HT levels to be maintained.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In support of this hypothesis, coadministration of a 5-HT<sub>1A</sub> antagonist with an SSRI has been reported to accelerate the onset of anxiolytic/antidepressant activity of SSRIs both in preclinical<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and clinical<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> settings and, accordingly, several researchers have endeavored to identify dual acting 5-HT<sub>1A</sub> antagonists/SSRIs that hold the promise of faster onset of therapeutic efficacy in the treatment of depression.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">5-HT<sub>1</sub> autoreceptors are located on both the cell bodies (5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, and 5-HT<sub>1D</sub> receptor subtypes) and nerve terminals (5-HT<sub>1B</sub> and 5-HT<sub>1D</sub> receptor subtypes) of 5-HT neurons.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> They are widely distributed in the brain, and it has been documented that the 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, and 5-HT<sub>1D</sub> receptors play an important role in regulating the release of 5-HT on the 5-HT cell bodies<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and on the nerve terminals.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Thus the concurrent blockade of all three autoreceptors, 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, and 5-HT<sub>1D</sub>, should lead to an elevation of extracellular 5-HT concentrations. Indeed, microdialysis studies in guinea pig have confirmed that the combination of 5-HT<sub>1A</sub> and 5-HT<sub>1B</sub> antagonism results in an acute synergistic enhancement of 5-HT levels,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> comparable to that observed following a period of chronic SSRI treatment. It follows, therefore, that a pan-antagonist of the 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, and 5-HT<sub>1D</sub> receptors may be postulated to exhibit a similar therapeutic profile to a dual acting 5-HT<sub>1A</sub> antagonist/SSRI through an acute and sustained increase of postsynaptic 5-HT neurotransmission. Consequently, a pan-antagonist of the 5-HT<sub>1</sub> autoreceptors may constitute a novel approach for the treatment of depression/anxiety with potential advantages in the latency to therapeutic onset.</div><div class="NLM_p">This approach has been targeted within our laboratories, as well as by others,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and a series of recent publications have documented our progress.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> A tactic that has proven successful in furnishing selective 5-HT<sub>1</sub> antagonist tools, such as <b>1</b>, is the modification of the benzoxazinone portion of the dual acting 5-HT<sub>1</sub> antagonist/SSRI lead <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) identified within our laboratories.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Exclusion of the benzoxazinone substructure, which is a key pharmacophoric requirement for potent inhibition of the serotonin transporter (SerT), readily removed SerT activity while judicious replacement with alternative groups allowed potent 5-HT<sub>1</sub> binding to be restored.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Recently, our laboratories have described a newer benzoxazinone dual acting 5-HT<sub>1</sub> antagonist/SSRI lead <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>),<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> endowed with increased 5-HT<sub>1</sub> antagonist activity and a superior pharmacokinetic profile. Here, we report our studies applying an analogous tactic, modifying the benzoxazinone moiety of <b>3</b>, that led to the discovery of a new potent and selective series of 5-HT<sub>1</sub> antagonists from which a preclinical candidate was selected.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-23/jm100714c/production/images/medium/jm-2010-00714c_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-23/jm100714c/production/images/large/jm-2010-00714c_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of <b>1</b>, a 5-HT<sub>1</sub> receptor antagonist, and <b>2</b> and <b>3</b>, dual acting 5-HT<sub>1</sub> receptor antagonist/serotonin reuptake inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-23/jm100714c/production/images/large/jm-2010-00714c_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100714c&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88058" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88058" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">From the outset, the medicinal chemistry strategy was entirely focused on replacement of the benzoxazinone portion of molecule <b>3</b>. Experience gained working with related series of 5-HT<sub>1A/B/D</sub> antagonists and dual acting 5-HT<sub>1A</sub> antagonists/SSRIs has taught that the 2-methylquinoline is fundamental for combining high 5-HT<sub>1A/B/D</sub> affinities with low intrinsic activities;<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> as such, the 2-methylquinoline group is considered optimal and hence this portion of the molecule was not targeted for modification. Likewise, modifications to the ethylpiperazine linker were not envisaged because our starting point, compound <b>3</b>, was itself the product of an extensive exploration of the linker group<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and the ethylpiperazine linker was considered optimized.</div><div class="NLM_p">On the basis of the findings from the SAR exploration around lead <b>2</b> that had led to the identification of compound <b>1</b>,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> we began by targeting the replacement of the benzoxazinone group in compound <b>3</b> with a 3-substituted phenyl group, in particular the methyl sulfonamide derivative. The target compounds were prepared following the synthetic sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> that was designed to allow rapid parallel SAR expansion.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-23/jm100714c/production/images/medium/jm-2010-00714c_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-23/jm100714c/production/images/large/jm-2010-00714c_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-23/jm100714c/production/images/large/jm-2010-00714c_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100714c&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Tf<sub>2</sub>O, pyridine, dichloromethane, 0 °C, 92%; (ii) 1-Boc-piperazine, Cs<sub>2</sub>CO<sub>4</sub>, Pd(OAc)<sub>2</sub>, BINAP, toluene, reflux, 62%; (iii) TFA, dichloromethane, room temp, 96%; (iv) 2-(3-nitrophenyl)ethyl methanesulfonate, DIPEA, DMF, 100 °C, 64%; (v) Fe powder, NH<sub>4</sub>Cl, MeOH, reflux, 84%; (vi) for sulfonamides RSO<sub>2</sub>Cl, pyridine, room temp, 44−62%; for amides RCO<sub>2</sub>H, EDC, HOBt, dichloromethane/DMF, room temp or RCOCl, DIPEA, dichloromethane, room temp; for ureas RNCO, dichloromethane, room temp or triphosgene, TEA, RNH<sub>2</sub>, 0 °C; for carbamates (RO)COCl, DIPEA, dichloromethane, 0 °C; (vii) MeI, NaH, THF, 0 °C; (viii) NaH, THF, 0 °C.</p></p></figure><div class="NLM_p">A slightly modified route to prepare 2-methyl-5-(1-piperazinyl)quinoline <b>7</b> than previously published was employed. A palladium catalyzed Buchwald−Hartwig coupling remains a key step in the synthetic sequence, but passing via the triflate ester of the quinoline group rather than the corresponding bromide afforded greatly improved yields and simplified purification procedures. Subsequent alkylation with (3-nitrophenyl)ethyl methanesulfonate and reduction of the nitro group with iron powder/ammonium chloride in methanol afforded the versatile intermediate <b>9</b>, ready for functionalization.</div><div class="NLM_p">The in vitro target activities of the compounds described in this manuscript were assessed using a two-tier screening cascade. First, the 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, and 5-HT<sub>1D</sub> affinities of all compounds prepared were evaluated in radioligand binding assays in stably transfected recombinant cell lines. Subsequently, the functional activities of selected compounds were assessed in [<sup>35</sup>S]-GTPγS binding assays, again in cells stably transfected with the relevant receptor. Data are reported as p<i>K</i><sub>i</sub> values from the binding assays and intrinsic activities (IA) from the functional assays. Intrinsic activities are reported relative to the maximum response elicited by the endogenous agonist 5-HT (IA = 1.0); in some cases, test compounds were found to lower [<sup>35</sup>S]-GTPγS binding below basal levels and these are indicated as inverse agonists (IA = inv). The desired profile for compound progression was set at p<i>K</i><sub>i</sub> > 8.0 for all three targets and either silent antagonism (IA = 0.0) or inverse agonism at each receptor.</div><div class="NLM_p">In confirmation of our working hypothesis, the initially prepared methyl sulfonamide derivative <b>10</b> was found to maintain subnanomolar affinity for the 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, and 5-HT<sub>1D</sub> receptors while the SerT activity was reduced by more than 100-fold compared to the parent benzoxazinone structure <b>3</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Furthermore, the intrinsic activities observed for <b>10</b> were even lower than those of <b>3</b>, eliminating any risk of inducing partial agonism in an in vivo setting;</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Receptor Binding Affinity (p<i>K</i><sub>i</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a>) and Intrinsic Activities for 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, and 5-HT<sub>1D</sub> Receptors and Functional Inhibition of SerT for Novel Compounds</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-23/jm100714c/production/images/medium/jm-2010-00714c_0002.gif" alt="" id="fx1" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="4" align="center" char=".">p<i>K</i><sub>i</sub></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center" char=".">5-HT<sub>1A</sub> (IA)</th><th class="colsep0 rowsep0" align="center">5-HT<sub>1B</sub> (IA)</th><th class="colsep0 rowsep0" align="center" char=".">5-HT<sub>1D</sub> (IA)</th><th class="colsep0 rowsep0" align="center" char=".">SerT</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">8.6 (inv)</td><td class="colsep0 rowsep0" align="left">8.7 (0.3)</td><td class="colsep0 rowsep0" align="char" char=".">9.3 (0.0)</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">9.6 (0.2)</td><td class="colsep0 rowsep0" align="left">9.3 (0.1)</td><td class="colsep0 rowsep0" align="char" char=".">9.8 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">7.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">7.8 (ND)</td><td class="colsep0 rowsep0" align="left">8.1 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">9.3 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">−SO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">9.1 (0.0)</td><td class="colsep0 rowsep0" align="left">9.1 (0.1)</td><td class="colsep0 rowsep0" align="char" char=".">9.9 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">−SO<sub>2</sub>Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">8.8 (ND)</td><td class="colsep0 rowsep0" align="left">8.7 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">9.2 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">−COMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">9.0 (0.0)</td><td class="colsep0 rowsep0" align="left">9.3 (0.0)</td><td class="colsep0 rowsep0" align="char" char=".">9.6 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">−COEt</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">8.7 (0.0)</td><td class="colsep0 rowsep0" align="left">8.9 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">9.7 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">−CO<sup><i>i</i></sup>Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">8.7 (inv)</td><td class="colsep0 rowsep0" align="left">8.8 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">9.8 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">−CO<sup><i>t</i></sup>Bu</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">8.2 (inv)</td><td class="colsep0 rowsep0" align="left">8.7 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">9.5 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">5.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">−COPh</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">9.0 (inv)</td><td class="colsep0 rowsep0" align="left">8.6 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">9.5 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">5.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">−CO-2-F-Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">9.0 (inv)</td><td class="colsep0 rowsep0" align="left">8.5 (0.0)</td><td class="colsep0 rowsep0" align="char" char=".">9.6 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">6.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">−CO-3-F-Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">9.2 (inv)</td><td class="colsep0 rowsep0" align="left">8.5 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">9.5 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">6.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">−CO-4-F-Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">8.9 (inv)</td><td class="colsep0 rowsep0" align="left">8.3 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">9.4 (0.0)</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">−CO-2-OMe-Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">8.6 (ND)</td><td class="colsep0 rowsep0" align="left">8.4 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">9.2 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">−CO-3-OMe-Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">8.7 (ND)</td><td class="colsep0 rowsep0" align="left">8.8 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">9.8 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">−CO-4-OMe-Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">8.5 (inv)</td><td class="colsep0 rowsep0" align="left">8.4 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">9.3 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">−CO-pyrazin-2-yl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">9.3 (ND)</td><td class="colsep0 rowsep0" align="left">8.9 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">9.7 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">−CO-2-Me-thiazol-4-yl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">9.1 (inv)</td><td class="colsep0 rowsep0" align="left">8.5 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">9.4 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">−CO-4-Me-thiazol-5-yl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">9.4 (inv)</td><td class="colsep0 rowsep0" align="left">8.7 (0.0)</td><td class="colsep0 rowsep0" align="char" char=".">9.6 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">−CONHEt</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">8.7 (0.0)</td><td class="colsep0 rowsep0" align="left">8.9 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">9.8 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">−CONHPr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">8.3 (ND)</td><td class="colsep0 rowsep0" align="left">8.7 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">9.8 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">−CONH<sup><i>t</i></sup>Bu</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">8.1 (ND)</td><td class="colsep0 rowsep0" align="left">8.4 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">9.6 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">−CONHPh</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">8.4 (0.0)</td><td class="colsep0 rowsep0" align="left">8.5 (0.0)</td><td class="colsep0 rowsep0" align="char" char=".">9.5 (0.0)</td><td class="colsep0 rowsep0" align="char" char=".">5.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">−CONH-2-F-Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">8.5 (ND)</td><td class="colsep0 rowsep0" align="left">9 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">9.7 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">5.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">−CONH-3-F-Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">8.4 (0.0)</td><td class="colsep0 rowsep0" align="left">8.4 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">9.2 (0.0)</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">−CONH-4-F-Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">8.6 (ND)</td><td class="colsep0 rowsep0" align="left">8.5 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">9.3 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">−CO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">9.4 (0.0)</td><td class="colsep0 rowsep0" align="left">9.3 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">9.6 (0.0)</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">−CO<sub>2</sub>Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">8.9 (ND)</td><td class="colsep0 rowsep0" align="left">8.9 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">9.9 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">−COMe</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">8.7 (0.1)</td><td class="colsep0 rowsep0" align="left">7.9 (0.2)</td><td class="colsep0 rowsep0" align="char" char=".">9.5 (0.0)</td><td class="colsep0 rowsep0" align="char" char=".">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">−CONHCH<sub>2</sub>CH<sub>2</sub>−</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">9.4 (0.0)</td><td class="colsep0 rowsep0" align="left">8.5 (0.0)</td><td class="colsep0 rowsep0" align="char" char=".">9.7 (0.0)</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">−CONHCH<sub>2</sub> CH<sub>2</sub>CH<sub>2</sub>−</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">8.5 (ND)</td><td class="colsep0 rowsep0" align="left">7.4 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">9.5 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">−CO<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>−</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">9.4 (0.0)</td><td class="colsep0 rowsep0" align="left">8.7 (0.0)</td><td class="colsep0 rowsep0" align="char" char=".">9.8 (inv)</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">−CO<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>−</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">8.6 (ND)</td><td class="colsep0 rowsep0" align="left">7.5 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">9.6 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">−COCH<sub>2</sub>CH<sub>2</sub>CO−</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">8.5 (ND)</td><td class="colsep0 rowsep0" align="left">7.4 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">8.8 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">−NCHCHCH−</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">9.3 (ND)</td><td class="colsep0 rowsep0" align="left">8.8 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">9.8 (ND)</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Radioligand binding assay to determine affinity at human recombinant 5-HT receptors and functional [<sup>3</sup>H]-5-HT uptake assays in rat cortical synaptosomes to determine potency for SerT. Each determination lies within 0.3 log units of the mean with a minimum of three replicates. Values in parentheses are intrinsic activity (IA) values relative to the maximum response elicited by the endogenous agonist 5-HT. inv = inverse agonist behavior was observed. ND = value not determined.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">All compounds were characterized and purity was assessed using <sup>1</sup>H NMR and LCMS.</p></div></div></div><div class="NLM_p">Having verified that such a strategy was valid, we embarked on a broader exploration of the substituent at the 3-position of the phenyl ring. Aniline <b>9</b> reacted smoothly with a variety of electrophiles to generate a series of sulfonamide, amide, urea, and carbamate derivatives. Cyclic urea and carbamate derivatives were accessed by reaction with halogenated isocyanates or chloroformates and subsequent cyclization with sodium hydride. Gratifyingly, the majority of the analogues demonstrated high binding affinities (p<i>K</i><sub>i</sub> > 8) against all three target receptors, including the 5-HT<sub>1B</sub> receptor, which had proven the most elusive in previous pan 5-HT<sub>1</sub> antagonist series.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Moreover, SerT activities were uniformly low such that these analogues all exhibited >100-fold selectivity over SerT as desired. In contrast to our previous experience,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> the nature of the 3-substituent in this series was found to have little or no influence on the intrinsic activities, with all compounds exhibiting silent antagonism (IA = 0.0) or inverse agonism in GTPγS functional assays. Data for a selection of the compounds prepared is shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</div><div class="NLM_p">It is noteworthy that such a large variety of functionalities are well tolerated, suggesting that the substituent at the 3-position does not represent a key pharmacophoric point, yet the intermediate <b>9</b> has modest affinities for 5-HT<sub>1A</sub> and 5-HT<sub>1B</sub> and <i>N</i>-methylation of the acetamide derivative leads to an appreciable drop in 5-HT<sub>1B</sub> affinity (<b>35</b> vs <b>12</b>), indicating that both hydrogen bond acceptor and hydrogen bond donor interactions may be contributing to the high affinities observed. Although there does not appear to be any particular restriction to the size of the substituent that is tolerated in this position, there is a tendency for the smallest substituents to have the highest affinities, especially at the 5-HT<sub>1A</sub> receptor. The marked preference for the 5- vs 6-membered cyclic urea/carbamate derivatives (<b>36</b> vs <b>37</b> and <b>38</b> vs <b>39</b>) is believed to be more a consequence of the spatial orientation of the hydrogen bond acceptor than a result of steric incompatibility.</div><div class="NLM_p">With a large number of compounds satisfying progression criteria in our primary assays, the secondary screening cascade became the principal filter for triaging compounds. Typical in vitro DMPK screening consisting of determining metabolic stability toward rat/human liver microsomes and CYP450 inhibition also proved inefficient in prioritizing between compounds, with essentially all compounds exhibiting good metabolic stability and low CYP450 inhibition (data not shown). However, monitoring metabolic stability in the higher species and screening for off-target selectivity against monoamine targets allowed differentiation of the best molecules for progression into in vivo studies. Data for some representative examples are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. As can be appreciated, selectivity against other 5-HT receptor subtypes and dopamine receptors was generally high, although some specific substitution patterns had modest 5-HT<sub>7</sub> or D3 affinities such that selectivity dropped below 50-fold. On the other hand, affinity toward the human ether-a-go-go-related-gene (hERG) potassium channel and high intrinsic clearance in dog liver microsomes represented an issue for a number of substrates.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Intrinsic Clearance (Cl<sub>int</sub>) in Rat, Human, and Dog Liver Microsomes and in Vitro Cross-Screening (p<i>K</i><sub>i</sub>) in Radioligand Binding Assays<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" colspan="5" align="center" char=".">p<i>K</i><sub>i</sub> 5-HT</th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">p<i>K</i><sub>i</sub> dopamine</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">Cl<sub>int</sub> (mL/min/g) rat/hum/dog</th><th class="colsep0 rowsep0" align="center" char=".">p<i>K</i><sub>i</sub> hERG</th><th class="colsep0 rowsep0" align="center" char=".">clogP<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">2A</th><th class="colsep0 rowsep0" align="center" char=".">2B</th><th class="colsep0 rowsep0" align="center" char=".">2C</th><th class="colsep0 rowsep0" align="center" char=".">6</th><th class="colsep0 rowsep0" align="center" char=".">7</th><th class="colsep0 rowsep0" align="center" char=".">D2</th><th class="colsep0 rowsep0" align="center" char=".">D3</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">1.4/<0.5/14.4</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char="."><5.6</td><td class="colsep0 rowsep0" align="char" char=".">7.0</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">6.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left"><0.5/<0.5/7.7</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="char" char=".">6.6</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char="."><5.4</td><td class="colsep0 rowsep0" align="char" char=".">7.2</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">1.7/2.8/46.0</td><td class="colsep0 rowsep0" align="char" char=".">7.3</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">6.9</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char="."><6.0</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">7.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">0.7/4.9/16.0</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char="."><5.8</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char=".">6.7</td><td class="colsep0 rowsep0" align="char" char=".">6.7</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">1.8/3.1/9.9</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">0.7/1.3/1.3</td><td class="colsep0 rowsep0" align="char" char=".">6.2</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char="."><5.2</td><td class="colsep0 rowsep0" align="char" char=".">7.4</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">6.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">2.0/1.8/18.2</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">5.8</td><td class="colsep0 rowsep0" align="char" char="."><5.2</td><td class="colsep0 rowsep0" align="char" char="."><5.2</td><td class="colsep0 rowsep0" align="char" char="."><5.0</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">7.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">2.3/<0.5/-</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="char" char=".">6.7</td><td class="colsep0 rowsep0" align="char" char=".">6.7</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char="."><5.8</td><td class="colsep0 rowsep0" align="char" char=".">7.6</td><td class="colsep0 rowsep0" align="char" char=".">6.7</td><td class="colsep0 rowsep0" align="char" char=".">7.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">0.7/1.2/5.0</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td><td class="colsep0 rowsep0" align="char" char=".">5.8</td><td class="colsep0 rowsep0" align="char" char="."><5.3</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td><td class="colsep0 rowsep0" align="char" char=".">6.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left"><0.5/1.2/3.8</td><td class="colsep0 rowsep0" align="char" char=".">5.7</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="char" char="."><5.3</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char=".">6.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left"><0.5/3.5/-</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">5.7</td><td class="colsep0 rowsep0" align="char" char="."><5.0</td><td class="colsep0 rowsep0" align="char" char=".">6.9</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">7.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Radioligand binding assay to determine affinity at human recombinant 5-HT, dopamine receptors and hERG channel. Each determination lies within 0.3 log units of the mean with a minimum of two replicates. ND = value not determined.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">All compounds were characterized and purity was assessed using <sup>1</sup>H NMR and LCMS.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Calculated octanol/water partition coefficient using Daylight 4.81 software.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></p></div></div></div><div class="NLM_p">Although low metabolic stability in the dog posed a problem, in that it could potentially preclude the possibility of reaching adequate systemic exposure in toxicological studies, the affinity of compounds toward the hERG channel was a much greater concern. Inhibition of the hERG channel is associated with prolongation of the cardiac QT interval, an effect which is in turn linked to life-threatening ventricular arrhythmias (Torsades de Pointes) in the clinic.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> With the exception of a few outliers, such as the sulphonamide <b>10</b> which presumably has a specific interaction with the channel, the affinity for hERG grew steadily with increasing lipophilicity of the substrate. The substrates with lower hERG affinities, and hence lower lipophilicities, also tended to be those with lower intrinsic clearances, making them the obvious choice for progression into in vivo pharmacokinetic studies.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">In accord with the low intrinsic clearance values measured in vitro and their favorable physicochemical properties, the selection of compounds further profiled in rat pharmacokinetic studies showed low blood clearance, high oral bioavailability, and moderate half-lives (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Additionally, all substrates showed appreciable partitioning into the central nervous system (CNS), confirming their suitability as centrally acting 5-HT<sub>1</sub> antagonists.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Solubility,<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> Pharmacokinetic Properties in Rat<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> and in Vivo Activity in 5-HT<sub>1A</sub>-Agonist Driven Pharmacodynamic (PD) Model in Rat<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="/" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char="/">solubility at pH1.2/pH5.5 (mg/mL)</th><th class="colsep0 rowsep0" align="center" char=".">Cl<sub>b</sub> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i><sub>po</sub> %</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>0−inf</sub> (ng·h/mL)</th><th class="colsep0 rowsep0" align="center" char=".">CNS Br/Bl</th><th class="colsep0 rowsep0" align="center" char=".">hLMA ED<sub>50</sub> (mg/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char="/">>10/0.6</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">56</td><td class="colsep0 rowsep0" align="char" char=".">243</td><td class="colsep0 rowsep0" align="char" char=".">1446</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char="/">>10/5.0</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="char" char=".">51</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char=".">893</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="char" char="/">>10/0.5</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">58</td><td class="colsep0 rowsep0" align="char" char=".">122</td><td class="colsep0 rowsep0" align="char" char=".">889</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">All compounds demonstrated pH dependent solubility profiles. Solubilities are shown for pH 1.2 (simulated gastric fluid, SGF) and pH 5.5 (fed state simulated intestinal fluid, FeSSIF) at 25 °C. The solubilities of the dihydrochloride salts of <b>10</b>, <b>12</b>, and <b>36</b> in water were >10 mg/mL.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">In vivo data were determined with dihydrochloride salts by 0.5 mg/kg iv study in rat; brain/blood ratio was measured after 1 h. Oral bioavailability (<i>F</i><sub>po</sub>) and area under the curve extrapolated to infinity (AUC<sub>0−inf</sub>) were determined by an additional 1 mg/kg po rat PK study.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">In vivo antagonist activity was determined by monitoring the inhibition of the hyperlocomotor activity (hLMA) elicited by sc administration of the 5-HT<sub>1A</sub> agonist 8-OH-DPAT (0.2 mg/kg).</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">All compounds were characterized and purity was assessed using <sup>1</sup>H NMR and LCMS.</p></div></div></div><div class="NLM_p">To establish that the compounds were functionally exerting their pharmacological activity in vivo, they were investigated in a 5-HT<sub>1A</sub> pharmacodynamic (PD) model in rats. In this model, compounds are evaluated for their ability to reverse the hyperlocomotion induced by administration of the selective 5-HT<sub>1A</sub> agonist 8-OH-DPAT (0.2 mg/kg sc). Compounds <b>10</b>, <b>12</b>, and <b>36</b> all demonstrated clear dose-dependent inhibition of the 8-OH-DPAT-induced hyperlocomotor activity (hLMA), with ED<sub>50</sub> values ranging from 0.03 to 1 mg/kg (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). In particular, attention was drawn to the exceptionally high in vivo potency observed for compound <b>36</b>, which was further complemented by the fact that <b>36</b> has the lowest hERG activity seen within the series, ensuring an ample safety margin toward cardiac QT effects.</div><div class="NLM_p">Consequently, more in-depth profiling of compound <b>36</b> was conducted to ascertain its suitability for progression as a potential drug candidate.</div><div class="NLM_p">A low potential for causing drug−drug interactions (DDI) was confirmed with low CYP450 inhibition being observed in the five major human isoforms expressed recombinantly (IC<sub>50</sub>s for Gentest Supersomes, 1A2 = 96 μM, 2C9 = 60 μM, 2C19 = 76 μM, 2D6 = 86 μM, 3A4 = 67 μM) as well as in human liver microsomes (3A4 = 21−30 μM with midazolam, atorvastatin, and nifedipine as probes); furthermore, no evidence of time-dependent inhibition of 3A4 was observed in human liver microsomes with the same probes. Further selectivity screening performed within GlaxoSmithKline as well as a receptorgram screen run at CEREP<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (Diversity profile) evidenced an excellent overall selectivity profile on >200 targets with selectivity falling below 30-fold only against α adrenergic receptors (pIC<sub>50</sub> at rat native receptors, α<sub>1A</sub> = 7.6, α<sub>1B</sub> = 7.6); a follow-up study in rabbit thoracic aorta preparations determined that <b>36</b> was devoid of agonist activity at α<sub>1</sub> receptors, but rather it demonstrated a moderate functional antagonism of the phenylephrine-induced contraction of rabbit aorta (pIC<sub>50</sub> = 6.9). Taking into account the low predicted systemic concentrations at therapeutic doses, this degree of off-target activity was deemed tolerable for progression.</div><div class="NLM_p">The susceptibility of compound <b>36</b> to the P-glycoprotein (P-gp) efflux transporter was evaluated in MDCK cells expressing hMDR1. At 1 μM concentration, the ratio of the apparent permeabilities measured from basolateral-to-apical (BA) to apical-to-basolateral (AB) indicated that <b>36</b> is a moderate P-gp substrate (BA/AB = 2.8; the BA/AB ratio drops to 1.6 in the presence of the specific P-gp inhibitor GF120918).</div><div class="NLM_p">The extent of plasma protein binding was determined in rat, dog, and human plasma by equilibrium dialysis at a concentration of 1 μg/mL showing values of 95.9, 95.5 and 95.9% bound, respectively.</div><div class="NLM_p">Pharmacokinetic studies in higher preclinical species revealed very high blood clearance in dog (>100% of liver blood flow) and consequently low oral bioavailability in this species (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). It is likely that other elimination routes, besides hepatic extraction, are operating in this species. In spite of this, a supraproportional increase in systemic exposure was observed upon increasing the oral dose from 1 to 10 mg/kg, suggesting saturation of the hepatic first-pass metabolism, such that adequate exposures were achieved to be able to consider the dog as a possible toxicological test species. However, higher systemic exposures and a lower, albeit moderate, blood clearance (57% of liver blood flow) were seen in cynomolgus monkey (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), and this species was elected as the second preclinical species for safety assessment studies.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Pharmacokinetic Properties of Compound <b>36</b> in Dog and Cynomolgous Monkey<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">Cl<sub>b</sub> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i><sub>po</sub> %</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>0−inf</sub> (ng·h/mL)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">60</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">1305</td><td class="colsep0 rowsep0" align="char" char=".">2550</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cynomolgus monkey</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="char" char=".">1390</td><td class="colsep0 rowsep0" align="char" char=".">4224</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">In vivo data were determined with the dihydrochloride salt by 0.5 mg/kg iv study in dog and 1.0 mg/kg iv study in cynomolgus monkey. Oral bioavailability (<i>F</i><sub>po</sub>) in dog was determined by an additional 1 mg/kg po dog PK study. Oral bioavailability (<i>F</i><sub>po</sub>) in cynomolgus monkey as well as maximum blood exposure (<i>C</i><sub>max</sub>) and area under the curve extrapolated to infinity (AUC<sub>0−inf</sub>) were determined by additional 10 mg/kg po dog and cynomolgus monkey PK studies.</p></div></div></div><div class="NLM_p last">When doses of compound <b>36</b> were escalated, some behavioral observations were noted in rat and cynomolgus monkey. Starting from 3 mg/kg in rat and 10 mg/kg in cynomolgus monkey, some of the animals treated with compound <b>36</b> were observed to have half-closed eyes and subdued behavior. These effects were temporary and reversible but increased in incidence and severity with increasing dose. It is not believed that these side effects are related to the 5-HT<sub>1A/1B/1D</sub> activity of <b>36</b>, but rather they are assumed to be the consequence of unspecified off-target activities. Although these behavioral side effects were not linked to any toxicological outcome in the animals, they may prudentially be considered a potentially limiting factor. As the systemic exposures associated with these effects (524 ng/mL in rat and 1390 ng/mL in cynomolgus monkey) were much higher than those required for efficacy in animal models of anxiety (ranging from 2 to 30 ng/mL in various rat and primate models), there was an ample therapeutic index to endorse the selection of compound <b>36</b> as a preclinical development candidate.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10265" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10265" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In conclusion, a novel series of selective 5-HT<sub>1</sub> antagonists were prepared via modification of the benzoxazinone moiety of a known dual acting 5-HT<sub>1</sub> antagonist/SSRI structure. The majority of compounds prepared showed potent affinity and low intrinsic activities at the autoreceptors 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, and 5-HT<sub>1D</sub> and high selectivity over SerT. From among these analogues, the cyclic urea derivative, 1-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone <b>36</b> (GSK163090), emerged due to its low hERG affinity and excellent in vitro DMPK profile. The superior quality of <b>36</b> was further highlighted by its commendable in vivo pharmacokinetic profile in rat and its outstanding activity in the 5-HT<sub>1A</sub> PD model, where 50% efficacy was achieved at a blood concentration of 3 ng/mL. On the basis of these results and its promising preclinical developability profile, compound <b>36</b> was selected as an appropriate development candidate for progression toward clinical proof-of-concept studies.</div><div class="NLM_p last">Evidence supporting fast-onset antidepressant/anxiolytic activity of compound <b>36</b> was obtained from both neurochemical studies and validated rodent and primate animal models of anxiety, which will be the subject of a separate publication.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02063" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02063" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> In Vitro Biological Test Methods. Receptor Affinities at Human Recombinant 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, and 5-HT<sub>1D</sub> receptors</h3><div class="NLM_p last">The affinities of the compounds toward the 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, and 5-HT<sub>1D</sub> receptors were determined by the following assay. CHO cells expressing 5-HT<sub>1A</sub> receptors (4 × 10<sup>7</sup> cells/mL) were homogenized in Tris buffer and stored in 1 mL aliquots. CHO cells expressing 5-HT<sub>1B</sub> receptors (4 × 10<sup>7</sup> cells/mL) were homogenized in Tris buffer and stored in 1.5 mL aliquots. CHO cells expressing 5-HT<sub>1D</sub> receptors (1 × 10<sup>8</sup>/mL) were homogenized in Tris buffer and stored in 1 mL aliquots. Then 0.4 mL of a cell suspension is incubated with [<sup>3</sup>H]-5-HT (4nM) for 5-HT<sub>1B/1D</sub> receptors and [<sup>3</sup>H]-WAY100635 (1nM) for 5-HT<sub>1A</sub> receptors in Tris Mg HCl buffer (pH 7.7) and test drug at 37 °C for 45 min. Each test drug is tested at 10 concentrations (0.01−0.3 nM final concentration), with nonspecific binding defined using 0.01 mM 5-HT. The total assay volume is 0.5 mL. Incubation is stopped by rapid filtration using a Packard Filtermate and radioactivity measured by Topcount scintillation counting. p<i>K</i><sub>i</sub> values are calculated from the IC<sub>50</sub> generated by an iterative least-squares curve fitting program.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Functional Activities at Human Recombinant 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, and 5-HT<sub>1D</sub> Receptors</h3><div class="NLM_p last">Intrinsic activities were determined according to the following assay. HEK293 cell membranes stably expressing human 5-HT<sub>1A</sub> receptors and CHO cell membranes stably expressing human 5-HT<sub>1B</sub> or 5-HT<sub>1D</sub> receptors are homogenized in HEPES/EDTA buffer and stored in 1 mL aliquots, and [<sup>35</sup>S]-GTPγS binding studies were carried out essentially as described by Lazareno et al.,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> with some minor modifications. Membranes from 10<sup>6</sup> cells were preincubated at 30 °C for 30 min in 20 mM HEPES buffer (pH 7.4) in the presence of MgCl<sub>2</sub> (3 mM), NaCl (100 mM), GDP (10 μM), and ascorbate (0.2 mM), with or without test compounds. The reaction was started by the addition of 50 μL of [<sup>35</sup>S]-GTPγS (100 pM, assay concentration), followed by a further 30 min incubation at 30 °C. Nonspecific binding was determined using nonradiolabeled GTPγS (20 μM) added prior to the membranes. The reaction was terminated by rapid filtration through Whatman GF/B grade filters. followed by 5 × 1 mL washes with ice cold HEPES (20 mM)/MgCl<sub>2</sub> (3 mM) buffer. Radioactivity was measured using liquid scintillation spectrometry.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Functional Activity for Inhibition of the Serotonin Reuptake Transporter (SerT)</h3><div class="NLM_p last">The efficacy to inhibit the reuptake of serotonin was measured in a 5-HT uptake assay by measurement of uptake of [<sup>3</sup>H]-5-HT into LLCPK cells expressing human serotonin transporters. In brief, cells were harvested and plated onto 96-well plates (10000 cells per well). Twenty-four hours later, cells were washed twice with HBSSH (Hanks’ balanced salt solution +20 mM HEPES). Then 50 μL of test compound or vehicle was added to each well and incubated for 10 min. Subsequently, [<sup>3</sup>H]-5-HT (final concentration 25 nM) was added, and the test mixture was incubated for a further 7 min. The reaction was terminated by aspiration of test mixture, and the cells were washed six times with HBSSH. Scintillation cocktail (50 μL, Microscint-20, Packard) was added to the cells, and the top and bottom of the plate was sealed. Plates were read, 30 min later, in a Packard TopCount instrument.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> hERG [<sup>3</sup>H]-Dofetilide Binding Assay</h3><div class="NLM_p last">hERG activity was measured using [<sup>3</sup>H]-dofetilide binding in a scintillation proximity assay (SPA) format. The activity was measured with a PerkinElmer Viewlux imager.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> DMPK Test Methods. Intrinsic Clearance (Cl<sub>int</sub>) Assay</h3><div class="NLM_p last">Intrinsic clearance (Cl<sub>int</sub>) values were determined in rat, dog, and human liver microsomes. Test compounds (0.5 μM) were incubated at 37 °C for 30 min in 50 mM potassium phosphate buffer (pH 7.4) containing 0.5 mg of microsomal protein/mL. The reaction was started by addition of cofactor (NADPH; 8 mg/mL). The final concentration of solvent was 1% of the final volume. At 0, 3, 6, 9, 15, and 30 min, an aliquot (50 μL) was taken, quenched with acetonitrile containing an appropriate internal standard, and analyzed by HPLC-MS/MS. The intrinsic clearance (Cl<sub>int</sub>) was determined from the first-order elimination constant by nonlinear regression using Grafit v5 (Erithacus software, UK), corrected for the volume of the incubation and assuming 52.5 mg microsomal protein/g liver for all species. Values for Cl<sub>int</sub> were expressed as mL/min/g liver. The lower limit of quantification of clearance was determined to be when <15% of the compound had been metabolized by 30 min, and this corresponded to a Cl<sub>int</sub> value of 0.5 mL/min/g liver. The upper limit was 50 mL/min/g liver.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> CYP450 Inhibition Assay</h3><div class="NLM_p last">Inhibition potential (IC<sub>50</sub>) of test compound for inhibition of human CYP1A2, 2C9, 2C19, 2D6, and 3A4 was determined. A range of concentrations (0.1, 0.33, 1, 3.3, 10, 33, and 100 μM) of test compound prepared in methanol were preincubated at 37 °C for 10 min in 50 mM potassium phosphate buffer (pH 7.4) containing 0.1, 0.16, 0.2, or 0.4 mg recombinant human CYP450 microsomal protein mL<sup>−1</sup> (Gentest Corporation, USA) and substrate. Following preincubation, 25 μL mL<sup>−1</sup> of a NADPH regenerating system (7.8 mg glucose 6-phosphate, 1.7 mg NADP, and 6 U glucose 6-phosphate dehydrogenase mL<sup>−1</sup> 2% w/v NaHCO<sub>3</sub>) was added to each well to start the reaction. Production of fluorescent metabolite was then measured over a 10 min time-course using a Spectrafluor plus plate reader (Tecan). The rate of metabolite production (AFU/min) was determined for each concentration of compound and converted to a percentage of the mean control rate using Magellan v3.0 (Tecan software). The inhibitory potential (IC<sub>50</sub>) was determined from the slope of the plot using Grafit v4.12 (Erithacus software, UK). Miconazole was added as a positive control to each plate.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> CYP450 Inhibition Using Human Liver Microsomes</h3><div class="NLM_p">A range of concentrations (0.1, 0.33, 1, 3.3, 10, 33, and 100 μM) of test compound were prepared in methanol. These were preincubated at 37 °C for 20 min in 50 mM potassium phosphate buffer (pH 7.4) containing pooled human liver microsomal protein (0.1 mg/mL; Xenotech) and CYP3A4 substrate (midazolam, atorvastatin or nifedipine; 2.5, 10, or 50 μM, respectively). To start the reaction, NADPH regenerating system (7.8 mg glucose 6-phosphate, 1.7 mg NADP, and 6 units glucose-6-phosphate dehydrogenase/mL of 2% (w/v) NaHCO<sub>3</sub>; 50 μL/mL) was added. Following a 5 min incubation, reactions were terminated with the addition of 250 μL of acetonitrile.</div><div class="NLM_p last">Quantification of 1′-hydroxy midazolam, <i>o</i>-hydroxy atorvastatin, and oxidized nifedipine metabolites was carried out using validated HPLC-MS analytical methods. Inhibition (IC<sub>50</sub>) was determined using Grafit (Erithacus software, UK).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Metabolism-Dependent Inhibition of CYP3A4 in Human Liver Microsomes</h3><div class="NLM_p">A range of concentrations (0.1, 0.33, 1, 3.3, 10, 33, and 100 μM) of the test compound and troleandomycin (positive control) were prepared in methanol. These were pre-incubated at 37 °C for 20 min in 50 mM potassium phosphate buffer (pH 7.4) containing pooled human liver microsomal protein (0.1 mg/mL; Xenotech) and NADPH regenerating system (7.8 mg glucose 6-phosphate, 1.7 mg NADP, and 6 units glucose-6-phosphate dehydrogenase/mL of 2% (w/v) NaHCO<sub>3</sub>; 50 μL/mL) [Cofactor preincubation samples] or CYP3A4 substrate (midazolam, atorvastatin, or nifedipine; 2.5, 10, or 50 μM, respectively) [substrate preincubation samples]. To start the reaction, CYP3A4 substrate (midazolam, atorvastatin, or nifedipine; 2.5, 10, or 50 μM, respectively) was added to the cofactor preincubation samples and NADPH regenerating system (50 μL/mL) to the substrate preincubation samples. Following 5 min incubation for midazolam and 10 min incubation for atorvastatin or nifedipine, reactions were terminated with the addition of 250 μL of acetonitrile.</div><div class="NLM_p last">Quantification of 1′-hydroxy midazolam, <i>o</i>-hydroxy atorvastatin, and oxidized nifedipine metabolites was carried out using validated HPLC-MS analytical methods. Inhibition (IC<sub>50</sub>) was determined using Grafit (Erithacus software, UK) and TDI assessed, comparing the difference in IC<sub>50</sub> between the cofactor and substrate preincubation samples for each CYP3A4 substrate.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Rat Pharmacokinetics</h3><div class="NLM_p">Test compounds were administered to male Sprague−Dawley rats as cassette. The compounds were dosed intravenous (0.5 mg/kg, 2 mL/kg, 2.5% DMSO in glucosate solution; <i>n</i> = 3 for the iv pharmacokinetic study and <i>n</i> = 3 for the brain penetration study) and po (1 mg/kg, 10 mL/kg, 1% DMSO in aqueous methocel 0.5%, <i>n</i> = 3).</div><div class="NLM_p">In the po and iv pharmacokinetic studies, blood samples were collected at intervals up to 24 h after each administration. In the brain penetration study, at 1 h after intravenous dosing, animals were anaesthetised using carbon dioxide. A blood sample was collected via a heart puncture and the brain removed.</div><div class="NLM_p last">Blood and brain samples were analyzed for test compounds using a method based on protein precipitation followed by LC-MS/MS analysis.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> In Vitro P-Glycoprotein Assay</h3><div class="NLM_p">MDCK cells expressing human MDR1 were used to determine whether test compounds are substrates for human P-glycoprotein (P-gp). Compounds were tested in duplicate in two directions (apical-to-basolateral and basolateral-to-apical) and in the presence and absence of GF120918 (2 μM), a specific inhibitor of P-gp. Amprenavir (1 and 0.5 μM), a known P-gp substrate, was included as positive control. The apparent permeability value (<i>P</i><sub>app</sub>) was measured from the apical (which represents the blood lumen) to the basolateral (which simulates the brain side) compartment (<i>P</i><sub>app</sub> AB) and from basolateral to apical side (<i>P</i><sub>app</sub> BA) in order to determine the BA/AB ratio.</div><div class="NLM_p last">A compound is considered to be a substrate for P-gp when the BA/AB ratio in the absence of GF120918 is greater than 1.8 and is significantly reduced in the presence of GF120918.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> In Vivo Biological Test Methods</h3><div class="NLM_p">All the work involving animals was carried out in accordance with European directive 86/609/EEC governing animal welfare and protection, which is acknowledged by Italian Legislative Decree no. 116, 27 January 1992, and according to internal review performed by the GlaxoSmithKline Committee on Animal Research & Ethics (CARE) and to the company Policy on the Care and Use of Laboratory Animals.</div><div class="NLM_p last">Adult male Sprague−Dawley rats (Charles River, Italy) were group-housed upon arrival and left to acclimatize for at least 5 days in a room controlled for temperature (23 ± 1 °C), humidity (60%), and lighting (12 h light−dark cycle; lights on 0600−1800 h) with ad libitum access to food pellets (Riepper, Italy) and tap water.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Rat Hyperlocomotion 5-HT<sub>1A</sub> Pharmacdynamic Model</h3><div class="NLM_p">Rats (250−350 g at test) were used. Rat locomotory activity was assessed as the total distance (cm) traveled by each rat in the test arena over a 30 min period using Digiscan analyzer system (Omnitech, model RXYZCM-8, Columbus, OH). Rats were placed individually into clear plexiglas boxes, measuring 40 cm × 40 cm × 30.5 cm and covered with a perforated plexiglas lid. Infrared monitoring sensors were located around the perimeter walls. Data were collected and analyzed by a Digiscan analyzer (Omnitech, model DCM-4, Columbus, OH), which in turn transferred information to a computer. Total distance was recorded during 30 min test period.</div><div class="NLM_p">Rats were treated orally (5 mL/kg, body weight) with vehicle or compound <b>36</b> at 0.03, 0.1, or 0.3 mg/kg 60 min before a subcutaneous (sc, 2 mL/kg) injection of 0.2 mg/kg of 8-OH-DPAT, then immediately assessed for their locomotor activity. The standard 5-HT<sub>1A</sub> receptor antagonist WAY-100,635 was also included in the experiment as a positive control (0.03 mg/kg sc 30 min before test). Eight to nine rats in each group of treatment were used.</div><div class="NLM_p last">Drugs: Compound <b>36</b> was suspended in Methocel 0.5% (w/v, HPCM Colorcon, Dow Chemical Company, Midland, MI). 8-OH-DPAT was purchased by Sigma (Italy) and dissolved in saline before use. WAY-100,635 (<i>N</i>-{2-[4-(2-methoxyphenyl)-1-piperaziny]ethyl}-<i>N</i>-(2-pyridinyl) cyclohexane-carboxamide trihydrochloride) was synthesized in-house and dissolved in sterile water before use. All compounds were prepared with correction for salt form such that doses cited refer to mg/kg of active principle.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Chemistry. General Methods</h3><div class="NLM_p">Proton magnetic resonance (NMR) spectra were recorded either on Varian instruments at 300, 400, or 500 MHz, or on a Bruker instrument at 300 MHz. Chemical shifts are reported in ppm (δ) using the residual solvent line as internal standard. Splitting patterns are designed as s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; b, broad. The NMR spectra were recorded at a temperature ranging from 25 to 90 °C. When more than one conformer was detected, the chemical shifts for the most abundant one was reported. Mass spectra (MS) were typically taken on a 4 II triple quadrupole mass spectrometer (Micromass UK) or on a Agilent MSD 1100 mass spectrometer, operating in ES (+) and ES (−) ionization mode or on an Agilent LC/MSD 1100 mass spectrometer, operating in ES (+) and ES (−) ionization mode coupled with HPLC instrument Agilent 1100 series [LC/MS-ES (+): analysis performed on a Supelcosil ABZ +Plus (33 mm × 4.6 mm, 3 μm) (mobile phase, 100% [water + 0.1% HCO<sub>2</sub>H] for 1 min, then from 100% [water + 0.1% HCO<sub>2</sub>H] to 5% [water + 0.1% HCO<sub>2</sub>H] and 95% [CH<sub>3</sub>CN] in 5 min, finally under these conditions for 2 min; <i>T</i> = 40 °C; flux = 1 mL/min; LC/MS-ES: analysis performed on a Supelcosil ABZ +Plus (33 mm × 4.6 mm, 3 μm) (mobile phase: 100% [water +0.05% NH<sub>3</sub>] for 1 min, then from 100% [water +0.05% NH<sub>3</sub> to 5% [water +0.05% NH<sub>3</sub>] and 95% [CH<sub>3</sub>CN] in 5 min, finally under these conditions for 2 min; <i>T</i> = 40 °C; flux = 1 mL/min]]; in the mass spectra, only one peak in the molecular ion cluster is reported.</div><div class="NLM_p">DAD chromatographic traces, mass chromatograms, and mass spectra were taken on a UPLC/MS Acquity system coupled with a Micromass ZQ mass spectrometer operating in ESI positive or negative. The phases used were: (A) H<sub>2</sub>O/ACN 95/5 + 0.1% TFA; (B) H<sub>2</sub>O/ACN 5/95 + 0.1% TFA. The gradient was: <i>t</i> = 0 min) 95%A 5%B, <i>t</i> = 0.25) 95%A 5%B, <i>t</i> = 3.30) 100%B, <i>t</i> = 4.0) 100%B, followed by 1 min of reconditioning. Flash silica gel chromatography was carried out on silica gel 230−400 mesh (supplied by Merck AG Darmstadt, Germany) or over Varian Mega Be−Si prepacked cartridges or over prepacked Biotage silica cartridges. SPE-SCX cartridges were ion exchange solid phase extraction columns supplied by Varian. The eluent used with SPE-SCX cartridges was methanol, followed by 2N ammonia solution in methanol. In a number of preparations, purification was performed using either Biotage manual flash chromatography (Flash+) or automatic flash chromatography (Horizon, SP1) systems. All these instruments work with Biotage Silica cartridges. SPE-Si cartridges were silica solid-phase extraction columns supplied by Varian. Microwave reactions were carried out in a Personal Chemistry Emrys Optimiser (300 W). All reactions were carried out under anhydrous nitrogen or argon atmosphere using standard Schlenk techniques. Most chemicals and solvents were analytical grade and used without further purification.</div><div class="NLM_p last">The purity of the compounds reported in the manuscript was established through HPLC methodology. All the compounds reported in the manuscript have a chemical purity ≥95%.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Chemistry. General Procedures</h3><div class="NLM_p">The general synthetic scheme used for the preparation of the reported compounds is shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Experimental procedures and analytical data for compounds <b>5</b>−<b>41</b> are described below.</div><div id="sec4_14_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 2-Methyl-5-quinolinyl Trifluoromethanesulfonate (<b>5</b>)</h4><div class="NLM_p last">A solution of 2-methyl-quinolin-5-ol (2.5 g; 1 equiv) in dichloromethane (25 mL) and pyridine (6.4 mL; 5 equiv) was cooled to 0 °C, and trifluoromethanesulfonic anhydride (4.2 mL; 1.6 equiv) was added dropwise over 10 min. The reaction mixture was stirred under an inert atmosphere at rt for 1 h, then poured into water (20 mL) and extracted into ethyl acetate (3 × 15 mL). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude was purified by flash chromatography, eluting with ethyl acetate/cyclohexane (4/6), affording the title compound in 92% yield (4.2 g). MS (ES) <i>m</i>/<i>z</i>: 292.3 [MH<sup>+</sup>]. C<sub>11</sub>H<sub>8</sub>F<sub>3</sub>NO<sub>3</sub>S requires 291. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.05 (d, 1 H), 7.85 (d, 1 H), 7.64 (t, 1H), 7.48 (d, 1 H), 7.43 (d, 1 H), 2.48 (s, 3 H).</div></div><div id="sec4_14_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 1,1-Dimethylethyl 4-(2-methyl-5-quinolinyl)-1-piperazinecarboxylate (<b>6</b>)</h4><div class="NLM_p last"><i>tert</i>-Butyl 1-piperazine carboxylate (1.6 g; 1.2 equiv), cesium carbonate (1.7 g; 1.5 equiv), palladium acetate (0.33 g; 0.14 equiv), and 2,2′-bis(diphenylphosphino)-1,1′-binaphthyl (0.97 mg; 0.15 equiv) were added to a solution of intermediate <b>5</b> in toluene (20 mL) under an inert atmosphere. The reaction mixture was stirred at reflux under nitrogen for 8 h. The reaction was quenched at room temperature using a saturated aqueous solution of ammonium chloride (15 mL) and extracted into ethyl acetate (3 × 20 mL). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude was purified by flash chromatography, eluting with ethyl acetate/cyclohexane (3/7), affording the title compound in 62% yield (1.4 g). MS (ES) <i>m</i>/<i>z</i>: 328.4 [MH]<sup>+</sup>. C<sub>19</sub>H<sub>25</sub>N<sub>3</sub>O<sub>2</sub> requires 327. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ (ppm): 8.40 (d, 1 H), 7.76 (d, 1 H), 7.61 (t, 1 H), 7.29 (d, 1 H), 7.06 (d, 1 H), 3.69 (bs, 4 H), 3.03 (bs, 4 H), 2.74 (s, 3 H), 1.51 (s, 9 H).</div></div><div id="sec4_14_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 2-Methyl-5-(1-piperazinyl)quinoline (<b>7</b>)</h4><div class="NLM_p">Intermediate <b>6</b> (1.1 g) in a 25% solution of trifluoroacetic acid in dichloromethane (10 mL) was stirred at rt under an inert atmosphere for 3 h. The reaction mixture was concentrated under reduced pressure and desalted by means of a 20 g SCX cartridge, affording the title compound in 96% yield (0.74 g). MS (ES) <i>m</i>/<i>z</i>: 228.4 [MH]<sup>+</sup>. C<sub>14</sub>H<sub>17</sub>N<sub>3</sub> requires 227. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.34 (d, 1 H), 7.57 (m, 2 H), 7.35 (m, 1 H), 7.06 (m, 1 H), 2.93 (bm, 8 H), 2.62 (s, 3 H).</div><div class="NLM_p last"><b>2-(3-Nitrophenyl)ethyl methanesulfonate</b> used in the synthesis of <b>8</b> was prepared as follows: Methanesulfonyl chloride (0.28 mL) was added dropwise to a stirred solution of 2-(3-nitrophenyl)ethanol (0.5 g; 1 equiv) in dichloromethane (3 mL) and triethylamine (0.5 mL; 1.2 equiv) at 0 °C under an inert atmosphere. The solution was allowed to reach rt and stirred for 5 h. The reaction mixture was diluted with water (3 mL) and extracted into dichloromethane (3 × 3 mL). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude was purified by flash chromatography, eluting with a gradient from dichloromethane to dichloromethane/MeOH (98/2), affording the title compound in 84% yield (0.62 g). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ (ppm): 8.15 (m, 2 H), 7.53 (m, 2 H), 4.45 (t, 2 H), 3,15 (t, 2H), 2.92 (s, 3 H).</div></div><div id="sec4_14_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 2-Methyl-5-{4-[2-(3-nitrophenyl)ethyl]-1-piperazinyl}quinoline (<b>8</b>)</h4><div class="NLM_p last"><i>N</i>,<i>N</i>-Diisopropylethylamine (0.8 mL; 5 equiv) was added to a solution of intermediate <b>7</b> (0.2 g; 1 equiv) and 2-(3-nitrophenyl)ethyl methanesulfonate (0.22; 1 equiv) in dimethylformamide (1.5 mL). The reaction mixture was heated to 100 °C for 10 h. The dark solution was concentrated under reduced pressure, diluted with water (3 mL) and brine (1 mL), and extracted into ethyl acetate (3 × 3 mL). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude was purified by flash chromatography, eluting with a gradient from dichloromethane to dichloromethane/MeOH (98/2), affording the title compound in 64% yield (0.21 g). MS (ES) <i>m</i>/<i>z</i>: 377.4 [MH]<sup>+</sup>. C<sub>22</sub>H<sub>24</sub>N<sub>4</sub>O<sub>2</sub> requires 376. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ (ppm): 8.35 (d, 1 H), 8.11 (s, 1 H), 8.05 (d, 1 H), 7.70 (d, 1 H), 7.55 (m, 2 H), 7.45 (t, 1 H), 7.25 (m, 1 H), 7.05 (d, 1 H), 3.10 (mt, 4 H), 2.95 (bm, 2 H), 2.75 (bm, 6 H), 2.70 (s, 3 H).</div></div><div id="sec4_14_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}aniline (<b>9</b>)</h4><div class="NLM_p last">A solution of intermediate <b>8</b> (0.14 g; 1 equiv) in methanol (3 mL) was added dropwise to a suspension of iron powder (0.07 g; 3.2 equiv) and ammonium chloride (0.1 g; 5.3 equiv) in water (3 mL). The reactants were heated at reflux for 8 h, adding additional amounts of iron powder (total 0.07 g; 3.2 equiv) and ammonium chloride (total 0.1 g; 5.03 equiv) in 3 portions during the reaction. The reaction mixture was filtered using a Millipore filter. The filtrate was concentrated under reduced pressure, diluted with water (5 mL) and a saturated aqueous solution of sodium hydrogen carbonate (2 mL), extracted into ethyl acetate (3 × 5 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure, obtaining the title compound in 84% yield (0.11 g). MS (ES) <i>m</i>/<i>z</i>: 347.4 [MH]<sup>+</sup>. C<sub>22</sub>H<sub>26</sub>N<sub>4</sub> requires 346. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ (ppm): 8.35 (d, 1 H), 7.70 (d, 1 H), 7.55 (t, 1 H), 7.25 (d, 1 H), 7.08 (m, 2 H), 6.65 (md, 1 H), 6.55 (m, 2 H), 3.65 (bs, 2 H), 3.15 (t, 4 H), 2.80 (m, 4 H), 2.75 (s, 3 H), 2.70 (m, 4 H).</div></div><div id="sec4_14_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)methanesulfonamide (<b>10</b>)</h4><div class="NLM_p last">Methanesulfonyl chloride (8 μL; 1.2 equiv) was added dropwise to a solution of intermediate <b>9</b> (0.03 g; 1 equiv) in pyridine (0.5 mL). The reaction was stirred at rt overnight. The reaction mixture was concentrated under reduced pressure, diluted with water (1 mL) and a saturated aqueous solution of sodium hydrogen carbonate (1 mL), extracted into dichloromethane (3 × 2 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude was purified by flash chromatography, eluting with a gradient from dichloromethane to dichloromethane/MeOH (98/2), affording the title compound in 44% yield (0.016 g). MS (ES) <i>m</i>/<i>z</i>: 425.4 [MH]<sup>+</sup>. C<sub>23</sub>H<sub>28</sub>N<sub>4</sub>O<sub>2</sub>S requires 424. <sup>1</sup>H NMR (300 MHz, MeOD) δ (ppm): 8.40 (d, 1 H), 7.55 (m, 2 H), 7.30 (d, 1 H), 7.15 (t, 1 H), 7.10 (m, 2 H), 6.90 (bt, 2 H), 3.05 (bt, 4 H), 2.85 (s, 3 H), 2.83−2.63 (bm, 8 H), 2.60 (s, 3 H).</div></div><div id="sec4_14_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>N</i>-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-1-propanesulfonamide (<b>11</b>)</h4><div class="NLM_p last">The title compound was prepared in 62% yield using a similar procedure to compound <b>10</b> starting from intermediate <b>9</b> and propanesulfonyl chloride. MS (ES) <i>m</i>/<i>z</i>: 453.4 [MH]<sup>+</sup>. C<sub>25</sub>H<sub>32</sub>N<sub>4</sub>O<sub>2</sub>S requires 452. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ (ppm): 8.35 (d, 1 H), 7.70 (d, 1 H), 7.60 (t, 1 H), 7.30 (m, 2 H), 7.1 (m, 2H), 7.01 (d, 1 H), 3.30 (bm, 6 H), 2.80 (bm, 6 H), 2.60 (s, 3 H), 1.80 (m, 2 H), 1.0 (t, 3 H).</div></div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Procedure for the Preparation of Amides and Their Corresponding Dihydrochloride Salts Starting from Intermediate <b>9</b></h3><div id="sec4_15_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Method A</h4><div class="NLM_p last">Triethylamine or diisopropylethylamine (1.7 equiv) and then an acyl chloride (1.5 equiv) were added dropwise to a stirred solution of intermediate <b>9</b> (1 equiv) in dichloromethane at room temperature under an inert atmosphere. The reaction was left under stirring for 16 h. The mixture was then washed with a saturated aqueous solution of NH<sub>4</sub>Cl, a saturated aqueous solution of NaHCO<sub>3</sub>, brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under reduced pressure. The crude material was purified on SPE cartridge (Silica) using as eluent a gradient from dichloromethane/MeOH 99/1 to dichloromethane/MeOH 98/2, affording the final compound (yields ranged from 30 to 80%).</div></div><div id="sec4_15_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Method B</h4><div class="NLM_p">EDC·HCl (1.5 equiv) and HOBt (1.5 equiv) were added sequentially to a stirred solution of a carboxylic acid (1.5 equiv) in dichloromethane/dimethylformamide (1/1) at room temperature. The reaction mixture was left under stirring for 30 min, and then intermediate <b>9</b> (1 equiv) dissolved in dichloromethane/dimethylformamide (1/1) was added dropwise. The solution was stirred for 16 h and then diluted with dichloromethane and washed with a saturated aqueous solution of NaHCO<sub>3</sub> and brine and then dried over Na<sub>2</sub>SO<sub>4</sub>. The solution was concentrated under reduced pressure, and the residual solvent was removed by means of an SCX cartridge. The crude material was purified on SPE cartridge (Silica) eluting from a gradient from dichloromethane/MeOH 99/1 to dichloromethane/MeOH 98/2, affording the final compound (yields ranged from 20 to 96%).</div><div class="NLM_p last">The free base could be converted into its dihydrochloride salt by dissolving the compound in dichloromethane and adding a 1 M ethereal solution of HCl (2.1 equiv) dropwise. A yellow solid precipitated and the suspension was stirred for 15 min. The solvent was removed under reduced pressure, affording a crude material which was triturated with Et<sub>2</sub>O. The final compound was then recovered by filtration (yield quantitative).</div></div><div id="sec4_15_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>N</i>-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)acetamide (<b>12</b>)</h4><div class="NLM_p last">The title compound was prepared in 52% yield according to the general procedure for the preparation of the amides (method A) starting from intermediate <b>9</b> and acetyl chloride. MS (ES) <i>m</i>/<i>z</i>: 389 [MH]<sup>+</sup>. C<sub>24</sub>H<sub>28</sub>N<sub>4</sub>O requires 388. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 9.84 (s, 1 H), 8.33 (d, 1 H), 7.58 (m, 2 H), 7.46 (s, 1 H), 7.39 (m, 2 H), 7.19 (t, 1 H), 7.10 (dd, 1 H), 6.92 (d, 1 H), 3.03 (bm, 4 H), 2.73 (bm, 6 H), 2.62 (s + bm, 5 H), 2.02 (s, 3 H).</div></div><div id="sec4_15_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)propanamide (<b>13</b>)</h4><div class="NLM_p last">The title compound was prepared in 73% yield according to the general procedure for the preparation of the amides (method A) starting from intermediate <b>9</b> and propanoyl chloride. MS (ES/+) <i>m</i>/<i>z</i>: 403 [MH<sup>+</sup>]. C<sub>25</sub>H<sub>30</sub>N<sub>4</sub>O requires 402. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ (ppm): 8.35 (d, 1H), 7.70 (d, 1H), 7.55 (t, 1H), 7.50 (br s, 1H), 7.25 (m, 3H), 7.12 (br, 1H), 7.07 (d, 1H), 6.98 (br d, 1H), 3.20 (br m, 4H), 3.00−2.75 (br m, 8H), 2.73 (s, 3H), 2.37 (q, 2H), 1.23 (t, 3H).</div></div><div id="sec4_15_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2-Methyl-<i>N</i>-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl) propanamide (<b>14</b>)</h4><div class="NLM_p last">The title compound was prepared in 81% yield according to the general procedure for the preparation of the amides (method A) starting from intermediate <b>9</b> and 2-methylpropanoyl chloride. MS (ES/+) <i>m</i>/<i>z</i>: 417 [MH<sup>+</sup>]. C<sub>26</sub>H<sub>32</sub>N<sub>4</sub>O requires 416. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ (ppm): 8.35 (d, 1H), 7.70 (d, 1 H), 7.55 (m, 2H), 7.25 (m, 3H), 7.13 (br s, 1H), 7.08 (d, 1H), 6.98 (br d, 1H), 3.20 (br m, 4H), 3.00−2.75 (br m, 8 H), 2.73 (s, 3H), 2.48 (m, 1H), 1.25 (d, 6H).</div></div><div id="sec4_15_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2,2-Dimethyl-<i>N</i>-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl) propanamide (<b>15</b>)</h4><div class="NLM_p last">The title compound was prepared in 66% yield according to the general procedure for the preparation of the amides (method A) starting from intermediate <b>9</b> and 2,2-dimethylpropanoyl chloride. MS (ES/+) <i>m</i>/<i>z</i>: 431 [MH<sup>+</sup>]. C<sub>27</sub>H<sub>34</sub>N<sub>4</sub>O requires 430. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ (ppm): 8.35 (d, 1H), 7.70 (d, 1H), 7.55 (t, 2H), 7.30−7.20 (m, 4H), 7.10 (d, 1H), 7.00 (m, 1H), 3.20 (br s, 4H), 2.85 (br s, 8H), 2.70 (s, 3H), 1.30 (s, 9H).</div></div><div id="sec4_15_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>N</i>-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)benzamide (<b>16</b>)</h4><div class="NLM_p last">The title compound was prepared in 60% yield according to the general procedure for the preparation of the amides (method A) starting from intermediate <b>9</b> and benzoyl chloride. MS (ES/+) <i>m</i>/<i>z</i>: 451 [MH<sup>+</sup>]. C<sub>29</sub>H<sub>30</sub>N<sub>4</sub>O requires 450. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ (ppm): 8.35 (d, 1H), 7.87 (m, 2H), 7.80 (br s, 1H), 7.72 (d, 1H), 7.65 (br s, 1H), 7.6−7.4 (m, 5H), 7.30 (t, 1H), 7.27 (m, 1H), 7.08 (d, 1H), 7.05 (d, 1H), 3.18 (br s, 4H), 3.00−2.75 (br m, 8H), 2.72 (s, 3H).</div></div><div id="sec4_15_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2-Fluoro-<i>N</i>-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl) Benzamide Dihydrochloride Salt (<b>17</b>)</h4><div class="NLM_p last">The title compound was prepared in 96% yield according to the general procedure for the preparation of the amides (method B) starting from intermediate <b>9</b> and 2-fluorobenzoic acid. MS (ES/+) <i>m</i>/<i>z</i>: 469 [MH<sup>+</sup>]. C<sub>29</sub>H<sub>29</sub>FN<sub>4</sub>O requires 468. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 11.00 (br s, 1H), 10.46 (s. 1H), 8.80 (br s, 1H), 8.00−7.72 (m, 4H), 7.65 (t, 1H), 7.58 (q, 1H), 7.52 (d, 1H), 7.73 (br s, 1H), 7.37−7.32 (m, 3H), 7.08 (d, 1H), 3.74 (d, 2H), 3.7−3.3 (m, 9H), 3.15 (m, 2H), 2.88 (s, 3H).</div></div><div id="sec4_15_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 3-Fluoro-<i>N</i>-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl) Benzamide Dihydrochloride Salt (<b>18</b>)</h4><div class="NLM_p last">The title compound was prepared in 91% yield according to the general procedure for the preparation of the amides (method B) starting from intermediate <b>9</b> and 3-fluorobenzoic acid. HPLC/MS (ES/+): <i>t</i><sub>R</sub>= 6.45 min; assay >99% a/a; <i>m</i>/<i>z</i>: 469 [MH<sup>+</sup>]. C<sub>29</sub>H<sub>29</sub>FN<sub>4</sub>O requires 468. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 11.18 (br s, 1H), 10.41 (s, 1H), 8.94 (br s, 1H), 7.97 (br s, 2H), 7.87 (br s, 2H), 7.80 (m, 2H), 7.62 (m, 2H), 7.48 (m, 2H), 7.10 (d, 1H), 3.80−3.30 (m, 10H), 3.18 (m, 2H), 2.92 (br s, 3H).</div></div><div id="sec4_15_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 4-Fluoro-<i>N</i>-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl) Benzamide Dihydrochloride Salt (<b>19</b>)</h4><div class="NLM_p last">The title compound was prepared in 82% yield according to the general procedure for the preparation of the amides (method B) starting from intermediate <b>9</b> and 4-fluorobenzoic acid. HPLC/MS (ES/+): <i>t</i><sub>R</sub> = 6.45 min; assay 98.2% a/a; <i>m</i>/<i>z</i>: 469 [MH<sup>+</sup>]. C<sub>29</sub>H<sub>29</sub>FN<sub>4</sub>O requires 468. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 11.29 (br s, 1H), 10.36 (s, 1H), 8.96 (br s, 1 H), 8.08 (m, 2H), 7.99 (br s, 1H), 7.86 (br s, 1H), 7.62 (d, 1H), 7.47 (br d, 1H), 7.40 (m, 3H), 7.09 (d, 1H), 3.70−3.30 (m, 10H), 3.18 (dd, 2H), 2.93 (br s, 3H).</div></div><div id="sec4_15_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 2-(Methyloxy)-<i>N</i>-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl) Benzamide Dihydrochloride Salt (<b>20</b>)</h4><div class="NLM_p last">The title compound was prepared in 85% yield according to the general procedure for the preparation of the amides (method B) starting from intermediate <b>9</b> and 2-(methyloxy)benzoic acid. HPLC/MS (ES/+): <i>t</i><sub>R</sub>= 6.54 min; assay >99% a/a; <i>m</i>/<i>z</i>: 481 [MH+]. C<sub>30</sub>H<sub>30</sub>N<sub>4</sub>O<sub>2</sub> requires 480. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 11.13 (br s, 1H), 10.17 (s, 1H), 8.93 (br s, 1H), 7.97 (s, 2H), 7.86−7.78 (br s, 1H), 7.64 (dd, 1H), 7.58−7.50(m, 2H), 7.47 (br s, 1H), 7.36 (t, 1H), 7.21 (d, 1H), 7.09 (dt, 1H), 7.07 (d, 1H), 3.92 (s, 3H), 3.76 (d, 2H), 3.70−3.30 (m, 8H), 3.17 (m, 2H), 2.91(br s, 3H).</div></div><div id="sec4_15_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 3-(Methyloxy)-<i>N</i>-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl) Benzamide Dihydrochloride Salt (<b>21</b>)</h4><div class="NLM_p last">The title compound was prepared in 83% yield according to the general procedure for the preparation of the amides (method B) starting from intermediate <b>9</b> and 3-(methyloxy)benzoic acid. HPLC/MS (ES/+): <i>t</i><sub>R</sub>= 6.39 min; assay >99% a/a; <i>m</i>/<i>z</i>: 481[MH<sup>+</sup>]. C<sub>30</sub>H<sub>30</sub>N<sub>4</sub>O<sub>2</sub> requires 480. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 11.88 (br s, 1H), 10.30 (s, 1H), 8.86 (br s, 1H), 7.91 (br s, 2H), 7.87 (br s, 1H), 7.78 (br s, 2H), 7.63 (dd, 1H), 7.56 (d, 1H), 7.51 (m, 1H), 7.47 (t, 1H), 7.47 (br s, 1H), 7.38 (t, 1H), 7.19 (dm, 1H), 7.09 (d, 1H), 3.86 (s, 3H), 3.76 (d, 2H), 3.70−3.25 (m, 8H), 3.17 (m, 2H), 2.88 (br s, 3H).</div></div><div id="sec4_15_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 4-(Methyloxy)-<i>N</i>-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl) Benzamide Dihydrochloride Salt (<b>22</b>)</h4><div class="NLM_p last">The title compound was prepared in 83% yield according to the general procedure for the preparation of the amides (method B) starting from intermediate <b>9</b> and 4-(methyloxy)benzoic acid. HPLC/MS (ES/+): <i>t</i><sub>R</sub> = 6.21 min; assay >99% a/a; <i>m</i>/<i>z</i>: 481 [MH<sup>+</sup>]. C<sub>30</sub>H<sub>30</sub>N<sub>4</sub>O<sub>2</sub> requires 480. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 11.09 (br s, 1H), 10.16 (s, 1H), 8.91 (br s, 1H), 7.97 (d, 2H), 7.94 (br s, 2H), 7.84 (s, 1H), 7.81 (br s, 1H), 7.60 (d, 1H), 7.44 (br s, 1H), 7.34 (t, 1H), 7.05 (m, 3H), 3.83 (s, 3H), 3.74 (br d, 2H), 3.60−3.40 (m, 6H), 3.33 (br t, 2H), 3.14 (dd, 2H), 2.89 (br s, 3H).</div></div><div id="sec4_15_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-pyrazine Carboxamide (<b>23</b>)</h4><div class="NLM_p last">The title compound was prepared in 89% yield according to the general procedure for the preparation of the amides (method B) starting from intermediate <b>9</b> and 2-pyrazinecarboxylic acid. MS (ES/+) <i>m</i>/<i>z</i>: 453 [MH<sup>+</sup>]. C<sub>27</sub>H<sub>28</sub>N<sub>6</sub>O requires 452. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ (ppm): 9.65 (s, 1H), 9.50 (m, 1H), 8.80 (d, 1H), 8.60 (t, 1H) 8.38 (d, 1H), 7.75 (d, 1H), 7.70 (d, 1H), 7.58 (t, 1H), 7.55 (dd, 1H), 7.35 (t, 1H), 7.28 (d, 1H), 7.08 (m, 2H), 3.15 (br s, 4H) 2.95−2.70 (m, 8H), 2.70 (br s, 3H).</div></div><div id="sec4_15_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 2-Methyl-<i>N</i>-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-1,3-thiazole-4-carboxamide Dihydrochloride Salt (<b>24</b>)</h4><div class="NLM_p last">The title compound was prepared in 52% yield according to the general procedure for the preparation of the amides (method B) starting from intermediate <b>9</b> and 2-methyl-1,3-thiazole-4-carboxylic acid. MS (ES/+) <i>m</i>/<i>z</i>: 472 [MH<sup>+</sup>]. C<sub>27</sub>H<sub>29</sub>N<sub>5</sub>OS requires 471. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.70 (br s, 1H), 10.15 (s, 1H), 8.77 (br s, 1H), 8.26 (s, 1H), 7.87 (br s, 1H), 7.75−7.85 (m, 2H), 7.39 (br s, 1H), 7.34 (t, 1H), 7.06 (d, 1H), 3.80−3.20 (m, 10H), 3.12 (dd, 2H), 2.83 (br s, 3H), 2.76 (s, 3H).</div></div><div id="sec4_15_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 4-Methyl-<i>N</i>-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-1,3-thiazole-5-carboxamide Dihydrochloride Salt (<b>25</b>)</h4><div class="NLM_p last">The title compound was prepared in 46% yield according to the general procedure for the preparation of the amides (method B) starting from intermediate <b>9</b> and 4-methyl-1,3-thiazole-5-carboxylic acid. MS (ES/+) <i>m</i>/<i>z</i>: 472 [MH<sup>+</sup>]. C<sub>27</sub>H<sub>29</sub>N<sub>5</sub>OS requires 471. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.83 (br s, 1H), 10.28 (s, 1H), 9.13 (s, 1H), 8.86 (br s, 1H), 7.90 (br s, 2H), 7.80−7.74 (br s-s, 2H), 7.50 (d, 1H), 7.43 (br s, 1H), 7.35 (t, 1H), 7.08 (d, 1H), 3.9−3.2 (m, 10H), 3.13 (dd, 2H), 2.87 (br s, 3H), 2.61 (s, 3H).</div></div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> General Procedure for the Preparation of Ureas and Their Corresponding Dihydrochloride Salts Starting from Intermediate <b>9</b></h3><div id="sec4_16_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Method C</h4><div class="NLM_p">An isocyanate was added to a stirred solution of intermediate <b>9</b> (1 equiv) in dichloromethane at room temperature under an inert atmosphere, and the reaction was left under stirring for 16 h. The solution was then poured into water and extracted with dichloromethane, the organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under reduced pressure. The crude material was purified on SPE cartridge (Silica) using a gradient from dichloromethane to dichloromethane/MeOH 95/5 as eluent, affording the final compound (yields ranged from 30 to 80%).</div><div class="NLM_p last">The free base could be converted into its dihydrochloride salt by dissolving the compound in dichloromethane and adding a 1 M ethereal solution of HCl (2.1 equiv) dropwise. A yellow solid precipitated and the suspension was stirred for 15 min. The solvent was removed under reduced pressure, affording a crude material which was triturated with Et<sub>2</sub>O. The final compound was then recovered by filtration (yield quantitative).</div></div><div id="sec4_16_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-Ethyl-<i>N</i>′-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)urea Dihydrochloride (<b>26</b>)</h4><div class="NLM_p last">The title compound was prepared in 95% yield according to the general procedure for the preparation of ureas (method C) starting from intermediate <b>9</b> and isocyanatoethane. MS (ES/+) <i>m</i>/<i>z</i>: 418 [MH<sup>+</sup>] C<sub>25</sub>H<sub>31</sub>N<sub>5</sub>O requires 417. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.89 (bs, 1 H), 8.60 (bs, 1 H), 8.90 (s, 1 H), 7.92 (bs, 2 H), 7.80 (bs, 1 H), 7.44 (s, 2 H), 7.19 (m, 2 H), 6.81 (m, 1 H), 3.71 (d, 2 H), 3.6−3.2 (m, 10 H), 3.07 (m, 2 H), 2.87 (bs, 3 H), 1.02 (t, 3 H).</div></div><div id="sec4_16_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-<i>N</i>′-propylurea dihydrochloride (<b>27</b>)</h4><div class="NLM_p last">The title compound was prepared in 53% yield according to the general procedure for the preparation of ureas (method C) starting from intermediate <b>9</b> and 1-isocyanatopropane. MS (ES/+) <i>m</i>/<i>z</i>: 432 [MH<sup>+</sup>] C<sub>26</sub>H<sub>33</sub>N<sub>5</sub>O requires 431. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.5 (bs, 1 H), 8.75 (bs, 1 H), 8.54 (s, 1H), 7.83 (bs, 2 H), 7.7 (bs, 1 H), 7.45 (s, 1 H), 7.38 (bs, 1 H), 7.18 (m, 2 H), 6.81 (d, 1 H), 6.23 (bt, 1 H), 3.7−3.25 (bd, 4 H), 3.6−3.3 (m, 4 H), 3.4−3.02 (m, 6 H), 2.81 (bs, 3 H), 1.41 (m, 2 H), 0.85 (t, 3 H).</div></div><div id="sec4_16_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i>-(1,1-Dimethylethyl)-<i>N</i>′-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)urea Dihydrochloride (<b>28</b>)</h4><div class="NLM_p last">The title compound was prepared in 79% yield according to the general procedure for the preparation of ureas (method C) starting from intermediate <b>9</b> and 2-isocyanato-2-methylpropane. MS (ES/+) <i>m</i>/<i>z</i>: 446 [MH<sup>+</sup>] C<sub>27</sub>H<sub>35</sub>N<sub>5</sub>O requires 445. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.48 (bs, 1 H), 8.75 (bs, 1 H), 8.37 (s, 1H), 7.83 (bs, 2 H), 7.7 (bs, 1 H), 7.51 (s, 1 H), 7.38 (bs, 1 H), 7.17 (t, 1 H), 7.04 (dd, 1 H), 6.79 (d, 1 H), 6.08 (s, 1 H), 3.71−3.24 (bd, bt, 4 H), 3.6−3.3 (m, 4 H), 3.40 (m, 2 H), 3.02 (m, 2 H), 2.81 (bs, 3 H), 1.27 (s, 9 H).</div></div><div id="sec4_16_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>N</i>-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-<i>N</i>′-phenylurea Dihydrochloride (<b>29</b>)</h4><div class="NLM_p last">The title compound was prepared in 73% yield according to the general procedure for the preparation of ureas (method C) starting from intermediate <b>9</b> and isocyanatobenzene. MS (ES/+) <i>m</i>/<i>z</i>: 466 [MH<sup>+</sup>] C<sub>29</sub>H<sub>31</sub>N<sub>5</sub>O requires 465. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.4 (bs, 1 H), 8.95 (bd, 2 H), 8.75 (bs, 1 H), 7.83 (bs, 2 H), 7.7 (bs, 1 H), 7.54 (s, 1 H), 7.45 (dd, 2 H), 7.38 (bs, 1 H), 7.27 (m, 4 H), 6.96(m, 1 H), 6.91 (m, 1 H), 3.73 (bd, 2 H), 3.6−3.3(m, 6 H), 3.24 (t, 2 H), 3.08 (dd, 2 H), 2.81 (bs, 3 H).</div></div><div id="sec4_16_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>N</i>-(2-Fluorophenyl)-<i>N</i>′-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)urea Dihydrochloride (<b>30</b>)</h4><div class="NLM_p last">The title compound was prepared in 75% yield according to the general procedure for the preparation of ureas (method C) starting from intermediate <b>9</b> and 1-fluoro-2-isocyanatobenzene. MS (ES/+) <i>m</i>/<i>z</i>: 484 [MH<sup>+</sup>] C<sub>29</sub>H<sub>30</sub>FN<sub>5</sub>O requires 483. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10. 9 (bs, 1 H), 9.36 (s, 1 H), 8.8 (bs, 1H), 8.67 (s, 1 H), 8.11 (t, 1 H), 7.86 (bs, 2H), 7.71 (bs, 1 H), 7.49 (d, 1 H), 7.37 (bs, 1 H), 7.26 (m, 2 H), 7.20 (dd, 1 H), 7.07 (dd, 1 H), 6.98 (m, 1 H), 6.90 (m, 1 H), 3.69 (d, 2 H), 3.5−3.2(m, 8 H), 3.09 (m, 2 H), 2.82 (bs, 3 H).</div></div><div id="sec4_16_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>N</i>-(3-Fluorophenyl)-<i>N</i>′-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)urea Dihydrochloride (<b>31</b>)</h4><div class="NLM_p last">The title compound was prepared in 48% yield according to the general procedure for the preparation of ureas (method C) starting from intermediate <b>9</b> and 1-fluoro-3-isocyanatobenzene. MS (ES/+) <i>m</i>/<i>z</i>: 484 [MH<sup>+</sup>] C<sub>29</sub>H<sub>30</sub>FN<sub>5</sub>O requires 483. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.7 (bs, 1 H), 9.47 (s, 1 H), 9.24 (s, 1H), 8.75 (bs, 1 H), 7.81 (bs, 2 H), 7.68 (bs, 1H), 7.50 (d+bs, 2 H), 7.44 (bs, 1 H), 7.31 (t, 1 H), 7.3−7.24 (m, 2 H), 7.09 (d, 1 H), 6.89 (d, 1 H), 6.74 (td, 1 H), 3.7−3.2(m, 10 H), 3.07 (m, 2 H), 2.8 (bs, 3 H).</div></div><div id="sec4_16_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i>-(4-Fluorophenyl)-<i>N</i>′-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)urea Dihydrochloride (<b>32</b>)</h4><div class="NLM_p last">The title compound was prepared in 64% yield according to the general procedure for the preparation of ureas (method C) starting from intermediate <b>9</b> and 1-fluoro-4-isocyanatobenzene. MS (ES/+) <i>m</i>/<i>z</i>: 484 [MH<sup>+</sup>]. C<sub>29</sub>H<sub>30</sub>FN<sub>5</sub>O requires 483. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.49 (bs, 1 H), 9.40 (s, 1 H), 8.96 (s, 1H), 8.77 (bs, 1 H), 7.83 (bs, 2 H), 7.71 (bs, 1H), 7.51(bs, 1 H), 7.45 (dd, 2 H), 7.37 (bs, 1 H), 7.25 (bd, 2 H), 7.10 (t, 2 H), 6.90 (bt, 1 H), 3.8−3.2(m, 10 H), 3.06 (dd, 2 H), 2.81 (bs, 3 H).</div></div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> General Procedure for the Preparation of Carbamates and Their Corresponding Dihydrochloride Salts Starting from Intermediate <b>9</b></h3><div id="sec4_17_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Method D</h4><div class="NLM_p">Diisopropylethylamine (1.5 equiv) and a chloroformate (1.2 equiv) were added sequentially to a stirred solution of intermediate <b>9</b> (1 equiv) in dichloromethane at 0 °C. The solution was stirred for 1 h at room temperature and then diluted with dichloromethane and washed with a saturated aqueous solution of NH<sub>4</sub>Cl and brine and then dried over Na<sub>2</sub>SO<sub>4</sub>. The solution was concentrated under reduced pressure. The crude material was purified on SPE cartridge (Silica) eluting with a gradient from dichloromethane/MeOH 99/1 to dichloromethane/MeOH 98/2, affording the final compound (yields ranged from 43 to 78%).</div><div class="NLM_p last">The free base could be converted into its dihydrochloride salt by dissolving the compound in dichloromethane and adding a 1 M ethereal solution of HCl (2.1 equiv) dropwise. A yellow solid precipitated and the suspension was stirred for 15 min. The solvent was removed under reduced pressure affording a crude material which was triturated with Et<sub>2</sub>O. The final compound was then recovered by filtration (yield quantitative).</div></div><div id="sec4_17_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Methyl (3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)carbamate (<b>33</b>)</h4><div class="NLM_p last">The title compound was prepared in 41% yield according to the general procedure for the preparation of carbamates (method D) starting from intermediate <b>9</b> and methyl chloroformate. MS (ES) <i>m</i>/<i>z</i>: 405.4 [MH]<sup>+</sup>. C<sub>24</sub>H<sub>28</sub>N<sub>4</sub>O<sub>2</sub> requires 404. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ (ppm): 8.33 (d, 1 H), 7.70 (d, 1 H), 7.6 (t, 1 H), 7.30 (bs, 1 H), 7.25 (t, 1 H), 7.22 (dd, 1 H), 7.20 (d, 1 H), 7.10 (d, 1 H), 6.95 (dd, 1 H), 6.55 (bs, 1 H), 3.8 (s, 3 H), 3.28 (bm, 4 H), 3.28 (t, 2 H), 2.85 (t, 2 H), 2.75 (bm, 4 H), 2.66 (s, 3 H).</div></div><div id="sec4_17_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Ethyl (3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)carbamate Fihydrochloride (<b>34</b>)</h4><div class="NLM_p last">The title compound was prepared in 79% yield according to the general procedure for the preparation of carbamates (method D) starting from intermediate <b>9</b> and ethyl chloroformate. MS (ES) <i>m</i>/<i>z</i>: 419 [MH<sup>+</sup>]. C<sub>25</sub>H<sub>30</sub>N<sub>4</sub>O<sub>2</sub> requires 418. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 11.00 (bs, 1H), 9.74 (s, 1H), 8.95 (s, 1H), 8.00 (s, 2H), 7.87 (s, 1H), 7.57 (s, 1H), 7.51 (bs, 1H), 7.36 (m, 2H), 7.02 (d, 1H), 4.21 (q, 2H), 3.80 (d, 2H), 3.7−3.3 (m 8H), 3.17 (m, 2H), 2.96 (bs, 3H), 1.33 (t, 3H).</div></div><div id="sec4_17_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>N</i>-Methyl-<i>N</i>-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl) Acetamide (<b>35</b>)</h4><div class="NLM_p last">A solution of intermediate <b>12</b> (50 mg) was dissolved in THF (2.5 mL), and sodium hydride (60% w/w oil dispersion, 0.005 g, 1 equiv) was added at 0 °C. After 5 min, iodomethane was added (5 μL, 1.0 equiv), and the mixture was warmed to room temperature. After 10 h, the solution was partitioned between water (3 mL) and ethyl acetate (3 × 5 mL). The combined organic extracts were washed with brine, dried over sodium sulfate, and concentrated under vacuum. The crude was purified by flash chromatography on silica gel, eluting with a gradient from dichloromethane to dichloromethane−methanol (98:2), affording the title compound in 61% yield (0.02 g). MS (ES) <i>m</i>/<i>z</i>: 403.4 [MH<sup>+</sup>]. C<sub>25</sub>H<sub>31</sub>ClNO<sub>4</sub> requires 402. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.85 (bs, 1H), 8.79 (bs, 1H), 8−7 (bm, 16H), 3.8−3.0 (bm, 15H), 2.84 (bs, 3H), 1.79 (bs, 3H).</div></div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> General Procedure for the Synthesis of Cyclic Ureas and Carbamates and Their Corresponding Dihydrochloride Salts Starting from Intermediate <b>9</b></h3><div id="sec4_18_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Method E</h4><div class="NLM_p">Diisopropylethylamine (1.5 equiv) and a chloroformate or isocyanate (1.2eq) were added sequentially to a stirred solution of intermediate <b>9</b> (1 equiv) in dichloromethane at 0 °C. The solution was stirred for 1 h at room temperature and then diluted with dichloromethane and washed with a saturated aqueous solution of NH<sub>4</sub>Cl and brine and then dried over Na<sub>2</sub>SO<sub>4</sub>. The solution was concentrated under reduced pressure. The crude material was dissolved in dimethylformamide, cooled to 0 °C, and NaH (1.1 equiv) was added portionwise under an inert atmosphere. The mixture was stirred for 2 h at room temperature, and then the solvent was removed by means of an SCX cartridge. The crude material was purified on SPE cartridge (Silica) eluting with a gradient from dichloromethane/MeOH 99/1 to dichloromethane/MeOH 98/2, affording the final compound (yields ranged from 22 to 87%).</div><div class="NLM_p last">The free base could be converted into its dihydrochloride salt by dissolving the compound in Et<sub>2</sub>O and MeOH and adding an 1 M ethereal solution of HCl (2.1 equiv) dropwise. A yellow solid precipitated, and the suspension was stirred for 15 min. The solvent was removed under reduced pressure, affording a crude material which was triturated with Et<sub>2</sub>O. The final compound was then recovered by filtration (yield quantitative).</div></div><div id="sec4_18_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 1-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone Dihydrochloride (<b>36</b>)</h4><div class="NLM_p last">The title compound was prepared in 22% yield according to the general procedure for the synthesis of cyclic ureas and carbamates (method E) starting from intermediate <b>9</b> and 1-chloro-2-isocyanatoethane. MS (ES) <i>m</i>/<i>z</i>: 416 [MH<sup>+</sup>]. C<sub>25</sub>H<sub>29</sub>N<sub>5</sub>O requires 415. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.60 (bs, 1H), 8.77 (s, 1H), 7.85 (s, 2H), 7.71 (s, 1H), 7.59 (s, 1H), 7.38 (dd, 1H), 7.28 (t, 1H), 6.96 (bs, 1H), 6.92 (d, 1H), 3.83 (m, 2H), 3.71 (d, 2H), 3.7−3.2 (m, 10H), 3.08 (m, 2H), 2.82 (bs, 3H).</div></div><div id="sec4_18_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 1-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)tetrahydro-2(1<i>H</i>)-pyrimidinone Dihydrochloride (<b>37</b>)</h4><div class="NLM_p last">The title compound was prepared in 87% yield according to the general procedure for the synthesis of cyclic ureas and carbamates (method E) starting from intermediate <b>9</b> and 1-chloro-3-isocyanatopropane. MS (ES) <i>m</i>/<i>z</i>: 430 [MH<sup>+</sup>]. C<sub>26</sub>H<sub>31</sub>N<sub>5</sub>O requires 429. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 11.05 (bs, 1H), 8.94 (s, 1H), 7.97 (s, 2H), 7.84 (d, 1H), 7.46 (bs, 1H), 7.30 (m, 2H), 7.19 (dd, 1H), 7.08 (d, 1H), 6.58 (s, 1H), 3.70 (bm, 4H), 3.63 (t, 2H), 3.6−3.3 (bm, 6H), 3.24 (t, 2H), 3.12 (m, 2H), 2.91 (s, 3H), 1.95 (t, 2H).</div></div><div id="sec4_18_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 3-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-1,3-oxazolidin-2-one Dihydrochloride (<b>38</b>)</h4><div class="NLM_p last">The title compound was prepared in 81% yield according to the general procedure for the synthesis of cyclic ureas and carbamates (method E) starting from intermediate <b>9</b> and (2-bromoethyl)carbamic chloride. MS (ES) <i>m</i>/<i>z</i>: 417 [MH<sup>+</sup>]. C<sub>25</sub>H<sub>28</sub>N<sub>4</sub>O<sub>2</sub> requires 416. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.99 (bs, 1H), 8.87 (bm, 1H), 7.91 (bm, 2H), 7.79 (bm, 1H), 7.57 (s, 1H), 7.40 (m, 3H), 7.08 (d, 1H), 4.43 (t, 2H), 4.07 (t, 2H), 3.72−3.3 (m, 10H), 3.15 (m, 2H), 2.87 (bs, 3H).</div></div><div id="sec4_18_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 3-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)tetrahydro-2<i>H</i>-1,3-oxazin-2-one Dihydrochloride (<b>39</b>)</h4><div class="NLM_p last">The title compound was prepared in 75% yield according to the general procedure for the synthesis of cyclic ureas and carbamates (method E) starting from intermediate <b>9</b> and (3-chloropropyl)carbamic chloride. MS (ES) <i>m</i>/<i>z</i>: 431 [MH<sup>+</sup>]. C<sub>26</sub>H<sub>30</sub>N<sub>4</sub>O<sub>2</sub> requires 430. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.89 (bs, 1H), 8.84 (bm, 1H), 7.89 (bm, 2H), 7.76 (bm, 1H), 7.40 (m, 4H), 7.31 (s, 1H), 4.32 (t, 2H), 3.72−3.3 (m, 10H), 3.66 (t, 2H), 3.13 (m, 2H), 2.85 (bs, 3H), 2.10 (m, 2H).</div></div><div id="sec4_18_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 1-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2,5-pyrrolidinedione (<b>40</b>)</h4><div class="NLM_p">Dihydro-2,5-furandione (2 equiv) was added to a stirred solution of intermediate (<b>9</b>) (1 equiv) in toluene/pyridine (3:2) at room temperature under an inert atmosphere. The solution was stirred for 30 min at room temperature and then irradiated in a microwave reactor (PersonalChemistry Emrys Optimiser, 300W, 170 °C, 20 min, 4 cycles), diluted with dichloromethane, and washed with a saturated aqueous solution of NH<sub>4</sub>Cl and brine and then dried over Na<sub>2</sub>SO<sub>4</sub>. The solution was concentrated under reduced pressure. The crude material was purified on SPE cartridge (Silica) eluting with a gradient from dichloromethane/MeOH 99/1 to dichloromethane/MeOH 98/2, affording the final compound in 76% yield.</div><div class="NLM_p">The free base was converted into its dihydrochloride salt by dissolving the compound in Et<sub>2</sub>O and MeOH and adding an 1 M ethereal solution of HCl (2.1 equiv) dropwise. A yellow solid precipitated, and the suspension was stirred for 15 min. The solvent was removed under reduced pressure, affording a crude material which was triturated with Et<sub>2</sub>O to give the title compound. MS (ES) <i>m</i>/<i>z</i>: 429 [MH<sup>+</sup>]. C<sub>26</sub>H<sub>28</sub>N<sub>4</sub>O<sub>2</sub> requires 428. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 11.1 (bs, 1H), 8.91 (bs, 1H), 7.94 (bs, 2H), 7.81 (bs, 1H), 7.49 (t, 1H), 7.44 (bs, 1H), 7.37 (d, 1H), 7.22 (s, 1H), 7.18 (d, 1H), 3.73 (bm, 2H), 3.59 (bm, 2H), 3.48 (bm, 4H), 3.33 (m, 2H), 3.19 (m, 2H), 2.89 (bs, 3H), 2.80 (bs, 4H).</div><div class="NLM_p"><b>[3</b>-<b>(1</b><i><b>H</b></i>-<b>Pyrazol</b>-<b>1</b>-<b>yl)phenyl]acetic acid</b><b>used in the synthesis of</b><b>2-methyl</b>-<b>5-(4</b>-<b>{[3</b>-<b>(1</b><i><b>H</b></i><b>-pyrazol-1-yl)phenyl]acetyl}</b>-<b>1</b>-<b>piperazinyl)quinoline</b> was prepared as follows: Pyrazole (1.2 equiv), Cs<sub>2</sub>CO<sub>3</sub> (2.5 equiv), CuI (0.5 equiv), <i>trans</i>-1,2-cyclohexanediamine (0.6 equiv), and dodecane (1 equiv) were added to a stirred solution of 3-bromophenylacetic acid (1 equiv) in dioxane at room temperature under an inert atmosphere. The mixture was irradiated in a microwave reactor (PersonalChemistry Emrys Optimiser, 300 W, 160 °C, 20 min) and then added to a 1N aqueous solution of NaOH and extracted with Et<sub>2</sub>O. The aqueous phase was acidified to pH = 3 with 2N HCl solution and then extracted with ethyl acetate; this phase was washed with brine and then dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under reduced pressure. The crude material was purified on SPE cartridge (Silica) eluting with a gradient from cyclohexane/ethyl acetate 8:2, to cyclohexane/ethyl acetate 1:1, affording the title compound in 65% yield. MS (ES) <i>m</i>/<i>z</i>: 203 [MH<sup>+</sup>]. C<sub>11</sub>H<sub>10</sub>N<sub>2</sub>O<sub>2</sub> requires 202. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ (ppm): 7.9 (m, 1H), 7.75 (m, 1H), 7.65 (m, 1H), 7.55 (d, 1H), 7.35 (t, 1H), 7.3−7.1 (m, 2H), 6.55 (m, 1H), 3.7 (s, 2H)</div><div class="NLM_p last"><b>2-Methyl</b>-<b>5</b>-<b>(4</b>-<b>{[3</b>-<b>(1</b><i><b>H</b></i>-<b>pyrazol</b>-<b>1</b>-<b>yl)phenyl]acetyl}</b>-<b>1</b>-<b>piperazinyl)quinoline</b> used in the synthesis of intermediate <b>41</b> was prepared as follows: EDC·HCl (1.5 equiv), HOBt (2 equiv), and intermediate <b>7</b> (1 equiv) were added sequentially to a stirred solution of [3-(1<i>H</i>-pyrazol-1-yl)phenyl]acetic acid (1.1 equiv) in dimethylformamide at room temperature under an inert atmosphere. The solvent was removed by means of an SCX cartridge. The crude material was purified on SPE cartridge (Silica) eluting with a gradient from dichloromethane/MeOH 99/1 to dichloromethane/MeOH 98/2, affording the title compound in 74% yield. MS (ES) <i>m</i>/<i>z</i>: 412 [MH<sup>+</sup>]. C<sub>25</sub>H<sub>25</sub>N<sub>5</sub>O requires 411. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 8.36 (d, 1H), 7.93 (d, 1H), 7.75 (d, 1H), 7.71 (s, 1H), 7.69 (s, 1H), 7.58 (d, 1H), 7.55 (t, 1H), 7.42 (t, 1H), 7.25 (m, 2H), 7.00 (d, 1H), 6.46 (s, 1H), 3.87 (s, 2H), 4.0−3.7 (m, 4H), 3.1−2.9 (m, 4H), 2.72 (s, 3H).</div></div><div id="sec4_18_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 2-Methyl-5-(4-{2-[3-(1<i>H</i>-pyrazol-1-yl)phenyl]ethyl}-1-piperazinyl)quinoline (<b>41</b>)</h4><div class="NLM_p last">A 1 M tetrahydrofuran solution of borane−tetrahydrofuran complex (3 equiv) was added to a stirred solution of 2-methyl-5-(4-{[3-(1<i>H</i>-pyrazol-1-yl)phenyl]acetyl}-1-piperazinyl)quinoline (1 equiv) in tetrahydrofuran at room temperature under an inert atmosphere. The solution was heated to 60 °C for 3 h. An aqueous 3N solution of HCl was added, and the solution was stirred at room temperature for 12 h. The solvent was removed under reduced pressure. The crude material was purified by SCX cartridge, affording the title compound in 52% yield. MS (ES) <i>m</i>/<i>z</i>: 398 [MH<sup>+</sup>]. C<sub>25</sub>H<sub>27</sub>N<sub>5</sub> requires 397. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ (ppm): 8.35 (d, 1H), 7.90 (d, 1H), 7.70 (d, 1H), 7.70 (s, 1H), 7.65 (t, 1H), 7.60 (t, 1H), 7.50 (dd, 1H), 7.35 (t, 1H), 7.25 (d, 1H), 7.15 (d, 1H), 7.05 (d, 1H), 6.45 (t, 1H), 3.20 (m, 4H), 3.0−2.7 (m, 8), 2.70 (s, 3H).</div></div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34537" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34537" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Colin P. Leslie</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline SpA, Medicines Research Centre, Via A. Fleming 4, 37135 Verona, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6605090a0f08480a03150a0f0326071612130f124805090b"><span class="__cf_email__" data-cfemail="f695999a9f98d89a93859a9f93b6978682839f82d895999b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matteo Biagetti</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline SpA, Medicines Research Centre, Via A. Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Silvia Bison</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline SpA, Medicines Research Centre, Via A. Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven M. Bromidge</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Romano Di Fabio</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline SpA, Medicines Research Centre, Via A. Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniele Donati</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline SpA, Medicines Research Centre, Via A. Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessandro Falchi</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline SpA, Medicines Research Centre, Via A. Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martine J. Garnier</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline SpA, Medicines Research Centre, Via A. Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Albert Jaxa-Chamiec</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline SpA, Medicines Research Centre, Via A. Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary Manchee</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline SpA, Medicines Research Centre, Via A. Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giancarlo Merlo</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline SpA, Medicines Research Centre, Via A. Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Domenica A. Pizzi</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline SpA, Medicines Research Centre, Via A. Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luigi P. Stasi</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline SpA, Medicines Research Centre, Via A. Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jessica Tibasco</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline SpA, Medicines Research Centre, Via A. Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonio Vong</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon E. Ward</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Zonzini</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline SpA, Medicines Research Centre, Via A. Fleming 4, 37135 Verona, Italy</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm100714c" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43361" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43361" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Carla Marchiorro and members of the Analytical Chemistry Department, Verona, for support in the analytical characterization of the compounds described. We also thank Laurie Gordon and Graham Riley of Molecular Discovery Research and Matthew Hill of the Neurosciences CEDD, Harlow, for support in the in vitro characterization of the compounds described.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22858" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22858" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 20 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hirschfeld, R. M. A.</span><span> </span><span class="NLM_article-title">History and evolution of the monoamine hypothesis of depression</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm100714c&amp;key=10.4088%2FJCP.v61n0405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm100714c&amp;key=10775017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtV2itL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2000&pages=4-6&author=R.+M.+A.+Hirschfeld&title=History+and+evolution+of+the+monoamine+hypothesis+of+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">History and evolution of the monoamine hypothesis of depression</span></div><div class="casAuthors">Hirschfeld, Robert M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">Suppl. 6</span>),
    <span class="NLM_cas:pages">4-6</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press, Inc.</span>)
        </div><div class="casAbstract">A review, with 24 refs.  The symptoms of depression can be improved by agents that act by various mechanisms to increase synaptic concns. of monoamines.  This finding led to the adoption of the monoamine hypothesis of depression, first put forward over 30 yr ago, which proposes that the underlying biol. or neuroanatomical basis for depression is a deficiency of central noradrenergic and/or serotonergic systems and that targeting this neuronal lesion with an antidepressant would tend to restore normal function in depressed patients.  The hypothesis has enjoyed considerable support, since it attempts to provide a pathophysiol. explanation of the actions of antidepressants.  However, in its original form it is clearly inadequate, as it does not provide a complete explanation for the actions of antidepressants, and the pathophysiol. of depression itself remains unknown.  The hypothesis has evolved over the years to include, for example, adaptive changes in receptors to explain why there should be only a gradual clin. response to antidepressant treatment when the increase in availability of monoamines is rapid.  Still, the monoamine hypothesis does not address key issues such as why antidepressants are also effective in other disorders such as panic disorder, obsessive-compulsive disorder, and bulimia, or why all drugs that enhance serotonergic or noradrenergic transmission are not necessarily effective in depression.  Despite these limitations, however, it is clear that the development of the monoamine hypothesis has been of great importance in understanding depression and in the development of safe and effective pharmacol. agents for its treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZF-M-PX4Qp7Vg90H21EOLACvtfcHk0liHmw0TT4TDJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtV2itL4%253D&md5=0bddf7611fade8f2fd1148ec216066f2</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.4088%2FJCP.v61n0405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4088%252FJCP.v61n0405%26sid%3Dliteratum%253Aachs%26aulast%3DHirschfeld%26aufirst%3DR.%2BM.%2BA.%26atitle%3DHistory%2520and%2520evolution%2520of%2520the%2520monoamine%2520hypothesis%2520of%2520depression%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2000%26volume%3D61%26spage%3D4%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lucki, I.</span><span> </span><span class="NLM_article-title">The spectrum of behaviors influenced by serotonin</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm100714c&amp;key=10.1016%2FS0006-3223%2898%2900139-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm100714c&amp;key=9693387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A528%3ADyaK1cXlsVOhsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1998&pages=151-162&author=I.+Lucki&title=The+spectrum+of+behaviors+influenced+by+serotonin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The spectrum of behaviors influenced by serotonin</span></div><div class="casAuthors">Lucki, Irwin</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">151-162</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review, with 110 refs., on the diverse array of behavioral effects of serotonin form the basis for understanding its potential role as an etiol. marker in psychiatric disorders and for the successful pharmacol. intervention of drugs regulating serotonin neurotransmission in behavior.  General theories of the behavioral functions of serotonin have implicated serotonin as a general inhibitor of behavioral responding and in modulating motor behavior.  The ability of serotonin to regulate behavioral satiety and macronutrient selection provides the basis for pharmacol. treatment of obesity and eating disorders.  The role of serotonin in behavioral suppression may be important in social behavior involving aggression and anxiety.  The role of serotonin in neuroendocrine regulation provides a basis for understanding serotonin dysregulation in depression.  Animal behavior tests are being used to better understand the neural substrates underlying the behavioral effects of antidepressant drugs and to address important issues in clin. treatment.  The integration of information between basic and clin. studies provides the basis for future development of more sophisticated pharmacol. treatments of psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGHI5Ew2l3Y7Vg90H21EOLACvtfcHk0lhWzkbDA7VVcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsVOhsb8%253D&md5=888b9d7d85a45ed3e65e0ef718b5b288</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2898%2900139-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252898%252900139-5%26sid%3Dliteratum%253Aachs%26aulast%3DLucki%26aufirst%3DI.%26atitle%3DThe%2520spectrum%2520of%2520behaviors%2520influenced%2520by%2520serotonin%26jtitle%3DBiol.%2520Psychiatry%26date%3D1998%26volume%3D44%26spage%3D151%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Naughton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulrooney, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, B. E.</span><span> </span><span class="NLM_article-title">A review of the role of serotonin receptors in psychiatric disorders</span> <span class="citation_source-journal">Human Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm100714c&amp;key=10.1002%2F1099-1077%28200008%2915%3A6%3C397%3A%3AAID-HUP212%3E3.0.CO%3B2-L" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm100714c&amp;key=12404302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntFCiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2000&pages=397-415&author=M.+Naughtonauthor=J.+B.+Mulrooneyauthor=B.+E.+Leonard&title=A+review+of+the+role+of+serotonin+receptors+in+psychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the role of serotonin receptors in psychiatric disorders</span></div><div class="casAuthors">Naughton, Marie; Mulrooney, Jane B.; Leonard, Brian E.</div><div class="citationInfo"><span class="NLM_cas:title">Human Psychopharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">397-415</span>CODEN:
                <span class="NLM_cas:coden">HUPSEC</span>;
        ISSN:<span class="NLM_cas:issn">0885-6222</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review with many refs.  Serotonin (5-hydroxytryptamine, 5-HT) mediates a wide variety of physiol. functions by activating multiple receptors, and abnormalities of these receptor systems was implicated in many psychiatric disorders including anxiety, depression, psychosis, migraine, disorders of sexual functioning, sleep, cognition, and feeding.  Many of the currently used treatments for these disorders act by affecting the serotonergic system.  Observation of serotonin receptor alterations, before and following effective treatments, may yield important insights into the etiol. of these psychiatric disorders and may ultimately lead to more selective and effective therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEhSNrDcM0h7Vg90H21EOLACvtfcHk0lhWzkbDA7VVcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntFCiurw%253D&md5=18be55930836492c6f605103ea4cc7b1</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1002%2F1099-1077%28200008%2915%3A6%3C397%3A%3AAID-HUP212%3E3.0.CO%3B2-L&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1099-1077%2528200008%252915%253A6%253C397%253A%253AAID-HUP212%253E3.0.CO%253B2-L%26sid%3Dliteratum%253Aachs%26aulast%3DNaughton%26aufirst%3DM.%26aulast%3DMulrooney%26aufirst%3DJ.%2BB.%26aulast%3DLeonard%26aufirst%3DB.%2BE.%26atitle%3DA%2520review%2520of%2520the%2520role%2520of%2520serotonin%2520receptors%2520in%2520psychiatric%2520disorders%26jtitle%3DHuman%2520Psychopharmacol.%26date%3D2000%26volume%3D15%26spage%3D397%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wood, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">Therapeutic potential of serotonin antagonists in depressive disorders</span> <span class="citation_source-journal">Exp. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2002&pages=457-467&author=M.+D.+Woodauthor=D.+R.+Thomasauthor=J.+M.+Watson&title=Therapeutic+potential+of+serotonin+antagonists+in+depressive+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DM.%2BD.%26aulast%3DThomas%26aufirst%3DD.%2BR.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3DTherapeutic%2520potential%2520of%2520serotonin%2520antagonists%2520in%2520depressive%2520disorders%26jtitle%3DExp.%2520Opin.%2520Invest.%2520Drugs%26date%3D2002%26volume%3D11%26spage%3D457%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Blier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Montigny, C.</span><span> </span><span class="NLM_article-title">Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">91S</span><span class="NLM_x">–</span> <span class="NLM_lpage">98S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1999&pages=91S-98S&author=P.+Blierauthor=C.+De+Montigny&title=Serotonin+and+drug-induced+therapeutic+responses+in+major+depression%2C+obsessive-compulsive+and+panic+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlier%26aufirst%3DP.%26aulast%3DDe%2BMontigny%26aufirst%3DC.%26atitle%3DSerotonin%2520and%2520drug-induced%2520therapeutic%2520responses%2520in%2520major%2520depression%252C%2520obsessive-compulsive%2520and%2520panic%2520disorders%26jtitle%3DNeuropsychopharmacology%26date%3D1999%26volume%3D21%26spage%3D91S%26epage%3D98S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Duxon, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upton, N.</span><span> </span><span class="NLM_article-title">Latency to paroxetine-induced anxiolysis in the rat is reduced by co-administration of the 5-HT<sub>1A</sub> receptor antagonist WAY100635</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">1713</span><span class="NLM_x">–</span> <span class="NLM_lpage">1719</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm100714c&amp;key=10.1038%2Fsj.bjp.0703496" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm100714c&amp;key=10928979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlslygs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2000&pages=1713-1719&author=M.+S.+Duxonauthor=K.+R.+Starrauthor=N.+Upton&title=Latency+to+paroxetine-induced+anxiolysis+in+the+rat+is+reduced+by+co-administration+of+the+5-HT1A+receptor+antagonist+WAY100635"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Latency to paroxetine-induced anxiolysis in the rat is reduced by co-administration of the 5-HT1A receptor antagonist WAY100635</span></div><div class="casAuthors">Duxon, M. S.; Starr, K. R.; Upton, N.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1713-1719</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report here the use of rat high-light social interaction to model the temporal anxiolytic/antidepressant effects of SSRIs seen in the clinic.  Compared to vehicle controls, 21, but not 14, days of paroxetine treatment (3 mg kg-1, p.o., daily) produced a marked increase in rat social interaction (Vehicle=71.3 ± 7.3 s; Paroxetine=116.7 ± 14.7 s; P<0.01) with no concurrent effect on locomotor activity, consistent with anxiolysis.  To assess whether concurrent 5-HT1A receptor blockade reduces the time to onset of anxiolysis seen with paroxetine alone (21 days), rats were implanted with osmotic minipumps to continuously infuse the 5-HT1A receptor antagonist WAY100635 (1 mg kg-1 day-1, s.c., 7 days) alone or in combination with paroxetine (3 mg kg-1, p.o., daily, 7 days), prior to anxiety testing.  Paroxetine (Veh/Par=61.9 ± 7.9 s) or WAY100635 (WAY/Veh=71.6 ± 4.7 s) alone, had no effect on social interaction time compared to vehicle treated controls (Veh/Veh = 76.4 ± 4.9 s), while coadministration of WAY100635 with paroxetine, produced a marked elevation in social interaction (WAY/Par=149.3 ± 16.8 s; P<0.01) relative to all other groups with no concurrent change in locomotor activity.  In contrast, acute administration of WAY100635 (0.03 mg kg-1, s.c.) with paroxetine (3 mg kg-1, p.o.) did not alter any behavioral measure, suggesting that the anxiolysis induced by the combination after 7 days is attributable to a CNS adaptive response.  This data demonstrates that coadministration of a 5-HT1A receptor antagonist with paroxetine markedly reduces the latency to anxiolysis, in the rat.  This study supports the use of the rat social interaction test to further delineate adaptive changes in the CNS responsible for the anxiolytic/antidepressant action of SSRIs seen in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOTWecxFYs9bVg90H21EOLACvtfcHk0lg8NWvfOQ3bDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlslygs7c%253D&md5=e5b489edbe2c074f13d48c25af29dc91</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703496%26sid%3Dliteratum%253Aachs%26aulast%3DDuxon%26aufirst%3DM.%2BS.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DUpton%26aufirst%3DN.%26atitle%3DLatency%2520to%2520paroxetine-induced%2520anxiolysis%2520in%2520the%2520rat%2520is%2520reduced%2520by%2520co-administration%2520of%2520the%25205-HT1A%2520receptor%2520antagonist%2520WAY100635%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D130%26spage%3D1713%26epage%3D1719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McAskill, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, D.</span><span> </span><span class="NLM_article-title">Pindolol augmentation of antidepressant therapy</span> <span class="citation_source-journal">Br. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm100714c&amp;key=10.1192%2Fbjp.173.3.203" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1998&pages=203-208&author=R.+McAskillauthor=S.+Mirauthor=D.+Taylor&title=Pindolol+augmentation+of+antidepressant+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1192%2Fbjp.173.3.203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1192%252Fbjp.173.3.203%26sid%3Dliteratum%253Aachs%26aulast%3DMcAskill%26aufirst%3DR.%26aulast%3DMir%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DD.%26atitle%3DPindolol%2520augmentation%2520of%2520antidepressant%2520therapy%26jtitle%3DBr.%2520J.%2520Psychiatry%26date%3D1998%26volume%3D73%26spage%3D203%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Artigas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, E.</span><span> </span><span class="NLM_article-title">Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">1994</span><span class="NLM_x">) </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm100714c&amp;key=10.1001%2Farchpsyc.1994.03950030084009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm100714c&amp;key=8122960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A280%3ADyaK2c7mvVGitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1994&pages=248-251&issue=1994&author=F.+Artigasauthor=V.+Perezauthor=E.+Alvarez&title=Pindolol+induces+a+rapid+improvement+of+depressed+patients+treated+with+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors</span></div><div class="casAuthors">Artigas F; Perez V; Alvarez E</div><div class="citationInfo"><span class="NLM_cas:title">Archives of general psychiatry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">248-51</span>
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8elF--uOnsj69zv1FsJFMfW6udTcc2ebohyzbSO5Czbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c7mvVGitw%253D%253D&md5=19dc44e630d37442b5707cc26daa4a90</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.1994.03950030084009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.1994.03950030084009%26sid%3Dliteratum%253Aachs%26aulast%3DArtigas%26aufirst%3DF.%26aulast%3DPerez%26aufirst%3DV.%26aulast%3DAlvarez%26aufirst%3DE.%26atitle%3DPindolol%2520induces%2520a%2520rapid%2520improvement%2520of%2520depressed%2520patients%2520treated%2520with%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1994%26volume%3D51%26issue%3D1994%26spage%3D248%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Blier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, R.</span><span> </span><span class="NLM_article-title">Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression</span> <span class="citation_source-journal">J. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Fjm100714c&amp;key=10.1097%2F00004714-199506000-00011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm100714c&amp;key=7636000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A280%3ADyaK2Mzmt1yktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=217-222&author=P.+Blierauthor=R.+Bergeron&title=Effectiveness+of+pindolol+with+selected+antidepressant+drugs+in+the+treatment+of+major+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression</span></div><div class="casAuthors">Blier P; Bergeron R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical psychopharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">217-22</span>
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    </div><div class="casAbstract">On the basis of a previous report suggesting the effectiveness of the beta-adrenoceptor/5-HT1A antagonist pindolol to accelerate the antidepressant effect of a selective serotonin reuptake inhibitor (SSRI) and to produce a therapeutic effect in drug-resistant depressed patients, these open studies were undertaken to further explore the safety and efficacy of this strategy.  In a first study, nine untreated unipolar depressed patients were given the SSRI paroxetine (20 mg/day) together with pindolol (2.5 mg thrice daily).  One patient stopped taking pindolol because of increased irritability after 3 days.  One week later, seven patients had their Hamilton Rating Scale for Depression Score decreased by more than 50%.  In a second study, 19 drug-resistant unipolar depressed patients (9 on paroxetine, 5 on sertraline, 3 on fluoxetine, and 2 on moclobemide) were also given pindolol at the same regimen and were assessed weekly.  Two patients (one on sertraline, one on moclobemide) stopped taking pindolol also because of increased irritability after 2 and 3 days, respectively.  After 1 week of pindolol addition, 10 patients had a more than 50% decrease of their depression score.  By day 14, all of the patients had a score of 10 or less, with the exception of those on sertraline.  Improvement was maintained in all patients for at least 28 days on this combination.  The results of these studies indicate that pindolol is safe when used in combination with an SSRI or moclobemide.  Given the positive results obtained in this second open trial in 28 patients, this treatment strategy should be tested under double-blind conditions to establish its efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQYSvrZzE62a62q3xNe7a7QfW6udTcc2ebohyzbSO5Czbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2Mzmt1yktg%253D%253D&md5=9ffbe5680925c387cd4946ef4edfc384</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1097%2F00004714-199506000-00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004714-199506000-00011%26sid%3Dliteratum%253Aachs%26aulast%3DBlier%26aufirst%3DP.%26aulast%3DBergeron%26aufirst%3DR.%26atitle%3DEffectiveness%2520of%2520pindolol%2520with%2520selected%2520antidepressant%2520drugs%2520in%2520the%2520treatment%2520of%2520major%2520depression%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D1995%26volume%3D15%26spage%3D217%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Artigas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celada, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laruelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adell, A.</span><span> </span><span class="NLM_article-title">How does pindolol improve antidepressant action?</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">228</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2001&pages=224-228&author=F.+Artigasauthor=P.+Celadaauthor=M.+Laruelleauthor=A.+Adell&title=How+does+pindolol+improve+antidepressant+action%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArtigas%26aufirst%3DF.%26aulast%3DCelada%26aufirst%3DP.%26aulast%3DLaruelle%26aufirst%3DM.%26aulast%3DAdell%26aufirst%3DA.%26atitle%3DHow%2520does%2520pindolol%2520improve%2520antidepressant%2520action%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2001%26volume%3D22%26spage%3D224%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Blier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, R.</span><span> </span><span class="NLM_article-title">The use of pindolol to potentiate antidepressant medication</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=8&amp;doi=10.1021%2Fjm100714c&amp;key=9635544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A528%3ADyaK1cXjslGksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1998&pages=16-25&author=P.+Blierauthor=R.+Bergeron&title=The+use+of+pindolol+to+potentiate+antidepressant+medication"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4eR"><div class="casContent"><span class="casTitleNuber">4e</span><div class="casTitle"><span class="NLM_cas:atitle">The use of pindolol to potentiate antidepressant medication</span></div><div class="casAuthors">Blier, Pierre; Bergeron, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">Suppl..5</span>),
    <span class="NLM_cas:pages">16-25</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press</span>)
        </div><div class="casAbstract">A review with 32 refs. followed by a discussion.  Serotonin (5-HT) selective reuptake inhibitors (SSRIs) and monoamine oxidase inhibitors are thought to have a delayed onset of antidepressant action attributable in part to the decrease in firing activity of 5-HT neurons they produce upon treatment initiation.  As cell body 5-HT1A autoreceptors desensitize, 5-HT neuronal firing is restored.  The agent pindolol, through its 5-HT1A receptor blocking property, has been shown to prevent the initial decrease in firing of rat 5-HT neurons assocd. with SSRI treatment.  Four open-label studies put into evidence a significant acceleration of the antidepressant effect of SSRIs when combined with pindolol.  Four of five placebo-controlled studies have confirmed this observation.  Controlled trials indicate that a greater rate of response may be obtained by combining pindolol from the beginning of the SSRI treatment.  The strategy of adding pindolol to the regimen of SSRI-resistant patients also appears to produce a therapeutic effect in a significant proportion of patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz0q4Q6ACnhrVg90H21EOLACvtfcHk0ljTw7fnKN-ytw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjslGksLs%253D&md5=a2d5fa78635c0e4427bd9c6fd6039271</span></div><a href="/servlet/linkout?suffix=cit4e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlier%26aufirst%3DP.%26aulast%3DBergeron%26aufirst%3DR.%26atitle%3DThe%2520use%2520of%2520pindolol%2520to%2520potentiate%2520antidepressant%2520medication%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D1998%26volume%3D59%26spage%3D16%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mewshaw, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meagher, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scerni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span> </span><span class="NLM_article-title">Studies toward the discovery of the next generation of antidepressants. Part 2: incorporating a 5-HT<sub>1A</sub> antagonist component into a class of serotonin reuptake inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=307-310&author=R.+E.+Mewshawauthor=K.+L.+Meagherauthor=P.+Zhouauthor=D.+Zhouauthor=X.+Shiauthor=R.+Scerniauthor=D.+L.+Smithauthor=L.+E.+Schechterauthor=T.+H.+Andree&title=Studies+toward+the+discovery+of+the+next+generation+of+antidepressants.+Part+2%3A+incorporating+a+5-HT1A+antagonist+component+into+a+class+of+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMewshaw%26aufirst%3DR.%2BE.%26aulast%3DMeagher%26aufirst%3DK.%2BL.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DScerni%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26atitle%3DStudies%2520toward%2520the%2520discovery%2520of%2520the%2520next%2520generation%2520of%2520antidepressants.%2520Part%25202%253A%2520incorporating%2520a%25205-HT1A%2520antagonist%2520component%2520into%2520a%2520class%2520of%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D307%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mewshaw, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornby, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spangler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scerni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span> </span><span class="NLM_article-title">Studies toward the discovery of the next generation of antidepressants. 3. Dual 5-HT<sub>1A</sub> and serotonin transporter affinity within a class of <i>N</i>-aryloxyethylindolylalkylamines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">3823</span><span class="NLM_x">–</span> <span class="NLM_lpage">3842</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0304010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvFyitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3823-3842&author=R.+E.+Mewshawauthor=D.+Zhouauthor=P.+Zhouauthor=X.+Shiauthor=G.+Hornbyauthor=T.+Spanglerauthor=R.+Scerniauthor=D.+Smithauthor=L.+E.+Schechterauthor=T.+H.+Andree&title=Studies+toward+the+discovery+of+the+next+generation+of+antidepressants.+3.+Dual+5-HT1A+and+serotonin+transporter+affinity+within+a+class+of+N-aryloxyethylindolylalkylamines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Studies toward the Discovery of the Next Generation of Antidepressants. 3. Dual 5-HT1A and Serotonin Transporter Affinity within a Class of N-Aryloxyethylindolylalkylamines</span></div><div class="casAuthors">Mewshaw, Richard E.; Zhou, Dahui; Zhou, Ping; Shi, Xiaojie; Hornby, Geoffrey; Spangler, Taylor; Scerni, Rosemary; Smith, Deborah; Schechter, Lee E.; Andree, Terrance H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3823-3842</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Aryloxylethylindolealkylamines (5) having dual 5-HT transporter and 5-HT1A affinity are described.  These compds. represent truncated analogs of our previously reported piperidinyl derivs. (3).  Compds. in this investigation were found to have more similar affinities and functional activities for the 5-HT1A receptor and 5-HT transporter.  Though 5-HT1A antagonism is not consistently obsd. throughout series 5, several mol. features were found to be essential to obtain high and balanced activities.  The proper placement of a heteroatom in the aryl ring and the length of the linkage used to tether the indole moiety had significant influence on 5-HT1A and 5-HT transporter affinities.  Introduction of a halogen into the aryl ring usually lowered intrinsic activity and in some cases led to full 5-HT1A antagonists.  Compds. 33 and 34 were obsd. to be full 5-HT1A antagonists with Ki values of approx. 30 nM for the 5-HT1A receptor and Ki values of 5 and 0.5 nM for the 5-HT transporter, resp.  Unfortunately, similar to our previous series (3), compds. in this report also had high affinity for the α1 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUlzq9C2T0QbVg90H21EOLACvtfcHk0ljTw7fnKN-ytw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvFyitLo%253D&md5=d2c2efc650a5c1749b7366c666419936</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1021%2Fjm0304010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0304010%26sid%3Dliteratum%253Aachs%26aulast%3DMewshaw%26aufirst%3DR.%2BE.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DHornby%26aufirst%3DG.%26aulast%3DSpangler%26aufirst%3DT.%26aulast%3DScerni%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26atitle%3DStudies%2520toward%2520the%2520discovery%2520of%2520the%2520next%2520generation%2520of%2520antidepressants.%25203.%2520Dual%25205-HT1A%2520and%2520serotonin%2520transporter%2520affinity%2520within%2520a%2520class%2520of%2520N-aryloxyethylindolylalkylamines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3823%26epage%3D3842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hornby, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spangler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazandarani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgaonkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span> </span><span class="NLM_article-title">SSRI/5-HT<sub>1A</sub> antagonists as future antidepressant agents: a neurochemical assessment of WAY-163426</span> <span class="citation_source-journal">Soc. Neurosci. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1024.14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2004&pages=1024.14&author=G.+A.+Hornbyauthor=G.+Stackauthor=L.+A.+Dawsonauthor=H.+Q.+Nguyenauthor=T.+Spanglerauthor=D.+L.+Smithauthor=H.+Mazandaraniauthor=M.+Tranauthor=S.+Kalgaonkarauthor=G.+Zhangauthor=L.+E.+Schechterauthor=T.+H.+Andree&title=SSRI%2F5-HT1A+antagonists+as+future+antidepressant+agents%3A+a+neurochemical+assessment+of+WAY-163426"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHornby%26aufirst%3DG.%2BA.%26aulast%3DStack%26aufirst%3DG.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DNguyen%26aufirst%3DH.%2BQ.%26aulast%3DSpangler%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DMazandarani%26aufirst%3DH.%26aulast%3DTran%26aufirst%3DM.%26aulast%3DKalgaonkar%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26atitle%3DSSRI%252F5-HT1A%2520antagonists%2520as%2520future%2520antidepressant%2520agents%253A%2520a%2520neurochemical%2520assessment%2520of%2520WAY-163426%26jtitle%3DSoc.%2520Neurosci.%2520Abstr.%26date%3D2004%26volume%3D30%26spage%3D1024.14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatzenbuhler, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evrard, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chlenov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golembieski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornby, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G. P.</span><span> </span><span class="NLM_article-title">Novel pyridyl-fused 3-amino chroman derivatives with dual action at serotonin transporter and 5-HT<sub>1A</sub> receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3117</span><span class="NLM_x">–</span> <span class="NLM_lpage">3121</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3117-3121&author=D.+Zhouauthor=N.+T.+Hatzenbuhlerauthor=J.+L.+Grossauthor=B.+L.+Harrisonauthor=D.+A.+Evrardauthor=M.+Chlenovauthor=J.+Golembieskiauthor=G.+Hornbyauthor=L.+E.+Schechterauthor=D.+L.+Smithauthor=T.+H.+Andreeauthor=G.+P.+Stack&title=Novel+pyridyl-fused+3-amino+chroman+derivatives+with+dual+action+at+serotonin+transporter+and+5-HT1A+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DHatzenbuhler%26aufirst%3DN.%2BT.%26aulast%3DGross%26aufirst%3DJ.%2BL.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DEvrard%26aufirst%3DD.%2BA.%26aulast%3DChlenov%26aufirst%3DM.%26aulast%3DGolembieski%26aufirst%3DJ.%26aulast%3DHornby%26aufirst%3DG.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26aulast%3DStack%26aufirst%3DG.%2BP.%26atitle%3DNovel%2520pyridyl-fused%25203-amino%2520chroman%2520derivatives%2520with%2520dual%2520action%2520at%2520serotonin%2520transporter%2520and%25205-HT1A%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3117%26epage%3D3121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honigschmidt, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocco, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinazze, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainscott, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Threlkeld, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. T.</span><span> </span><span class="NLM_article-title">Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT<sub>1A</sub> receptor antagonism/SSRI activities. Part 1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1903</span><span class="NLM_x">–</span> <span class="NLM_lpage">1905</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1903-1905&author=K.+Takeuchiauthor=T.+J.+Kohnauthor=N.+A.+Honigschmidtauthor=V.+P.+Roccoauthor=P.+G.+Spinazzeauthor=D.+J.+Kochauthor=D.+L.+G.+Nelsonauthor=D.+B.+Wainscottauthor=L.+J.+Ahmadauthor=J.+Shawauthor=P.+G.+Threlkeldauthor=D.+T.+Wong&title=Advances+toward+new+antidepressants+beyond+SSRIs%3A+1-aryloxy-3-piperidinylpropan-2-ols+with+dual+5-HT1A+receptor+antagonism%2FSSRI+activities.+Part+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DKohn%26aufirst%3DT.%2BJ.%26aulast%3DHonigschmidt%26aufirst%3DN.%2BA.%26aulast%3DRocco%26aufirst%3DV.%2BP.%26aulast%3DSpinazze%26aufirst%3DP.%2BG.%26aulast%3DKoch%26aufirst%3DD.%2BJ.%26aulast%3DNelson%26aufirst%3DD.%2BL.%2BG.%26aulast%3DWainscott%26aufirst%3DD.%2BB.%26aulast%3DAhmad%26aufirst%3DL.%2BJ.%26aulast%3DShaw%26aufirst%3DJ.%26aulast%3DThrelkeld%26aufirst%3DP.%2BG.%26aulast%3DWong%26aufirst%3DD.%2BT.%26atitle%3DAdvances%2520toward%2520new%2520antidepressants%2520beyond%2520SSRIs%253A%25201-aryloxy-3-piperidinylpropan-2-ols%2520with%2520dual%25205-HT1A%2520receptor%2520antagonism%252FSSRI%2520activities.%2520Part%25201%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1903%26epage%3D1905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, T .J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honigschmidt, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocco, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinazze, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hertel, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainscott, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Threlkeld, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. T.</span><span> </span><span class="NLM_article-title">Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT<sub>1A</sub> receptor antagonism/SSRI activities. Part 2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2393</span><span class="NLM_x">–</span> <span class="NLM_lpage">2397</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2393-2397&author=K.+Takeuchiauthor=T+.J.+Kohnauthor=N.+A.+Honigschmidtauthor=V.+P.+Roccoauthor=P.+G.+Spinazzeauthor=D.+J.+Kochauthor=S.+T.+Atkinsonauthor=L.+W.+Hertelauthor=D.+L.+Nelsonauthor=D.+B.+Wainscottauthor=L.+J.+Ahmadauthor=J.+Shawauthor=P.+G.+Threlkeldauthor=D.+T.+Wong&title=Advances+toward+new+antidepressants+beyond+SSRIs%3A+1-aryloxy-3-piperidinylpropan-2-ols+with+dual+5-HT1A+receptor+antagonism%2FSSRI+activities.+Part+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DKohn%26aufirst%3DT%2B.J.%26aulast%3DHonigschmidt%26aufirst%3DN.%2BA.%26aulast%3DRocco%26aufirst%3DV.%2BP.%26aulast%3DSpinazze%26aufirst%3DP.%2BG.%26aulast%3DKoch%26aufirst%3DD.%2BJ.%26aulast%3DAtkinson%26aufirst%3DS.%2BT.%26aulast%3DHertel%26aufirst%3DL.%2BW.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DWainscott%26aufirst%3DD.%2BB.%26aulast%3DAhmad%26aufirst%3DL.%2BJ.%26aulast%3DShaw%26aufirst%3DJ.%26aulast%3DThrelkeld%26aufirst%3DP.%2BG.%26aulast%3DWong%26aufirst%3DD.%2BT.%26atitle%3DAdvances%2520toward%2520new%2520antidepressants%2520beyond%2520SSRIs%253A%25201-aryloxy-3-piperidinylpropan-2-ols%2520with%2520dual%25205-HT1A%2520receptor%2520antagonism%252FSSRI%2520activities.%2520Part%25202%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2393%26epage%3D2397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, T .J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honigschmidt, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocco, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinazze, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hertel, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainscott, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Threlkeld, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. T.</span><span> </span><span class="NLM_article-title">Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT<sub>1A</sub> receptor antagonism/SSRI activities. Part 3</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3939</span><span class="NLM_x">–</span> <span class="NLM_lpage">3942</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3939-3942&author=K.+Takeuchiauthor=T+.J.+Kohnauthor=N.+A.+Honigschmidtauthor=V.+P.+Roccoauthor=P.+G.+Spinazzeauthor=S.+T.+Atkinsonauthor=L.+W.+Hertelauthor=D.+L.+Nelsonauthor=D.+B.+Wainscottauthor=L.+J.+Ahmadauthor=J.+Shawauthor=P.+G.+Threlkeldauthor=D.+T.+Wong&title=Advances+toward+new+antidepressants+beyond+SSRIs%3A+1-aryloxy-3-piperidinylpropan-2-ols+with+dual+5-HT1A+receptor+antagonism%2FSSRI+activities.+Part+3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DKohn%26aufirst%3DT%2B.J.%26aulast%3DHonigschmidt%26aufirst%3DN.%2BA.%26aulast%3DRocco%26aufirst%3DV.%2BP.%26aulast%3DSpinazze%26aufirst%3DP.%2BG.%26aulast%3DAtkinson%26aufirst%3DS.%2BT.%26aulast%3DHertel%26aufirst%3DL.%2BW.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DWainscott%26aufirst%3DD.%2BB.%26aulast%3DAhmad%26aufirst%3DL.%2BJ.%26aulast%3DShaw%26aufirst%3DJ.%26aulast%3DThrelkeld%26aufirst%3DP.%2BG.%26aulast%3DWong%26aufirst%3DD.%2BT.%26atitle%3DAdvances%2520toward%2520new%2520antidepressants%2520beyond%2520SSRIs%253A%25201-aryloxy-3-piperidinylpropan-2-ols%2520with%2520dual%25205-HT1A%2520receptor%2520antagonism%252FSSRI%2520activities.%2520Part%25203%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3939%26epage%3D3942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honigschmidt, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocco, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinazze, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemrick-Luecke, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Threlkeld, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. T.</span><span> </span><span class="NLM_article-title">Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT<sub>1A</sub> receptor antagonism/SSRI activities. Part 5</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">2347</span><span class="NLM_x">–</span> <span class="NLM_lpage">2351</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=2347-2351&author=K.+Takeuchiauthor=T.+J.+Kohnauthor=N.+A.+Honigschmidtauthor=V.+P.+Roccoauthor=P.+G.+Spinazzeauthor=S.+K.+Hemrick-Lueckeauthor=L.+K.+Thompsonauthor=D.+C.+Evansauthor=K.+Rasmussenauthor=D.+Kogerauthor=D.+Lodgeauthor=L.+J.+Martinauthor=J.+Shawauthor=P.+G.+Threlkeldauthor=D.+T.+Wong&title=Advances+toward+new+antidepressants+beyond+SSRIs%3A+1-aryloxy-3-piperidinylpropan-2-ols+with+dual+5-HT1A+receptor+antagonism%2FSSRI+activities.+Part+5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DKohn%26aufirst%3DT.%2BJ.%26aulast%3DHonigschmidt%26aufirst%3DN.%2BA.%26aulast%3DRocco%26aufirst%3DV.%2BP.%26aulast%3DSpinazze%26aufirst%3DP.%2BG.%26aulast%3DHemrick-Luecke%26aufirst%3DS.%2BK.%26aulast%3DThompson%26aufirst%3DL.%2BK.%26aulast%3DEvans%26aufirst%3DD.%2BC.%26aulast%3DRasmussen%26aufirst%3DK.%26aulast%3DKoger%26aufirst%3DD.%26aulast%3DLodge%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DL.%2BJ.%26aulast%3DShaw%26aufirst%3DJ.%26aulast%3DThrelkeld%26aufirst%3DP.%2BG.%26aulast%3DWong%26aufirst%3DD.%2BT.%26atitle%3DAdvances%2520toward%2520new%2520antidepressants%2520beyond%2520SSRIs%253A%25201-aryloxy-3-piperidinylpropan-2-ols%2520with%2520dual%25205-HT1A%2520receptor%2520antagonism%252FSSRI%2520activities.%2520Part%25205%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D1%26spage%3D2347%26epage%3D2351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Rocco, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinazze, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honigschmidt, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley Wainscott, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Threlkeld, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span> </span><span class="NLM_article-title">Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT<sub>1A</sub> receptor antagonism/SSRI activities. Part 4</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2653</span><span class="NLM_x">–</span> <span class="NLM_lpage">2656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2653-2656&author=V.+P.+Roccoauthor=P.+G.+Spinazzeauthor=T.+J.+Kohnauthor=N.+A.+Honigschmidtauthor=D.+L.+Nelsonauthor=D.+Bradley+Wainscottauthor=L.+J.+Ahmadauthor=J.+Shawauthor=P.+G.+Threlkeldauthor=D.+T.+Wongauthor=K.+Takeuchi&title=Advances+toward+new+antidepressants+beyond+SSRIs%3A+1-aryloxy-3-piperidinylpropan-2-ols+with+dual+5-HT1A+receptor+antagonism%2FSSRI+activities.+Part+4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRocco%26aufirst%3DV.%2BP.%26aulast%3DSpinazze%26aufirst%3DP.%2BG.%26aulast%3DKohn%26aufirst%3DT.%2BJ.%26aulast%3DHonigschmidt%26aufirst%3DN.%2BA.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DBradley%2BWainscott%26aufirst%3DD.%26aulast%3DAhmad%26aufirst%3DL.%2BJ.%26aulast%3DShaw%26aufirst%3DJ.%26aulast%3DThrelkeld%26aufirst%3DP.%2BG.%26aulast%3DWong%26aufirst%3DD.%2BT.%26aulast%3DTakeuchi%26aufirst%3DK.%26atitle%3DAdvances%2520toward%2520new%2520antidepressants%2520beyond%2520SSRIs%253A%25201-aryloxy-3-piperidinylpropan-2-ols%2520with%2520dual%25205-HT1A%2520receptor%2520antagonism%252FSSRI%2520activities.%2520Part%25204%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2653%26epage%3D2656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Atkinson, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bromidge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duxon, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaster, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadley, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">North, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rami, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vong, A. K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">3,4-Dihydro-2<i>H</i>-benzoxazinones are 5-HT<sub>1A</sub> receptor antagonists with potent 5-HT reuptake inhibitory activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=737-741&author=P.+J.+Atkinsonauthor=S.+M.+Bromidgeauthor=M.+S.+Duxonauthor=L.+M.+Gasterauthor=M.+S.+Hadleyauthor=B.+Hammondauthor=C.+N.+Johnsonauthor=D.+N.+Middlemissauthor=S.+E.+Northauthor=G.+W.+Priceauthor=H.+K.+Ramiauthor=G.+J.+Rileyauthor=C.+M.+Scottauthor=T.+E.+Shawauthor=K.+R.+Starrauthor=G.+Stempauthor=K.+M.+Thewlisauthor=D.+R.+Thomasauthor=M.+Thompsonauthor=A.+K.+K.+Vongauthor=J.+M.+Watson&title=3%2C4-Dihydro-2H-benzoxazinones+are+5-HT1A+receptor+antagonists+with+potent+5-HT+reuptake+inhibitory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAtkinson%26aufirst%3DP.%2BJ.%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26aulast%3DDuxon%26aufirst%3DM.%2BS.%26aulast%3DGaster%26aufirst%3DL.%2BM.%26aulast%3DHadley%26aufirst%3DM.%2BS.%26aulast%3DHammond%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DNorth%26aufirst%3DS.%2BE.%26aulast%3DPrice%26aufirst%3DG.%2BW.%26aulast%3DRami%26aufirst%3DH.%2BK.%26aulast%3DRiley%26aufirst%3DG.%2BJ.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DShaw%26aufirst%3DT.%2BE.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DStemp%26aufirst%3DG.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DThomas%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DM.%26aulast%3DVong%26aufirst%3DA.%2BK.%2BK.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3D3%252C4-Dihydro-2H-benzoxazinones%2520are%25205-HT1A%2520receptor%2520antagonists%2520with%2520potent%25205-HT%2520reuptake%2520inhibitory%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D737%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodacre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vong, A. K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">3,4-Dihydro-2<i>H</i>-benzoxazinones as dual-acting 5-HT<sub>1A</sub> receptor antagonists and serotonin reuptake inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1033</span><span class="NLM_x">–</span> <span class="NLM_lpage">1036</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1033-1036&author=P.+J.+Lovellauthor=F.+E.+Blaneyauthor=C.+J.+Goodacreauthor=C.+M.+Scottauthor=P.+W.+Smithauthor=K.+R.+Starrauthor=K.+M.+Thewlisauthor=A.+K.+K.+Vongauthor=S.+E.+Wardauthor=J.+M.+Watson&title=3%2C4-Dihydro-2H-benzoxazinones+as+dual-acting+5-HT1A+receptor+antagonists+and+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5k&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DBlaney%26aufirst%3DF.%2BE.%26aulast%3DGoodacre%26aufirst%3DC.%2BJ.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DVong%26aufirst%3DA.%2BK.%2BK.%26aulast%3DWard%26aufirst%3DS.%2BE.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3D3%252C4-Dihydro-2H-benzoxazinones%2520as%2520dual-acting%25205-HT1A%2520receptor%2520antagonists%2520and%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1033%26epage%3D1036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Moltzen, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkelsen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornholm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennum, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, C.</span><span> </span><span class="NLM_article-title">In vitro profile of LU 36−274: a compound with combined 5-HTT/5-HT<sub>1A</sub> activity and putative fast onset of antidepressant action</span> <span class="citation_source-journal">Soc. Neurosci. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">958.16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2003&pages=958.16&author=E.+K.+Moltzenauthor=I.+Mikkelsenauthor=B.+Bjornholmauthor=L.+T.+Brennumauthor=S.+Hoggauthor=C.+Sanchez&title=In+vitro+profile+of+LU+36%E2%88%92274%3A+a+compound+with+combined+5-HTT%2F5-HT1A+activity+and+putative+fast+onset+of+antidepressant+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5l&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoltzen%26aufirst%3DE.%2BK.%26aulast%3DMikkelsen%26aufirst%3DI.%26aulast%3DBjornholm%26aufirst%3DB.%26aulast%3DBrennum%26aufirst%3DL.%2BT.%26aulast%3DHogg%26aufirst%3DS.%26aulast%3DSanchez%26aufirst%3DC.%26atitle%3DIn%2520vitro%2520profile%2520of%2520LU%252036%25E2%2588%2592274%253A%2520a%2520compound%2520with%2520combined%25205-HTT%252F5-HT1A%2520activity%2520and%2520putative%2520fast%2520onset%2520of%2520antidepressant%2520action%26jtitle%3DSoc.%2520Neurosci.%2520Abstr.%26date%3D2003%26volume%3D29%26spage%3D958.16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Taber, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrente, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poss, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortolani, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yevich, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, R. J.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of BMS-296859, a novel serotonin reuptake inhibitor and serotonin 5-HT<sub>1A</sub> receptor antagonist</span> <span class="citation_source-journal">Soc. Neurosci. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">958.15</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2003&pages=958.15&author=M.+T.+Taberauthor=J.+R.+Torrenteauthor=J.+Palmerauthor=M.+A.+Possauthor=D.+R.+Tortolaniauthor=J.+P.+Yevichauthor=A.+D.+Starkauthor=R.+J.+Mattson&title=Pharmacological+characterization+of+BMS-296859%2C+a+novel+serotonin+reuptake+inhibitor+and+serotonin+5-HT1A+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaber%26aufirst%3DM.%2BT.%26aulast%3DTorrente%26aufirst%3DJ.%2BR.%26aulast%3DPalmer%26aufirst%3DJ.%26aulast%3DPoss%26aufirst%3DM.%2BA.%26aulast%3DTortolani%26aufirst%3DD.%2BR.%26aulast%3DYevich%26aufirst%3DJ.%2BP.%26aulast%3DStark%26aufirst%3DA.%2BD.%26aulast%3DMattson%26aufirst%3DR.%2BJ.%26atitle%3DPharmacological%2520characterization%2520of%2520BMS-296859%252C%2520a%2520novel%2520serotonin%2520reuptake%2520inhibitor%2520and%2520serotonin%25205-HT1A%2520receptor%2520antagonist%26jtitle%3DSoc.%2520Neurosci.%2520Abstr.%26date%3D2003%26volume%3D29%26spage%3D958.15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Roberts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span> </span><span class="NLM_article-title">Ligands for the investigation of 5-HT autoreceptor function</span> <span class="citation_source-journal">Brain Res. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm100714c&amp;key=10.1016%2FS0361-9230%2801%2900628-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm100714c&amp;key=11750791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptFylt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2001&pages=463-469&author=C.+Robertsauthor=G.+W.+Priceauthor=D.+N.+Middlemiss&title=Ligands+for+the+investigation+of+5-HT+autoreceptor+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Ligands for the investigation of 5-HT autoreceptor function</span></div><div class="casAuthors">Roberts, Claire; Price, Gary W.; Middlemiss, Derek N.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">463-469</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  The existence of multiple 5-HT autoreceptors in the central nervous system is now firmly established and they have been pharmacol. identified as belonging to the 5-HT1A, 5-HT1B, and 5-HT1D receptor subtypes.  In addn., 5-HT1F, 5-HT5A, and 5-HT7 receptors remain as potential candidates for addnl. autoreceptors.  The emergence of selective ligands, such as SB-224289 (5-HT1B receptor antagonist), BRL 15572 (5-HT1D receptor antagonist), GR 127935 (a mixed 5-HT1B/1D receptor antagonist), LY 334370 (5-HT1F receptor agonist), and SB-269970 (5-HT7 receptor antagonist), has aided the characterization of 5-HT autoreceptors and has highlighted the complexity of mechanisms which modulate the release of 5-HT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh3Lk0_xEYELVg90H21EOLACvtfcHk0lhmJRBKf40qTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptFylt7s%253D&md5=1b38f404662c50829d0f1d20bd313d84</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0361-9230%2801%2900628-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0361-9230%252801%252900628-1%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DC.%26aulast%3DPrice%26aufirst%3DG.%2BW.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26atitle%3DLigands%2520for%2520the%2520investigation%2520of%25205-HT%2520autoreceptor%2520function%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2001%26volume%3D56%26spage%3D463%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Davidson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, J. A.</span><span> </span><span class="NLM_article-title">Evidence that 5-hydroxytryptamine release in rat dorsal raphe nucleus is controlled by 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub> and 5-HT<sub>1D</sub> autoreceptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1109</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm100714c&amp;key=10.1111%2Fj.1476-5381.1995.tb13321.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm100714c&amp;key=7620698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A528%3ADyaK2MXksFyjtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=1995&pages=1107-1109&author=C.+Davidsonauthor=J.+A.+Stamford&title=Evidence+that+5-hydroxytryptamine+release+in+rat+dorsal+raphe+nucleus+is+controlled+by+5-HT1A%2C+5-HT1B+and+5-HT1D+autoreceptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence that 5-hydroxytryptamine release in rat dorsal raphe nucleus is controlled by 5-HT1A, 5-HT1B and 5-HT1D autoreceptors</span></div><div class="casAuthors">Davidson, Colin; Stamford, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1107-9</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">Elec. stimulated 5-HT release was monitored in slices of rat dorsal raphe nucleus (DRN) by fast cyclic voltammetry.  Pseudo-single pulse stimulations (5 pulses at 100 Hz) were used to enable the effect of various receptor agonists to be seen without competition from endogenously released transmitter.  The selective 5-HT1A receptor agonist, (+)-8-OH-DPAT (1.0 μM) decreased stimulated 5-HT release to 31% of controls.  This decrease was inhibited by the 5-HT1A receptor antagonists, (+)-WAY 100135 (1.0 μM) and WAY 100635 (0.1 μM) but not by the 5-HT1D/B antagonist, GR 127935 (0.05 μM).  The selective 5-HT1B receptor agonist, CP 93129 (0.3 μM) decreased stimulated 5-HT release to 61% of control.  This effect was antagonized by the 5-HT1B receptor antagonist, isamoltane (0.5 μM) but not by (+)-WAY 100135.  The 5-HT1D agonist, sumatriptan (0.5 μM) decreased stimulated 5-HT release to 52% of controls.  This decrease was blocked by GR 127935 but not by WAY 100635.  Apparently, 5-HT release in the rat DRN is under the control of 5-HT1A, 5-HT1B and 5-HT1D autoreceptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8kcNKxzVetLVg90H21EOLACvtfcHk0lhVBNDbjlEEBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXksFyjtrg%253D&md5=5b681d8d52622122cc580c60e9336dd7</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1995.tb13321.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1995.tb13321.x%26sid%3Dliteratum%253Aachs%26aulast%3DDavidson%26aufirst%3DC.%26aulast%3DStamford%26aufirst%3DJ.%2BA.%26atitle%3DEvidence%2520that%25205-hydroxytryptamine%2520release%2520in%2520rat%2520dorsal%2520raphe%2520nucleus%2520is%2520controlled%2520by%25205-HT1A%252C%25205-HT1B%2520and%25205-HT1D%2520autoreceptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D114%26spage%3D1107%26epage%3D1109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Davidson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, J. A.</span><span> </span><span class="NLM_article-title">Serotonin efflux in the rat ventral lateral geniculate nucleus assessed by fast cyclic voltammetry is modulated by 5-HT<sub>1B</sub> and 5-HT<sub>1D</sub> autoreceptors</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1627</span><span class="NLM_x">–</span> <span class="NLM_lpage">1634</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1996&pages=1627-1634&author=C.+Davidsonauthor=J.+A.+Stamford&title=Serotonin+efflux+in+the+rat+ventral+lateral+geniculate+nucleus+assessed+by+fast+cyclic+voltammetry+is+modulated+by+5-HT1B+and+5-HT1D+autoreceptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavidson%26aufirst%3DC.%26aulast%3DStamford%26aufirst%3DJ.%2BA.%26atitle%3DSerotonin%2520efflux%2520in%2520the%2520rat%2520ventral%2520lateral%2520geniculate%2520nucleus%2520assessed%2520by%2520fast%2520cyclic%2520voltammetry%2520is%2520modulated%2520by%25205-HT1B%2520and%25205-HT1D%2520autoreceptors%26jtitle%3DNeuropharmacology%26date%3D1996%26volume%3D35%26spage%3D1627%26epage%3D1634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Roberts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaster, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routledge, C.</span><span> </span><span class="NLM_article-title">Importance of h5-HT<sub>1B</sub> receptor selectivity for 5-HT terminal autoreceptor activity: an in vivo microdialysis study in the freely-moving guinea pig</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">549</span><span class="NLM_x">–</span> <span class="NLM_lpage">557</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=549-557&author=C.+Robertsauthor=G.+W.+Priceauthor=L.+Gasterauthor=B.+J.+Jonesauthor=D.+N.+Middlemissauthor=C.+Routledge&title=Importance+of+h5-HT1B+receptor+selectivity+for+5-HT+terminal+autoreceptor+activity%3A+an+in+vivo+microdialysis+study+in+the+freely-moving+guinea+pig"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DC.%26aulast%3DPrice%26aufirst%3DG.%2BW.%26aulast%3DGaster%26aufirst%3DL.%26aulast%3DJones%26aufirst%3DB.%2BJ.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DRoutledge%26aufirst%3DC.%26atitle%3DImportance%2520of%2520h5-HT1B%2520receptor%2520selectivity%2520for%25205-HT%2520terminal%2520autoreceptor%2520activity%253A%2520an%2520in%2520vivo%2520microdialysis%2520study%2520in%2520the%2520freely-moving%2520guinea%2520pig%26jtitle%3DNeuropharmacology%26date%3D1997%26volume%3D36%26spage%3D549%26epage%3D557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Roberts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. J.</span><span> </span><span class="NLM_article-title">The role of 5-HT<sub>1B/1D</sub> receptors in the modulation of 5-hydroxytryptamine levels in the frontal cortex of the conscious guinea pig</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Fjm100714c&amp;key=10.1016%2FS0014-2999%2897%2900156-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Fjm100714c&amp;key=9178651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A528%3ADyaK2sXjsVGhu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=1997&pages=23-30&author=C.+Robertsauthor=G.+W.+Priceauthor=B.+J.+Jones&title=The+role+of+5-HT1B%2F1D+receptors+in+the+modulation+of+5-hydroxytryptamine+levels+in+the+frontal+cortex+of+the+conscious+guinea+pig"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">The role of 5-HT1B/1D receptors in the modulation of 5-hydroxytryptamine levels in the frontal cortex of the conscious guinea pig</span></div><div class="casAuthors">Roberts, Claire; Price, Gary W.; Jones, Brian J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-30</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The role of 5-HT1B/1D receptors in modulating extracellular 5-hydroxytryptamine (5-HT) levels in the guinea pig was investigated with the nonselective 5-HT1B/1D receptor inverse agonist, methiothepin, and the selective 5-HT1B/1D receptor partial agonists, GR 127935 and GR 125743.  Extracellular 5-HT levels were measured using the technique of brain microdialysis, in the frontal cortex of the freely moving guinea pig.  Extracellular 5-HT was tetrodotoxin sensitive and calcium dependent, and increased when perfused with a high concn. of K+.  In addn., extracellular 5-HT levels were lowered by the 5-HT1B/1D receptor agonist, sumatriptan, and the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, while perfusion of the selective serotonin re-uptake inhibitor, paroxetine, increased 5-HT in a concn.-dependent manner.  Perfusion of methiothepin, GR 127935 and GR 125743 into the frontal cortex caused significant but transient increases of extracellular 5-HT.  However, systemic administration of methiothepin, GR 127935 and GR 125743, at 0.3 mg/kg i.p., produced significant decreases in extracellular 5-HT, to min. of 27%, 31% and 27% of basal, resp.  The increase of extracellular 5-HT, following 5-HT1B/1D receptor inverse and partial agonist perfusion into the frontal cortex, was probably a consequence of attenuation of an endogenous 5-HT tone at terminal 5-HT autoreceptors.  The unexpected decrease in 5-HT levels following systemic administration may be a result of addnl. attenuation of endogenous 5-HT tone at cell body autoreceptors in the raphe.  Such an increase in local 5-HT levels could then stimulate 5-HT1A receptors to inhibit cell firing and hence decrease 5-HT levels in the terminal regions.  This was confirmed when co-administration of the 5-HT1A receptor antagonist, WAY 100635, attenuated the GR 127935 decrease in 5-HT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroCdG0snkZCLVg90H21EOLACvtfcHk0lhY0TIt4HlXTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjsVGhu70%253D&md5=a89b3260998f97810b6862b604b03c95</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2897%2900156-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252897%252900156-8%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DC.%26aulast%3DPrice%26aufirst%3DG.%2BW.%26aulast%3DJones%26aufirst%3DB.%2BJ.%26atitle%3DThe%2520role%2520of%25205-HT1B%252F1D%2520receptors%2520in%2520the%2520modulation%2520of%25205-hydroxytryptamine%2520levels%2520in%2520the%2520frontal%2520cortex%2520of%2520the%2520conscious%2520guinea%2520pig%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D326%26spage%3D23%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hughes, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span> </span><span class="NLM_article-title">Differential autoreceptor control of extracellular 5-HT in guinea pig and rat: species and regional differences</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2004&pages=87-93&author=Z.+A.+Hughesauthor=L.+A.+Dawson&title=Differential+autoreceptor+control+of+extracellular+5-HT+in+guinea+pig+and+rat%3A+species+and+regional+differences"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DZ.%2BA.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26atitle%3DDifferential%2520autoreceptor%2520control%2520of%2520extracellular%25205-HT%2520in%2520guinea%2520pig%2520and%2520rat%253A%2520species%2520and%2520regional%2520differences%26jtitle%3DPsychopharmacology%26date%3D2004%26volume%3D172%26spage%3D87%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Stenfors, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallbus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S. B.</span><span> </span><span class="NLM_article-title">Synergism between 5-HT1B/1D and 5-HT1A receptor antagonists on turnover and release of 5-HT in guinea-pig brain in vivo</span> <span class="citation_source-journal">Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">359</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm100714c&amp;key=10.1007%2FPL00005329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm100714c&amp;key=10048595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A528%3ADyaK1MXkslymsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=1999&pages=110-116&author=C.+Stenforsauthor=T.+Magnussonauthor=L.+G.+Larssonauthor=H.+Yuauthor=M.+Hallbusauthor=O.+Magnussonauthor=S.+B.+Ross&title=Synergism+between+5-HT1B%2F1D+and+5-HT1A+receptor+antagonists+on+turnover+and+release+of+5-HT+in+guinea-pig+brain+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Synergism between 5-HT1B/1D and 5-HT1A receptor antagonists on turnover and release of 5-HT in guinea-pig brain in vivo</span></div><div class="casAuthors">Stenfors, C.; Magnusson, Teresa; Larsson, Lars-Gunnar; Yu, H.; Hallbus, Marie; Magnusson, O.; Ross, Svante B.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">359</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">110-116</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The effects on 5-HT turnover (5-HIAA/5-HT ratio) and extracellular 5-HT and 5-HIAA levels (in vivo microdialysis in freely moving animals) were analyzed in guinea-pig brains following the 5-HT1B receptor antagonist, GR 127935 {N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl) [1,1-biphenyl]-4-carboxamide}, or the 5-HT1A receptor antagonist, WAY-100635 (N-{2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl}-N-(2-pyridinyl) cyclohexanecarboxamide trihydrochloride), administered alone or in combination.  GR 127935, injected alone, increased 5-HT turnover with maximal effects approx. 50% above the control levels in the four brain regions examd. (hypothalamus, hippocampus, striatum and frontal cortex).  GR 127935 significantly increased extracellular concns. of 5-HT and 5-HIAA in frontal cortex (40%), whereas 5-HIAA, but not 5-HT, was elevated in striatum (20-30%).  WAY-100635 did not significantly change 5-HT turnover but caused a small significant increase in the extracellular 5-HT and 5-HIAA concns. in both striatum and frontal cortex.  The combined treatment with GR 127935 and WAY-100635 resulted in an increased 5-HT turnover reaching maximal effects of 70-90% above the control values in all brain regions tested and produced a significant elevation of striatal and frontal cortex extracellular 5-HT (40% and 60%, resp.) and 5-HIAA (60% and 70%, resp.) concns.  The synergistic effect of the two receptor antagonists on the 5-HT turnover and the terminal release of 5-HT indicate somatodendritic 5-HT release and stimulation of inhibitory 5-HT1A receptors at this level.  Extracellular 5-HIAA seems to be a better marker than 5-HT itself for the evoked 5-HT release when the reuptake mechanism is intact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroVi9rgL82jbVg90H21EOLACvtfcHk0ljg42GLoBL7zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkslymsw%253D%253D&md5=61caf9559f99dc706b8587a8c5bf47fe</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1007%2FPL00005329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FPL00005329%26sid%3Dliteratum%253Aachs%26aulast%3DStenfors%26aufirst%3DC.%26aulast%3DMagnusson%26aufirst%3DT.%26aulast%3DLarsson%26aufirst%3DL.%2BG.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DHallbus%26aufirst%3DM.%26aulast%3DMagnusson%26aufirst%3DO.%26aulast%3DRoss%26aufirst%3DS.%2BB.%26atitle%3DSynergism%2520between%25205-HT1B%252F1D%2520and%25205-HT1A%2520receptor%2520antagonists%2520on%2520turnover%2520and%2520release%2520of%25205-HT%2520in%2520guinea-pig%2520brain%2520in%2520vivo%26jtitle%3DArch.%2520Pharmacol.%26date%3D1999%26volume%3D359%26spage%3D110%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Kling, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, U. E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakker, M. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drescher, K. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornberger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchins, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moeller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wicke, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schellhaas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, G.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of highly potent dual 5-HT<sub>1A</sub> and 5-HT<sub>1B</sub> antagonists as potential antidepressant drugs</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">5567</span><span class="NLM_x">–</span> <span class="NLM_lpage">5573</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5567-5573&author=A.+Klingauthor=U.+E.+W.+Langeauthor=H.+Mackauthor=M.+H.+M.+Bakkerauthor=K.+U.+Drescherauthor=W.+Hornbergerauthor=C.+W.+Hutchinsauthor=A.+Moellerauthor=R.+Muellerauthor=M.+Schmidtauthor=L.+Ungerauthor=K.+Wickeauthor=K.+Schellhaasauthor=G.+Steiner&title=Synthesis+and+SAR+of+highly+potent+dual+5-HT1A+and+5-HT1B+antagonists+as+potential+antidepressant+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKling%26aufirst%3DA.%26aulast%3DLange%26aufirst%3DU.%2BE.%2BW.%26aulast%3DMack%26aufirst%3DH.%26aulast%3DBakker%26aufirst%3DM.%2BH.%2BM.%26aulast%3DDrescher%26aufirst%3DK.%2BU.%26aulast%3DHornberger%26aufirst%3DW.%26aulast%3DHutchins%26aufirst%3DC.%2BW.%26aulast%3DMoeller%26aufirst%3DA.%26aulast%3DMueller%26aufirst%3DR.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DUnger%26aufirst%3DL.%26aulast%3DWicke%26aufirst%3DK.%26aulast%3DSchellhaas%26aufirst%3DK.%26aulast%3DSteiner%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520highly%2520potent%2520dual%25205-HT1A%2520and%25205-HT1B%2520antagonists%2520as%2520potential%2520antidepressant%2520drugs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D5567%26epage%3D5573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ward, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vong, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">Studies on a series of potent, orally bioavailable, 5-HT<sub>1</sub> receptor ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5214</span><span class="NLM_x">–</span> <span class="NLM_lpage">5217</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5214-5217&author=S.+E.+Wardauthor=C.+N.+Johnsonauthor=P.+J.+Lovellauthor=C.+M.+Scottauthor=P.+W.+Smithauthor=G.+Stempauthor=K.+M.+Thewlisauthor=A.+K.+Vongauthor=J.+M.+Watson&title=Studies+on+a+series+of+potent%2C+orally+bioavailable%2C+5-HT1+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DS.%2BE.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DStemp%26aufirst%3DG.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DVong%26aufirst%3DA.%2BK.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3DStudies%2520on%2520a%2520series%2520of%2520potent%252C%2520orally%2520bioavailable%252C%25205-HT1%2520receptor%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5214%26epage%3D5217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ward, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddershaw, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">Discovery of Potent, Orally Bioavailable, Selective 5-HT<sub>1A/B/D</sub> Receptor Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2887</span><span class="NLM_x">–</span> <span class="NLM_lpage">2890</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8001444" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2887-2890&author=S.+E.+Wardauthor=P.+J.+Eddershawauthor=C.+M.+Scottauthor=L.+J.+Gordonauthor=P.+J.+Lovellauthor=S.+H.+Mooreauthor=P.+W.+Smithauthor=K.+R.+Starrauthor=K.+M.+Thewlisauthor=J.+M.+Watson&title=Discovery+of+Potent%2C+Orally+Bioavailable%2C+Selective+5-HT1A%2FB%2FD+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fjm8001444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8001444%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DS.%2BE.%26aulast%3DEddershaw%26aufirst%3DP.%2BJ.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DGordon%26aufirst%3DL.%2BJ.%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DMoore%26aufirst%3DS.%2BH.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3DDiscovery%2520of%2520Potent%252C%2520Orally%2520Bioavailable%252C%2520Selective%25205-HT1A%252FB%252FD%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2887%26epage%3D2890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ward, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddershaw, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyman, P. A.</span><span> </span><span class="NLM_article-title">Studies on a series of potent, orally bioavailable, 5-HT<sub>1</sub> receptor ligands-Part II</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">428</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=428-432&author=S.+E.+Wardauthor=P.+J.+Eddershawauthor=S.+T.+Flynnauthor=L.+Gordonauthor=P.+J.+Lovellauthor=S.+H.+Mooreauthor=C.+M.+Scottauthor=P.+W.+Smithauthor=K.+M.+Thewlisauthor=P.+A.+Wyman&title=Studies+on+a+series+of+potent%2C+orally+bioavailable%2C+5-HT1+receptor+ligands-Part+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DS.%2BE.%26aulast%3DEddershaw%26aufirst%3DP.%2BJ.%26aulast%3DFlynn%26aufirst%3DS.%2BT.%26aulast%3DGordon%26aufirst%3DL.%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DMoore%26aufirst%3DS.%2BH.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DWyman%26aufirst%3DP.%2BA.%26atitle%3DStudies%2520on%2520a%2520series%2520of%2520potent%252C%2520orally%2520bioavailable%252C%25205-HT1%2520receptor%2520ligands-Part%2520II%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D428%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Atkinson, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bromidge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duxon, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaster, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadley, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">North, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rami, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vong, A. K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">3,4-Dihydro-2<i>H</i>-benzoxazinones are 5-HT<sub>1A</sub> receptor antagonists with potent 5-HT reuptake inhibitory activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=737-741&author=P.+J.+Atkinsonauthor=S.+M.+Bromidgeauthor=M.+S.+Duxonauthor=L.+M.+Gasterauthor=M.+S.+Hadleyauthor=B.+Hammondauthor=C.+N.+Johnsonauthor=D.+N.+Middlemissauthor=S.+E.+Northauthor=G.+W.+Priceauthor=H.+K.+Ramiauthor=G.+J.+Rileyauthor=C.+M.+Scottauthor=T.+E.+Shawauthor=K.+R.+Starrauthor=G.+Stempauthor=K.+M.+Thewlisauthor=D.+R.+Thomasauthor=M.+Thompsonauthor=A.+K.+K.+Vongauthor=J.+M.+Watson&title=3%2C4-Dihydro-2H-benzoxazinones+are+5-HT1A+receptor+antagonists+with+potent+5-HT+reuptake+inhibitory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAtkinson%26aufirst%3DP.%2BJ.%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26aulast%3DDuxon%26aufirst%3DM.%2BS.%26aulast%3DGaster%26aufirst%3DL.%2BM.%26aulast%3DHadley%26aufirst%3DM.%2BS.%26aulast%3DHammond%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DNorth%26aufirst%3DS.%2BE.%26aulast%3DPrice%26aufirst%3DG.%2BW.%26aulast%3DRami%26aufirst%3DH.%2BK.%26aulast%3DRiley%26aufirst%3DG.%2BJ.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DShaw%26aufirst%3DT.%2BE.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DStemp%26aufirst%3DG.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DThomas%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DM.%26aulast%3DVong%26aufirst%3DA.%2BK.%2BK.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3D3%252C4-Dihydro-2H-benzoxazinones%2520are%25205-HT1A%2520receptor%2520antagonists%2520with%2520potent%25205-HT%2520reuptake%2520inhibitory%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D737%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Serafinowska, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">Novel 5-HT<sub>1A/1B/1D</sub> receptors antagonists with potent 5-HT reuptake inhibitory activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5581</span><span class="NLM_x">–</span> <span class="NLM_lpage">5585</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5581-5585&author=H.+T.+Serafinowskaauthor=F.+E.+Blaneyauthor=P.+J.+Lovellauthor=G.+G.+Merloauthor=C.+M.+Scottauthor=P.+W.+Smithauthor=K.+R.+Starrauthor=J.+M.+Watson&title=Novel+5-HT1A%2F1B%2F1D+receptors+antagonists+with+potent+5-HT+reuptake+inhibitory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSerafinowska%26aufirst%3DH.%2BT.%26aulast%3DBlaney%26aufirst%3DF.%2BE.%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DMerlo%26aufirst%3DG.%2BG.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3DNovel%25205-HT1A%252F1B%252F1D%2520receptors%2520antagonists%2520with%2520potent%25205-HT%2520reuptake%2520inhibitory%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5581%26epage%3D5585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Bromidge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borriello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faedo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granci, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stasi, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zucchelli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo, G</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesentini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zonzini, L.</span><span> </span><span class="NLM_article-title">6-[2-(4-Aryl-1-piperazinyl)ethyl]-2<i>H</i>-1,4-benzoxazin-3(4<i>H</i>)-ones: Dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5653</span><span class="NLM_x">–</span> <span class="NLM_lpage">5656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5653-5656&author=S.+M.+Bromidgeauthor=B.+Bertaniauthor=M.+Borrielloauthor=S.+Faedoauthor=L.+J.+Gordonauthor=E.+Granciauthor=M.+Hillauthor=H.+R.+Marshallauthor=L.+P.+Stasiauthor=V.+Zucchelliauthor=G+Merloauthor=A.+Vesentiniauthor=J.+M.+Watsonauthor=L.+Zonzini&title=6-%5B2-%284-Aryl-1-piperazinyl%29ethyl%5D-2H-1%2C4-benzoxazin-3%284H%29-ones%3A+Dual-acting+5-HT1+receptor+antagonists+and+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26aulast%3DBertani%26aufirst%3DB.%26aulast%3DBorriello%26aufirst%3DM.%26aulast%3DFaedo%26aufirst%3DS.%26aulast%3DGordon%26aufirst%3DL.%2BJ.%26aulast%3DGranci%26aufirst%3DE.%26aulast%3DHill%26aufirst%3DM.%26aulast%3DMarshall%26aufirst%3DH.%2BR.%26aulast%3DStasi%26aufirst%3DL.%2BP.%26aulast%3DZucchelli%26aufirst%3DV.%26aulast%3DMerlo%26aufirst%3DG%26aulast%3DVesentini%26aufirst%3DA.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26aulast%3DZonzini%26aufirst%3DL.%26atitle%3D6-%255B2-%25284-Aryl-1-piperazinyl%2529ethyl%255D-2H-1%252C4-benzoxazin-3%25284H%2529-ones%253A%2520Dual-acting%25205-HT1%2520receptor%2520antagonists%2520and%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5653%26epage%3D5656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span>Enterprise Level Cheminformatics; <span class="NLM_publisher-name">Daylight Chemical Information Systems Inc.</span>: <span class="NLM_publisher-loc">Laguna Niguel, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span><a href="http://www.daylight.com" class="extLink">http://www.daylight.com</a>. (Accessed March, 2010).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Enterprise+Level+Cheminformatics%3B+Daylight+Chemical+Information+Systems+Inc.%3A+Laguna+Niguel%2C+CA%2C+2008%3B+http%3A%2F%2Fwww.daylight.com.+%28Accessed+March%2C+2010%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DEnterprise%2520Level%2520Cheminformatics%26pub%3DDaylight%2520Chemical%2520Information%2520Systems%2520Inc%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tristani-Firouzi, M.</span><span> </span><span class="NLM_article-title">hERG potassium channels and cardiac arrhythmia</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Fjm100714c&amp;key=10.1038%2Fnature04710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Fjm100714c&amp;key=16554806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2006&pages=463-469&author=M.+C.+Sanguinettiauthor=M.+Tristani-Firouzi&title=hERG+potassium+channels+and+cardiac+arrhythmia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">hERG potassium channels and cardiac arrhythmia</span></div><div class="casAuthors">Sanguinetti, Michael C.; Tristani-Firouzi, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">440</span>
        (<span class="NLM_cas:issue">7083</span>),
    <span class="NLM_cas:pages">463-469</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  HERG potassium channels are essential for normal elec. activity in the heart.  Inherited mutations in the HERG gene cause long QT syndrome, a disorder that predisposes individuals to life-threatening arrhythmias.  Arrhythmia can also be induced by a blockage of hERG channels by a surprisingly diverse group of drugs.  This side effect is a common reason for drug failure in preclin. safety trials.  Insights gained from the crystal structures of other potassium channels have helped our understanding of the block of hERG channels and the mechanisms of gating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopS3WBEpuAUrVg90H21EOLACvtfcHk0ljl0QgD3ofnMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D&md5=3f355dcd51da3488d73c7c91cbe8d3b8</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1038%2Fnature04710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04710%26sid%3Dliteratum%253Aachs%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DTristani-Firouzi%26aufirst%3DM.%26atitle%3DhERG%2520potassium%2520channels%2520and%2520cardiac%2520arrhythmia%26jtitle%3DNature%26date%3D2006%26volume%3D440%26spage%3D463%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mitcheson, J. S.</span><span> </span><span class="NLM_article-title">hERG Potassium Channels and the Structural Basis of Drug-Induced Arrhythmias</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx800035b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=1005-1010&author=J.+S.+Mitcheson&title=hERG+Potassium+Channels+and+the+Structural+Basis+of+Drug-Induced+Arrhythmias"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Ftx800035b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800035b%26sid%3Dliteratum%253Aachs%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26atitle%3DhERG%2520Potassium%2520Channels%2520and%2520the%2520Structural%2520Basis%2520of%2520Drug-Induced%2520Arrhythmias%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D1005%26epage%3D1010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="note"><p class="first last">All the work involving animals was carried out in accordance with European directive 86/609/EEC governing animal welfare and protection, which is acknowledged by Italian Legislative Decree no. 116, 27 January 1992, and according to internal review performed by the GlaxoSmithKline Committee on Animal Research & Ethics (CARE) and to the company Policy on the Care and Use of Laboratory Animals</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span>Cerep; <span class="NLM_publisher-name">Cerep</span>: <span class="NLM_publisher-loc">Paris</span>; <a href="http://www.cerep.fr" class="extLink">http://www.cerep.fr</a>. (Accessed March, 2010).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Cerep%3B+Cerep%3A+Paris%3B+http%3A%2F%2Fwww.cerep.fr.+%28Accessed+March%2C+2010%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DCerep%26pub%3DCerep" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Lazareno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birdsall, N. J. M.</span><span> </span><span class="NLM_article-title">Pharmacology characterization of guanine nucleotide exchange reactions in membranes from Cho cells stably transfected with human muscarinic receptors m1−m4</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">449</span><span class="NLM_x">–</span> <span class="NLM_lpage">456</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1993&pages=449-456&author=S.+Lazarenoauthor=N.+J.+M.+Birdsall&title=Pharmacology+characterization+of+guanine+nucleotide+exchange+reactions+in+membranes+from+Cho+cells+stably+transfected+with+human+muscarinic+receptors+m1%E2%88%92m4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLazareno%26aufirst%3DS.%26aulast%3DBirdsall%26aufirst%3DN.%2BJ.%2BM.%26atitle%3DPharmacology%2520characterization%2520of%2520guanine%2520nucleotide%2520exchange%2520reactions%2520in%2520membranes%2520from%2520Cho%2520cells%2520stably%2520transfected%2520with%2520human%2520muscarinic%2520receptors%2520m1%25E2%2588%2592m4%26jtitle%3DLife%2520Sci.%26date%3D1993%26volume%3D52%26spage%3D449%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2a','cit2b'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c','cit4d','cit4e'],'ref5':['cit5a','cit5b','cit5c','cit5d','cit5e','cit5f','cit5g','cit5h','cit5i','cit5j','cit5k','cit5l','cit5m'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8a','cit8b','cit8c'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17a','cit17b'],'ref18':[],'ref19':['cit19'],'ref20':['cit20']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 9 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongjun  Mao</span>, <span class="hlFld-ContribAuthor ">Nan  Lin</span>, <span class="hlFld-ContribAuthor ">Wang  Tian</span>, <span class="hlFld-ContribAuthor ">Xiaofeng  Han</span>, <span class="hlFld-ContribAuthor ">Xiaobing  Han</span>, <span class="hlFld-ContribAuthor ">Ziwei  Huang</span>, and <span class="hlFld-ContribAuthor ">Jing  An</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of New Diaminoquinazolines as β-Catenin/Tcf4 Pathway Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (3)
                                     , 1346-1359. <a href="https://doi.org/10.1021/jm201494a" title="DOI URL">https://doi.org/10.1021/jm201494a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201494a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201494a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BNew%252BDiaminoquinazolines%252Bas%252B%2525CE%2525B2-Catenin%25252FTcf4%252BPathway%252BInhibitors%26aulast%3DMao%26aufirst%3DYongjun%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D04112011%26date%3D24012012%26date%3D09022012%26date%3D09012012%26volume%3D55%26issue%3D3%26spage%3D1346%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Navpreet  Kaur</span>, <span class="hlFld-ContribAuthor ">Priyanka  Singh</span>, <span class="hlFld-ContribAuthor ">Prabal  Banerjee</span>. </span><span class="cited-content_cbyCitation_article-title">Vinylogous Aza‐Michael Addition of Urea Derivatives with
              p
              ‐Quinone Methides Followed by Oxidative Dearomative Cyclization: Approach to Spiroimidazolidinone Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2021,</strong> <em>363 </em>
                                    (11)
                                     , 2813-2824. <a href="https://doi.org/10.1002/adsc.202100077" title="DOI URL">https://doi.org/10.1002/adsc.202100077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202100077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202100077%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DVinylogous%252BAza%2525E2%252580%252590Michael%252BAddition%252Bof%252BUrea%252BDerivatives%252Bwith%252Bp%252B%2525E2%252580%252590Quinone%252BMethides%252BFollowed%252Bby%252BOxidative%252BDearomative%252BCyclization%25253A%252BApproach%252Bto%252BSpiroimidazolidinone%252BDerivatives%26aulast%3DKaur%26aufirst%3DNavpreet%26date%3D2021%26date%3D2021%26volume%3D363%26issue%3D11%26spage%3D2813%26epage%3D2824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Attila  Egyed</span>, <span class="hlFld-ContribAuthor ">Ádám A.  Kelemen</span>, <span class="hlFld-ContribAuthor ">Márton  Vass</span>, <span class="hlFld-ContribAuthor ">András  Visegrády</span>, <span class="hlFld-ContribAuthor ">Stephanie A.  Thee</span>, <span class="hlFld-ContribAuthor ">Zhiyong  Wang</span>, <span class="hlFld-ContribAuthor ">Chris  de Graaf</span>, <span class="hlFld-ContribAuthor ">Jose  Brea</span>, <span class="hlFld-ContribAuthor ">Maria Isabel  Loza</span>, <span class="hlFld-ContribAuthor ">Rob  Leurs</span>, <span class="hlFld-ContribAuthor ">György M.  Keserű</span>. </span><span class="cited-content_cbyCitation_article-title">Controlling the selectivity of aminergic GPCR ligands from the extracellular vestibule. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>111 </em>, 104832. <a href="https://doi.org/10.1016/j.bioorg.2021.104832" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104832</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104832%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DControlling%252Bthe%252Bselectivity%252Bof%252Baminergic%252BGPCR%252Bligands%252Bfrom%252Bthe%252Bextracellular%252Bvestibule%26aulast%3DEgyed%26aufirst%3DAttila%26date%3D2021%26volume%3D111%26spage%3D104832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Costantino</span>, <span class="hlFld-ContribAuthor ">Daniela  Barlocco</span>. </span><span class="cited-content_cbyCitation_article-title">Designing Approaches to Multitarget Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 161-205. <a href="https://doi.org/10.1002/9783527674381.ch7" title="DOI URL">https://doi.org/10.1002/9783527674381.ch7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527674381.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527674381.ch7%26sid%3Dliteratum%253Aachs%26atitle%3DDesigning%252BApproaches%252Bto%252BMultitarget%252BDrugs%26aulast%3DCostantino%26aufirst%3DLuca%26date%3D2017%26date%3D2017%26spage%3D161%26epage%3D205%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DDrug%252BSelectivity%26aulast%3DHandler%26aufirst%3DNorbert%26date%3D2017%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad  Shaquiquzzaman</span>, <span class="hlFld-ContribAuthor ">Garima  Verma</span>, <span class="hlFld-ContribAuthor ">Akranth  Marella</span>, <span class="hlFld-ContribAuthor ">Mymoona  Akhter</span>, <span class="hlFld-ContribAuthor ">Wasim  Akhtar</span>, <span class="hlFld-ContribAuthor ">Mohemmed Faraz  Khan</span>, <span class="hlFld-ContribAuthor ">Sharba  Tasneem</span>, <span class="hlFld-ContribAuthor ">Mohammad Mumtaz  Alam</span>. </span><span class="cited-content_cbyCitation_article-title">Piperazine scaffold: A remarkable tool in generation of diverse pharmacological agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>102 </em>, 487-529. <a href="https://doi.org/10.1016/j.ejmech.2015.07.026" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.07.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.07.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.07.026%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPiperazine%252Bscaffold%25253A%252BA%252Bremarkable%252Btool%252Bin%252Bgeneration%252Bof%252Bdiverse%252Bpharmacological%252Bagents%26aulast%3DShaquiquzzaman%26aufirst%3DMohammad%26date%3D2015%26volume%3D102%26spage%3D487%26epage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert A.  Comley</span>, <span class="hlFld-ContribAuthor ">Jasper  van der Aart</span>, <span class="hlFld-ContribAuthor ">Balázs  Gulyás</span>, <span class="hlFld-ContribAuthor ">Martine  Garnier</span>, <span class="hlFld-ContribAuthor ">Laura  Iavarone</span>, <span class="hlFld-ContribAuthor ">Christer  Halldin</span>, <span class="hlFld-ContribAuthor ">Eugenii A.  Rabiner</span>. </span><span class="cited-content_cbyCitation_article-title">In vivo occupancy of the 5-HT1A receptor by a novel pan 5-HT1(A/B/D) receptor antagonist, GSK588045, using positron emission tomography. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2015,</strong> <em>92 </em>, 44-48. <a href="https://doi.org/10.1016/j.neuropharm.2014.11.017" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2014.11.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2014.11.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2014.11.017%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DIn%2525C2%2525A0vivo%252Boccupancy%252Bof%252Bthe%252B5-HT1A%252Breceptor%252Bby%252Ba%252Bnovel%252Bpan%252B5-HT1%252528A%25252FB%25252FD%252529%252Breceptor%252Bantagonist%25252C%252BGSK588045%25252C%252Busing%252Bpositron%252Bemission%252Btomography%26aulast%3DComley%26aufirst%3DRobert%2BA.%26date%3D2015%26volume%3D92%26spage%3D44%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dawid  Warszycki</span>, <span class="hlFld-ContribAuthor ">Stefan  Mordalski</span>, <span class="hlFld-ContribAuthor ">Jakub  Staroń</span>, <span class="hlFld-ContribAuthor ">Andrzej J.  Bojarski</span>. </span><span class="cited-content_cbyCitation_article-title">Bioisosteric Matrices for Ligands of Serotonin Receptors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2015,</strong> <em>10 </em>
                                    (4)
                                     , 601-605. <a href="https://doi.org/10.1002/cmdc.201402563" title="DOI URL">https://doi.org/10.1002/cmdc.201402563</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201402563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201402563%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DBioisosteric%252BMatrices%252Bfor%252BLigands%252Bof%252BSerotonin%252BReceptors%26aulast%3DWarszycki%26aufirst%3DDawid%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D4%26spage%3D601%26epage%3D605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun-An  Xiao</span>, <span class="hlFld-ContribAuthor ">Chao-Ming  Wang</span>, <span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">Guang-Chuan  Ou</span>, <span class="hlFld-ContribAuthor ">Xing-Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Hua  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Highly stereoselective synthesis of novel spiroimidazolidinones directed by pyridine prolinamide. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2015,</strong> <em>71 </em>
                                    (5)
                                     , 805-812. <a href="https://doi.org/10.1016/j.tet.2014.12.055" title="DOI URL">https://doi.org/10.1016/j.tet.2014.12.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.12.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.12.055%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DHighly%252Bstereoselective%252Bsynthesis%252Bof%252Bnovel%252Bspiroimidazolidinones%252Bdirected%252Bby%252Bpyridine%252Bprolinamide%26aulast%3DXiao%26aufirst%3DJun-An%26date%3D2015%26volume%3D71%26issue%3D5%26spage%3D805%26epage%3D812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuqiang  Ding</span>, <span class="hlFld-ContribAuthor ">Biao  Xiong</span>, <span class="hlFld-ContribAuthor ">Ting  Wang</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient One-Pot Synthesis of 2-Alkylquinolines under Solvent-Free Conditions Using Sulfonic Acid Functionalized Ionic Liquid as a Recoverable and Reusable Catalyst. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2011,</strong> <em>83 </em>
                                    (10)
                                     , 2289. <a href="https://doi.org/10.3987/COM-11-12289" title="DOI URL">https://doi.org/10.3987/COM-11-12289</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-11-12289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-11-12289%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DEfficient%252BOne-Pot%252BSynthesis%252Bof%252B2-Alkylquinolines%252Bunder%252BSolvent-Free%252BConditions%252BUsing%252BSulfonic%252BAcid%252BFunctionalized%252BIonic%252BLiquid%252Bas%252Ba%252BRecoverable%252Band%252BReusable%252BCatalyst%26aulast%3DZhang%26aufirst%3DMin%26date%3D2011%26volume%3D83%26issue%3D10%26spage%3D2289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-23/jm100714c/production/images/medium/jm-2010-00714c_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-23/jm100714c/production/images/large/jm-2010-00714c_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100714c&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-23/jm100714c/production/images/medium/jm-2010-00714c_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-23/jm100714c/production/images/large/jm-2010-00714c_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of <b>1</b>, a 5-HT<sub>1</sub> receptor antagonist, and <b>2</b> and <b>3</b>, dual acting 5-HT<sub>1</sub> receptor antagonist/serotonin reuptake inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-23/jm100714c/production/images/large/jm-2010-00714c_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100714c&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-23/jm100714c/production/images/medium/jm-2010-00714c_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-23/jm100714c/production/images/large/jm-2010-00714c_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-23/jm100714c/production/images/large/jm-2010-00714c_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100714c&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Tf<sub>2</sub>O, pyridine, dichloromethane, 0 °C, 92%; (ii) 1-Boc-piperazine, Cs<sub>2</sub>CO<sub>4</sub>, Pd(OAc)<sub>2</sub>, BINAP, toluene, reflux, 62%; (iii) TFA, dichloromethane, room temp, 96%; (iv) 2-(3-nitrophenyl)ethyl methanesulfonate, DIPEA, DMF, 100 °C, 64%; (v) Fe powder, NH<sub>4</sub>Cl, MeOH, reflux, 84%; (vi) for sulfonamides RSO<sub>2</sub>Cl, pyridine, room temp, 44−62%; for amides RCO<sub>2</sub>H, EDC, HOBt, dichloromethane/DMF, room temp or RCOCl, DIPEA, dichloromethane, room temp; for ureas RNCO, dichloromethane, room temp or triphosgene, TEA, RNH<sub>2</sub>, 0 °C; for carbamates (RO)COCl, DIPEA, dichloromethane, 0 °C; (vii) MeI, NaH, THF, 0 °C; (viii) NaH, THF, 0 °C.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i70">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 20 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hirschfeld, R. M. A.</span><span> </span><span class="NLM_article-title">History and evolution of the monoamine hypothesis of depression</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm100714c&amp;key=10.4088%2FJCP.v61n0405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm100714c&amp;key=10775017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtV2itL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2000&pages=4-6&author=R.+M.+A.+Hirschfeld&title=History+and+evolution+of+the+monoamine+hypothesis+of+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">History and evolution of the monoamine hypothesis of depression</span></div><div class="casAuthors">Hirschfeld, Robert M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">Suppl. 6</span>),
    <span class="NLM_cas:pages">4-6</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press, Inc.</span>)
        </div><div class="casAbstract">A review, with 24 refs.  The symptoms of depression can be improved by agents that act by various mechanisms to increase synaptic concns. of monoamines.  This finding led to the adoption of the monoamine hypothesis of depression, first put forward over 30 yr ago, which proposes that the underlying biol. or neuroanatomical basis for depression is a deficiency of central noradrenergic and/or serotonergic systems and that targeting this neuronal lesion with an antidepressant would tend to restore normal function in depressed patients.  The hypothesis has enjoyed considerable support, since it attempts to provide a pathophysiol. explanation of the actions of antidepressants.  However, in its original form it is clearly inadequate, as it does not provide a complete explanation for the actions of antidepressants, and the pathophysiol. of depression itself remains unknown.  The hypothesis has evolved over the years to include, for example, adaptive changes in receptors to explain why there should be only a gradual clin. response to antidepressant treatment when the increase in availability of monoamines is rapid.  Still, the monoamine hypothesis does not address key issues such as why antidepressants are also effective in other disorders such as panic disorder, obsessive-compulsive disorder, and bulimia, or why all drugs that enhance serotonergic or noradrenergic transmission are not necessarily effective in depression.  Despite these limitations, however, it is clear that the development of the monoamine hypothesis has been of great importance in understanding depression and in the development of safe and effective pharmacol. agents for its treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZF-M-PX4Qp7Vg90H21EOLACvtfcHk0lixd4MlmiwcGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtV2itL4%253D&md5=0bddf7611fade8f2fd1148ec216066f2</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.4088%2FJCP.v61n0405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4088%252FJCP.v61n0405%26sid%3Dliteratum%253Aachs%26aulast%3DHirschfeld%26aufirst%3DR.%2BM.%2BA.%26atitle%3DHistory%2520and%2520evolution%2520of%2520the%2520monoamine%2520hypothesis%2520of%2520depression%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2000%26volume%3D61%26spage%3D4%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lucki, I.</span><span> </span><span class="NLM_article-title">The spectrum of behaviors influenced by serotonin</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm100714c&amp;key=10.1016%2FS0006-3223%2898%2900139-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm100714c&amp;key=9693387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A528%3ADyaK1cXlsVOhsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1998&pages=151-162&author=I.+Lucki&title=The+spectrum+of+behaviors+influenced+by+serotonin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The spectrum of behaviors influenced by serotonin</span></div><div class="casAuthors">Lucki, Irwin</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">151-162</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review, with 110 refs., on the diverse array of behavioral effects of serotonin form the basis for understanding its potential role as an etiol. marker in psychiatric disorders and for the successful pharmacol. intervention of drugs regulating serotonin neurotransmission in behavior.  General theories of the behavioral functions of serotonin have implicated serotonin as a general inhibitor of behavioral responding and in modulating motor behavior.  The ability of serotonin to regulate behavioral satiety and macronutrient selection provides the basis for pharmacol. treatment of obesity and eating disorders.  The role of serotonin in behavioral suppression may be important in social behavior involving aggression and anxiety.  The role of serotonin in neuroendocrine regulation provides a basis for understanding serotonin dysregulation in depression.  Animal behavior tests are being used to better understand the neural substrates underlying the behavioral effects of antidepressant drugs and to address important issues in clin. treatment.  The integration of information between basic and clin. studies provides the basis for future development of more sophisticated pharmacol. treatments of psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGHI5Ew2l3Y7Vg90H21EOLACvtfcHk0linsUeB9MjVwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsVOhsb8%253D&md5=888b9d7d85a45ed3e65e0ef718b5b288</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2898%2900139-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252898%252900139-5%26sid%3Dliteratum%253Aachs%26aulast%3DLucki%26aufirst%3DI.%26atitle%3DThe%2520spectrum%2520of%2520behaviors%2520influenced%2520by%2520serotonin%26jtitle%3DBiol.%2520Psychiatry%26date%3D1998%26volume%3D44%26spage%3D151%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Naughton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulrooney, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, B. E.</span><span> </span><span class="NLM_article-title">A review of the role of serotonin receptors in psychiatric disorders</span> <span class="citation_source-journal">Human Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm100714c&amp;key=10.1002%2F1099-1077%28200008%2915%3A6%3C397%3A%3AAID-HUP212%3E3.0.CO%3B2-L" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm100714c&amp;key=12404302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntFCiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2000&pages=397-415&author=M.+Naughtonauthor=J.+B.+Mulrooneyauthor=B.+E.+Leonard&title=A+review+of+the+role+of+serotonin+receptors+in+psychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the role of serotonin receptors in psychiatric disorders</span></div><div class="casAuthors">Naughton, Marie; Mulrooney, Jane B.; Leonard, Brian E.</div><div class="citationInfo"><span class="NLM_cas:title">Human Psychopharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">397-415</span>CODEN:
                <span class="NLM_cas:coden">HUPSEC</span>;
        ISSN:<span class="NLM_cas:issn">0885-6222</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review with many refs.  Serotonin (5-hydroxytryptamine, 5-HT) mediates a wide variety of physiol. functions by activating multiple receptors, and abnormalities of these receptor systems was implicated in many psychiatric disorders including anxiety, depression, psychosis, migraine, disorders of sexual functioning, sleep, cognition, and feeding.  Many of the currently used treatments for these disorders act by affecting the serotonergic system.  Observation of serotonin receptor alterations, before and following effective treatments, may yield important insights into the etiol. of these psychiatric disorders and may ultimately lead to more selective and effective therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEhSNrDcM0h7Vg90H21EOLACvtfcHk0linsUeB9MjVwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntFCiurw%253D&md5=18be55930836492c6f605103ea4cc7b1</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1002%2F1099-1077%28200008%2915%3A6%3C397%3A%3AAID-HUP212%3E3.0.CO%3B2-L&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1099-1077%2528200008%252915%253A6%253C397%253A%253AAID-HUP212%253E3.0.CO%253B2-L%26sid%3Dliteratum%253Aachs%26aulast%3DNaughton%26aufirst%3DM.%26aulast%3DMulrooney%26aufirst%3DJ.%2BB.%26aulast%3DLeonard%26aufirst%3DB.%2BE.%26atitle%3DA%2520review%2520of%2520the%2520role%2520of%2520serotonin%2520receptors%2520in%2520psychiatric%2520disorders%26jtitle%3DHuman%2520Psychopharmacol.%26date%3D2000%26volume%3D15%26spage%3D397%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wood, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">Therapeutic potential of serotonin antagonists in depressive disorders</span> <span class="citation_source-journal">Exp. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2002&pages=457-467&author=M.+D.+Woodauthor=D.+R.+Thomasauthor=J.+M.+Watson&title=Therapeutic+potential+of+serotonin+antagonists+in+depressive+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DM.%2BD.%26aulast%3DThomas%26aufirst%3DD.%2BR.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3DTherapeutic%2520potential%2520of%2520serotonin%2520antagonists%2520in%2520depressive%2520disorders%26jtitle%3DExp.%2520Opin.%2520Invest.%2520Drugs%26date%3D2002%26volume%3D11%26spage%3D457%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Blier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Montigny, C.</span><span> </span><span class="NLM_article-title">Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">91S</span><span class="NLM_x">–</span> <span class="NLM_lpage">98S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1999&pages=91S-98S&author=P.+Blierauthor=C.+De+Montigny&title=Serotonin+and+drug-induced+therapeutic+responses+in+major+depression%2C+obsessive-compulsive+and+panic+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlier%26aufirst%3DP.%26aulast%3DDe%2BMontigny%26aufirst%3DC.%26atitle%3DSerotonin%2520and%2520drug-induced%2520therapeutic%2520responses%2520in%2520major%2520depression%252C%2520obsessive-compulsive%2520and%2520panic%2520disorders%26jtitle%3DNeuropsychopharmacology%26date%3D1999%26volume%3D21%26spage%3D91S%26epage%3D98S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Duxon, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upton, N.</span><span> </span><span class="NLM_article-title">Latency to paroxetine-induced anxiolysis in the rat is reduced by co-administration of the 5-HT<sub>1A</sub> receptor antagonist WAY100635</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">1713</span><span class="NLM_x">–</span> <span class="NLM_lpage">1719</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm100714c&amp;key=10.1038%2Fsj.bjp.0703496" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm100714c&amp;key=10928979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlslygs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2000&pages=1713-1719&author=M.+S.+Duxonauthor=K.+R.+Starrauthor=N.+Upton&title=Latency+to+paroxetine-induced+anxiolysis+in+the+rat+is+reduced+by+co-administration+of+the+5-HT1A+receptor+antagonist+WAY100635"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Latency to paroxetine-induced anxiolysis in the rat is reduced by co-administration of the 5-HT1A receptor antagonist WAY100635</span></div><div class="casAuthors">Duxon, M. S.; Starr, K. R.; Upton, N.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1713-1719</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report here the use of rat high-light social interaction to model the temporal anxiolytic/antidepressant effects of SSRIs seen in the clinic.  Compared to vehicle controls, 21, but not 14, days of paroxetine treatment (3 mg kg-1, p.o., daily) produced a marked increase in rat social interaction (Vehicle=71.3 ± 7.3 s; Paroxetine=116.7 ± 14.7 s; P<0.01) with no concurrent effect on locomotor activity, consistent with anxiolysis.  To assess whether concurrent 5-HT1A receptor blockade reduces the time to onset of anxiolysis seen with paroxetine alone (21 days), rats were implanted with osmotic minipumps to continuously infuse the 5-HT1A receptor antagonist WAY100635 (1 mg kg-1 day-1, s.c., 7 days) alone or in combination with paroxetine (3 mg kg-1, p.o., daily, 7 days), prior to anxiety testing.  Paroxetine (Veh/Par=61.9 ± 7.9 s) or WAY100635 (WAY/Veh=71.6 ± 4.7 s) alone, had no effect on social interaction time compared to vehicle treated controls (Veh/Veh = 76.4 ± 4.9 s), while coadministration of WAY100635 with paroxetine, produced a marked elevation in social interaction (WAY/Par=149.3 ± 16.8 s; P<0.01) relative to all other groups with no concurrent change in locomotor activity.  In contrast, acute administration of WAY100635 (0.03 mg kg-1, s.c.) with paroxetine (3 mg kg-1, p.o.) did not alter any behavioral measure, suggesting that the anxiolysis induced by the combination after 7 days is attributable to a CNS adaptive response.  This data demonstrates that coadministration of a 5-HT1A receptor antagonist with paroxetine markedly reduces the latency to anxiolysis, in the rat.  This study supports the use of the rat social interaction test to further delineate adaptive changes in the CNS responsible for the anxiolytic/antidepressant action of SSRIs seen in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOTWecxFYs9bVg90H21EOLACvtfcHk0linsUeB9MjVwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlslygs7c%253D&md5=e5b489edbe2c074f13d48c25af29dc91</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703496%26sid%3Dliteratum%253Aachs%26aulast%3DDuxon%26aufirst%3DM.%2BS.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DUpton%26aufirst%3DN.%26atitle%3DLatency%2520to%2520paroxetine-induced%2520anxiolysis%2520in%2520the%2520rat%2520is%2520reduced%2520by%2520co-administration%2520of%2520the%25205-HT1A%2520receptor%2520antagonist%2520WAY100635%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D130%26spage%3D1713%26epage%3D1719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McAskill, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, D.</span><span> </span><span class="NLM_article-title">Pindolol augmentation of antidepressant therapy</span> <span class="citation_source-journal">Br. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm100714c&amp;key=10.1192%2Fbjp.173.3.203" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1998&pages=203-208&author=R.+McAskillauthor=S.+Mirauthor=D.+Taylor&title=Pindolol+augmentation+of+antidepressant+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1192%2Fbjp.173.3.203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1192%252Fbjp.173.3.203%26sid%3Dliteratum%253Aachs%26aulast%3DMcAskill%26aufirst%3DR.%26aulast%3DMir%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DD.%26atitle%3DPindolol%2520augmentation%2520of%2520antidepressant%2520therapy%26jtitle%3DBr.%2520J.%2520Psychiatry%26date%3D1998%26volume%3D73%26spage%3D203%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Artigas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, E.</span><span> </span><span class="NLM_article-title">Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">1994</span><span class="NLM_x">) </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm100714c&amp;key=10.1001%2Farchpsyc.1994.03950030084009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm100714c&amp;key=8122960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A280%3ADyaK2c7mvVGitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1994&pages=248-251&issue=1994&author=F.+Artigasauthor=V.+Perezauthor=E.+Alvarez&title=Pindolol+induces+a+rapid+improvement+of+depressed+patients+treated+with+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors</span></div><div class="casAuthors">Artigas F; Perez V; Alvarez E</div><div class="citationInfo"><span class="NLM_cas:title">Archives of general psychiatry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">248-51</span>
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8elF--uOnsj69zv1FsJFMfW6udTcc2eaEXyzpz1_zlLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c7mvVGitw%253D%253D&md5=19dc44e630d37442b5707cc26daa4a90</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.1994.03950030084009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.1994.03950030084009%26sid%3Dliteratum%253Aachs%26aulast%3DArtigas%26aufirst%3DF.%26aulast%3DPerez%26aufirst%3DV.%26aulast%3DAlvarez%26aufirst%3DE.%26atitle%3DPindolol%2520induces%2520a%2520rapid%2520improvement%2520of%2520depressed%2520patients%2520treated%2520with%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1994%26volume%3D51%26issue%3D1994%26spage%3D248%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Blier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, R.</span><span> </span><span class="NLM_article-title">Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression</span> <span class="citation_source-journal">J. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Fjm100714c&amp;key=10.1097%2F00004714-199506000-00011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm100714c&amp;key=7636000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A280%3ADyaK2Mzmt1yktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=217-222&author=P.+Blierauthor=R.+Bergeron&title=Effectiveness+of+pindolol+with+selected+antidepressant+drugs+in+the+treatment+of+major+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression</span></div><div class="casAuthors">Blier P; Bergeron R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical psychopharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">217-22</span>
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    </div><div class="casAbstract">On the basis of a previous report suggesting the effectiveness of the beta-adrenoceptor/5-HT1A antagonist pindolol to accelerate the antidepressant effect of a selective serotonin reuptake inhibitor (SSRI) and to produce a therapeutic effect in drug-resistant depressed patients, these open studies were undertaken to further explore the safety and efficacy of this strategy.  In a first study, nine untreated unipolar depressed patients were given the SSRI paroxetine (20 mg/day) together with pindolol (2.5 mg thrice daily).  One patient stopped taking pindolol because of increased irritability after 3 days.  One week later, seven patients had their Hamilton Rating Scale for Depression Score decreased by more than 50%.  In a second study, 19 drug-resistant unipolar depressed patients (9 on paroxetine, 5 on sertraline, 3 on fluoxetine, and 2 on moclobemide) were also given pindolol at the same regimen and were assessed weekly.  Two patients (one on sertraline, one on moclobemide) stopped taking pindolol also because of increased irritability after 2 and 3 days, respectively.  After 1 week of pindolol addition, 10 patients had a more than 50% decrease of their depression score.  By day 14, all of the patients had a score of 10 or less, with the exception of those on sertraline.  Improvement was maintained in all patients for at least 28 days on this combination.  The results of these studies indicate that pindolol is safe when used in combination with an SSRI or moclobemide.  Given the positive results obtained in this second open trial in 28 patients, this treatment strategy should be tested under double-blind conditions to establish its efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQYSvrZzE62a62q3xNe7a7QfW6udTcc2eaEXyzpz1_zlLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2Mzmt1yktg%253D%253D&md5=9ffbe5680925c387cd4946ef4edfc384</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1097%2F00004714-199506000-00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004714-199506000-00011%26sid%3Dliteratum%253Aachs%26aulast%3DBlier%26aufirst%3DP.%26aulast%3DBergeron%26aufirst%3DR.%26atitle%3DEffectiveness%2520of%2520pindolol%2520with%2520selected%2520antidepressant%2520drugs%2520in%2520the%2520treatment%2520of%2520major%2520depression%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D1995%26volume%3D15%26spage%3D217%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Artigas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celada, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laruelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adell, A.</span><span> </span><span class="NLM_article-title">How does pindolol improve antidepressant action?</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">228</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2001&pages=224-228&author=F.+Artigasauthor=P.+Celadaauthor=M.+Laruelleauthor=A.+Adell&title=How+does+pindolol+improve+antidepressant+action%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArtigas%26aufirst%3DF.%26aulast%3DCelada%26aufirst%3DP.%26aulast%3DLaruelle%26aufirst%3DM.%26aulast%3DAdell%26aufirst%3DA.%26atitle%3DHow%2520does%2520pindolol%2520improve%2520antidepressant%2520action%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2001%26volume%3D22%26spage%3D224%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Blier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, R.</span><span> </span><span class="NLM_article-title">The use of pindolol to potentiate antidepressant medication</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=8&amp;doi=10.1021%2Fjm100714c&amp;key=9635544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A528%3ADyaK1cXjslGksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1998&pages=16-25&author=P.+Blierauthor=R.+Bergeron&title=The+use+of+pindolol+to+potentiate+antidepressant+medication"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4eR"><div class="casContent"><span class="casTitleNuber">4e</span><div class="casTitle"><span class="NLM_cas:atitle">The use of pindolol to potentiate antidepressant medication</span></div><div class="casAuthors">Blier, Pierre; Bergeron, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">Suppl..5</span>),
    <span class="NLM_cas:pages">16-25</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press</span>)
        </div><div class="casAbstract">A review with 32 refs. followed by a discussion.  Serotonin (5-HT) selective reuptake inhibitors (SSRIs) and monoamine oxidase inhibitors are thought to have a delayed onset of antidepressant action attributable in part to the decrease in firing activity of 5-HT neurons they produce upon treatment initiation.  As cell body 5-HT1A autoreceptors desensitize, 5-HT neuronal firing is restored.  The agent pindolol, through its 5-HT1A receptor blocking property, has been shown to prevent the initial decrease in firing of rat 5-HT neurons assocd. with SSRI treatment.  Four open-label studies put into evidence a significant acceleration of the antidepressant effect of SSRIs when combined with pindolol.  Four of five placebo-controlled studies have confirmed this observation.  Controlled trials indicate that a greater rate of response may be obtained by combining pindolol from the beginning of the SSRI treatment.  The strategy of adding pindolol to the regimen of SSRI-resistant patients also appears to produce a therapeutic effect in a significant proportion of patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz0q4Q6ACnhrVg90H21EOLACvtfcHk0lgBGpXlzGJiEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjslGksLs%253D&md5=a2d5fa78635c0e4427bd9c6fd6039271</span></div><a href="/servlet/linkout?suffix=cit4e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlier%26aufirst%3DP.%26aulast%3DBergeron%26aufirst%3DR.%26atitle%3DThe%2520use%2520of%2520pindolol%2520to%2520potentiate%2520antidepressant%2520medication%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D1998%26volume%3D59%26spage%3D16%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mewshaw, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meagher, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scerni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span> </span><span class="NLM_article-title">Studies toward the discovery of the next generation of antidepressants. Part 2: incorporating a 5-HT<sub>1A</sub> antagonist component into a class of serotonin reuptake inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=307-310&author=R.+E.+Mewshawauthor=K.+L.+Meagherauthor=P.+Zhouauthor=D.+Zhouauthor=X.+Shiauthor=R.+Scerniauthor=D.+L.+Smithauthor=L.+E.+Schechterauthor=T.+H.+Andree&title=Studies+toward+the+discovery+of+the+next+generation+of+antidepressants.+Part+2%3A+incorporating+a+5-HT1A+antagonist+component+into+a+class+of+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMewshaw%26aufirst%3DR.%2BE.%26aulast%3DMeagher%26aufirst%3DK.%2BL.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DScerni%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26atitle%3DStudies%2520toward%2520the%2520discovery%2520of%2520the%2520next%2520generation%2520of%2520antidepressants.%2520Part%25202%253A%2520incorporating%2520a%25205-HT1A%2520antagonist%2520component%2520into%2520a%2520class%2520of%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D307%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mewshaw, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornby, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spangler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scerni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span> </span><span class="NLM_article-title">Studies toward the discovery of the next generation of antidepressants. 3. Dual 5-HT<sub>1A</sub> and serotonin transporter affinity within a class of <i>N</i>-aryloxyethylindolylalkylamines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">3823</span><span class="NLM_x">–</span> <span class="NLM_lpage">3842</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0304010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvFyitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3823-3842&author=R.+E.+Mewshawauthor=D.+Zhouauthor=P.+Zhouauthor=X.+Shiauthor=G.+Hornbyauthor=T.+Spanglerauthor=R.+Scerniauthor=D.+Smithauthor=L.+E.+Schechterauthor=T.+H.+Andree&title=Studies+toward+the+discovery+of+the+next+generation+of+antidepressants.+3.+Dual+5-HT1A+and+serotonin+transporter+affinity+within+a+class+of+N-aryloxyethylindolylalkylamines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Studies toward the Discovery of the Next Generation of Antidepressants. 3. Dual 5-HT1A and Serotonin Transporter Affinity within a Class of N-Aryloxyethylindolylalkylamines</span></div><div class="casAuthors">Mewshaw, Richard E.; Zhou, Dahui; Zhou, Ping; Shi, Xiaojie; Hornby, Geoffrey; Spangler, Taylor; Scerni, Rosemary; Smith, Deborah; Schechter, Lee E.; Andree, Terrance H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3823-3842</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Aryloxylethylindolealkylamines (5) having dual 5-HT transporter and 5-HT1A affinity are described.  These compds. represent truncated analogs of our previously reported piperidinyl derivs. (3).  Compds. in this investigation were found to have more similar affinities and functional activities for the 5-HT1A receptor and 5-HT transporter.  Though 5-HT1A antagonism is not consistently obsd. throughout series 5, several mol. features were found to be essential to obtain high and balanced activities.  The proper placement of a heteroatom in the aryl ring and the length of the linkage used to tether the indole moiety had significant influence on 5-HT1A and 5-HT transporter affinities.  Introduction of a halogen into the aryl ring usually lowered intrinsic activity and in some cases led to full 5-HT1A antagonists.  Compds. 33 and 34 were obsd. to be full 5-HT1A antagonists with Ki values of approx. 30 nM for the 5-HT1A receptor and Ki values of 5 and 0.5 nM for the 5-HT transporter, resp.  Unfortunately, similar to our previous series (3), compds. in this report also had high affinity for the α1 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUlzq9C2T0QbVg90H21EOLACvtfcHk0lg8jGL0mReTfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvFyitLo%253D&md5=d2c2efc650a5c1749b7366c666419936</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1021%2Fjm0304010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0304010%26sid%3Dliteratum%253Aachs%26aulast%3DMewshaw%26aufirst%3DR.%2BE.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DHornby%26aufirst%3DG.%26aulast%3DSpangler%26aufirst%3DT.%26aulast%3DScerni%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26atitle%3DStudies%2520toward%2520the%2520discovery%2520of%2520the%2520next%2520generation%2520of%2520antidepressants.%25203.%2520Dual%25205-HT1A%2520and%2520serotonin%2520transporter%2520affinity%2520within%2520a%2520class%2520of%2520N-aryloxyethylindolylalkylamines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3823%26epage%3D3842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hornby, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spangler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazandarani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgaonkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span> </span><span class="NLM_article-title">SSRI/5-HT<sub>1A</sub> antagonists as future antidepressant agents: a neurochemical assessment of WAY-163426</span> <span class="citation_source-journal">Soc. Neurosci. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1024.14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2004&pages=1024.14&author=G.+A.+Hornbyauthor=G.+Stackauthor=L.+A.+Dawsonauthor=H.+Q.+Nguyenauthor=T.+Spanglerauthor=D.+L.+Smithauthor=H.+Mazandaraniauthor=M.+Tranauthor=S.+Kalgaonkarauthor=G.+Zhangauthor=L.+E.+Schechterauthor=T.+H.+Andree&title=SSRI%2F5-HT1A+antagonists+as+future+antidepressant+agents%3A+a+neurochemical+assessment+of+WAY-163426"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHornby%26aufirst%3DG.%2BA.%26aulast%3DStack%26aufirst%3DG.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DNguyen%26aufirst%3DH.%2BQ.%26aulast%3DSpangler%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DMazandarani%26aufirst%3DH.%26aulast%3DTran%26aufirst%3DM.%26aulast%3DKalgaonkar%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26atitle%3DSSRI%252F5-HT1A%2520antagonists%2520as%2520future%2520antidepressant%2520agents%253A%2520a%2520neurochemical%2520assessment%2520of%2520WAY-163426%26jtitle%3DSoc.%2520Neurosci.%2520Abstr.%26date%3D2004%26volume%3D30%26spage%3D1024.14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatzenbuhler, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evrard, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chlenov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golembieski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornby, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G. P.</span><span> </span><span class="NLM_article-title">Novel pyridyl-fused 3-amino chroman derivatives with dual action at serotonin transporter and 5-HT<sub>1A</sub> receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3117</span><span class="NLM_x">–</span> <span class="NLM_lpage">3121</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3117-3121&author=D.+Zhouauthor=N.+T.+Hatzenbuhlerauthor=J.+L.+Grossauthor=B.+L.+Harrisonauthor=D.+A.+Evrardauthor=M.+Chlenovauthor=J.+Golembieskiauthor=G.+Hornbyauthor=L.+E.+Schechterauthor=D.+L.+Smithauthor=T.+H.+Andreeauthor=G.+P.+Stack&title=Novel+pyridyl-fused+3-amino+chroman+derivatives+with+dual+action+at+serotonin+transporter+and+5-HT1A+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DHatzenbuhler%26aufirst%3DN.%2BT.%26aulast%3DGross%26aufirst%3DJ.%2BL.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DEvrard%26aufirst%3DD.%2BA.%26aulast%3DChlenov%26aufirst%3DM.%26aulast%3DGolembieski%26aufirst%3DJ.%26aulast%3DHornby%26aufirst%3DG.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26aulast%3DStack%26aufirst%3DG.%2BP.%26atitle%3DNovel%2520pyridyl-fused%25203-amino%2520chroman%2520derivatives%2520with%2520dual%2520action%2520at%2520serotonin%2520transporter%2520and%25205-HT1A%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3117%26epage%3D3121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honigschmidt, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocco, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinazze, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainscott, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Threlkeld, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. T.</span><span> </span><span class="NLM_article-title">Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT<sub>1A</sub> receptor antagonism/SSRI activities. Part 1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1903</span><span class="NLM_x">–</span> <span class="NLM_lpage">1905</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1903-1905&author=K.+Takeuchiauthor=T.+J.+Kohnauthor=N.+A.+Honigschmidtauthor=V.+P.+Roccoauthor=P.+G.+Spinazzeauthor=D.+J.+Kochauthor=D.+L.+G.+Nelsonauthor=D.+B.+Wainscottauthor=L.+J.+Ahmadauthor=J.+Shawauthor=P.+G.+Threlkeldauthor=D.+T.+Wong&title=Advances+toward+new+antidepressants+beyond+SSRIs%3A+1-aryloxy-3-piperidinylpropan-2-ols+with+dual+5-HT1A+receptor+antagonism%2FSSRI+activities.+Part+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DKohn%26aufirst%3DT.%2BJ.%26aulast%3DHonigschmidt%26aufirst%3DN.%2BA.%26aulast%3DRocco%26aufirst%3DV.%2BP.%26aulast%3DSpinazze%26aufirst%3DP.%2BG.%26aulast%3DKoch%26aufirst%3DD.%2BJ.%26aulast%3DNelson%26aufirst%3DD.%2BL.%2BG.%26aulast%3DWainscott%26aufirst%3DD.%2BB.%26aulast%3DAhmad%26aufirst%3DL.%2BJ.%26aulast%3DShaw%26aufirst%3DJ.%26aulast%3DThrelkeld%26aufirst%3DP.%2BG.%26aulast%3DWong%26aufirst%3DD.%2BT.%26atitle%3DAdvances%2520toward%2520new%2520antidepressants%2520beyond%2520SSRIs%253A%25201-aryloxy-3-piperidinylpropan-2-ols%2520with%2520dual%25205-HT1A%2520receptor%2520antagonism%252FSSRI%2520activities.%2520Part%25201%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1903%26epage%3D1905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, T .J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honigschmidt, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocco, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinazze, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hertel, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainscott, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Threlkeld, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. T.</span><span> </span><span class="NLM_article-title">Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT<sub>1A</sub> receptor antagonism/SSRI activities. Part 2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2393</span><span class="NLM_x">–</span> <span class="NLM_lpage">2397</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2393-2397&author=K.+Takeuchiauthor=T+.J.+Kohnauthor=N.+A.+Honigschmidtauthor=V.+P.+Roccoauthor=P.+G.+Spinazzeauthor=D.+J.+Kochauthor=S.+T.+Atkinsonauthor=L.+W.+Hertelauthor=D.+L.+Nelsonauthor=D.+B.+Wainscottauthor=L.+J.+Ahmadauthor=J.+Shawauthor=P.+G.+Threlkeldauthor=D.+T.+Wong&title=Advances+toward+new+antidepressants+beyond+SSRIs%3A+1-aryloxy-3-piperidinylpropan-2-ols+with+dual+5-HT1A+receptor+antagonism%2FSSRI+activities.+Part+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DKohn%26aufirst%3DT%2B.J.%26aulast%3DHonigschmidt%26aufirst%3DN.%2BA.%26aulast%3DRocco%26aufirst%3DV.%2BP.%26aulast%3DSpinazze%26aufirst%3DP.%2BG.%26aulast%3DKoch%26aufirst%3DD.%2BJ.%26aulast%3DAtkinson%26aufirst%3DS.%2BT.%26aulast%3DHertel%26aufirst%3DL.%2BW.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DWainscott%26aufirst%3DD.%2BB.%26aulast%3DAhmad%26aufirst%3DL.%2BJ.%26aulast%3DShaw%26aufirst%3DJ.%26aulast%3DThrelkeld%26aufirst%3DP.%2BG.%26aulast%3DWong%26aufirst%3DD.%2BT.%26atitle%3DAdvances%2520toward%2520new%2520antidepressants%2520beyond%2520SSRIs%253A%25201-aryloxy-3-piperidinylpropan-2-ols%2520with%2520dual%25205-HT1A%2520receptor%2520antagonism%252FSSRI%2520activities.%2520Part%25202%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2393%26epage%3D2397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, T .J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honigschmidt, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocco, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinazze, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hertel, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainscott, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Threlkeld, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. T.</span><span> </span><span class="NLM_article-title">Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT<sub>1A</sub> receptor antagonism/SSRI activities. Part 3</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3939</span><span class="NLM_x">–</span> <span class="NLM_lpage">3942</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3939-3942&author=K.+Takeuchiauthor=T+.J.+Kohnauthor=N.+A.+Honigschmidtauthor=V.+P.+Roccoauthor=P.+G.+Spinazzeauthor=S.+T.+Atkinsonauthor=L.+W.+Hertelauthor=D.+L.+Nelsonauthor=D.+B.+Wainscottauthor=L.+J.+Ahmadauthor=J.+Shawauthor=P.+G.+Threlkeldauthor=D.+T.+Wong&title=Advances+toward+new+antidepressants+beyond+SSRIs%3A+1-aryloxy-3-piperidinylpropan-2-ols+with+dual+5-HT1A+receptor+antagonism%2FSSRI+activities.+Part+3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DKohn%26aufirst%3DT%2B.J.%26aulast%3DHonigschmidt%26aufirst%3DN.%2BA.%26aulast%3DRocco%26aufirst%3DV.%2BP.%26aulast%3DSpinazze%26aufirst%3DP.%2BG.%26aulast%3DAtkinson%26aufirst%3DS.%2BT.%26aulast%3DHertel%26aufirst%3DL.%2BW.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DWainscott%26aufirst%3DD.%2BB.%26aulast%3DAhmad%26aufirst%3DL.%2BJ.%26aulast%3DShaw%26aufirst%3DJ.%26aulast%3DThrelkeld%26aufirst%3DP.%2BG.%26aulast%3DWong%26aufirst%3DD.%2BT.%26atitle%3DAdvances%2520toward%2520new%2520antidepressants%2520beyond%2520SSRIs%253A%25201-aryloxy-3-piperidinylpropan-2-ols%2520with%2520dual%25205-HT1A%2520receptor%2520antagonism%252FSSRI%2520activities.%2520Part%25203%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3939%26epage%3D3942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honigschmidt, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocco, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinazze, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemrick-Luecke, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Threlkeld, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. T.</span><span> </span><span class="NLM_article-title">Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT<sub>1A</sub> receptor antagonism/SSRI activities. Part 5</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">2347</span><span class="NLM_x">–</span> <span class="NLM_lpage">2351</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=2347-2351&author=K.+Takeuchiauthor=T.+J.+Kohnauthor=N.+A.+Honigschmidtauthor=V.+P.+Roccoauthor=P.+G.+Spinazzeauthor=S.+K.+Hemrick-Lueckeauthor=L.+K.+Thompsonauthor=D.+C.+Evansauthor=K.+Rasmussenauthor=D.+Kogerauthor=D.+Lodgeauthor=L.+J.+Martinauthor=J.+Shawauthor=P.+G.+Threlkeldauthor=D.+T.+Wong&title=Advances+toward+new+antidepressants+beyond+SSRIs%3A+1-aryloxy-3-piperidinylpropan-2-ols+with+dual+5-HT1A+receptor+antagonism%2FSSRI+activities.+Part+5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DKohn%26aufirst%3DT.%2BJ.%26aulast%3DHonigschmidt%26aufirst%3DN.%2BA.%26aulast%3DRocco%26aufirst%3DV.%2BP.%26aulast%3DSpinazze%26aufirst%3DP.%2BG.%26aulast%3DHemrick-Luecke%26aufirst%3DS.%2BK.%26aulast%3DThompson%26aufirst%3DL.%2BK.%26aulast%3DEvans%26aufirst%3DD.%2BC.%26aulast%3DRasmussen%26aufirst%3DK.%26aulast%3DKoger%26aufirst%3DD.%26aulast%3DLodge%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DL.%2BJ.%26aulast%3DShaw%26aufirst%3DJ.%26aulast%3DThrelkeld%26aufirst%3DP.%2BG.%26aulast%3DWong%26aufirst%3DD.%2BT.%26atitle%3DAdvances%2520toward%2520new%2520antidepressants%2520beyond%2520SSRIs%253A%25201-aryloxy-3-piperidinylpropan-2-ols%2520with%2520dual%25205-HT1A%2520receptor%2520antagonism%252FSSRI%2520activities.%2520Part%25205%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D1%26spage%3D2347%26epage%3D2351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Rocco, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinazze, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honigschmidt, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley Wainscott, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Threlkeld, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span> </span><span class="NLM_article-title">Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT<sub>1A</sub> receptor antagonism/SSRI activities. Part 4</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2653</span><span class="NLM_x">–</span> <span class="NLM_lpage">2656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2653-2656&author=V.+P.+Roccoauthor=P.+G.+Spinazzeauthor=T.+J.+Kohnauthor=N.+A.+Honigschmidtauthor=D.+L.+Nelsonauthor=D.+Bradley+Wainscottauthor=L.+J.+Ahmadauthor=J.+Shawauthor=P.+G.+Threlkeldauthor=D.+T.+Wongauthor=K.+Takeuchi&title=Advances+toward+new+antidepressants+beyond+SSRIs%3A+1-aryloxy-3-piperidinylpropan-2-ols+with+dual+5-HT1A+receptor+antagonism%2FSSRI+activities.+Part+4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRocco%26aufirst%3DV.%2BP.%26aulast%3DSpinazze%26aufirst%3DP.%2BG.%26aulast%3DKohn%26aufirst%3DT.%2BJ.%26aulast%3DHonigschmidt%26aufirst%3DN.%2BA.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DBradley%2BWainscott%26aufirst%3DD.%26aulast%3DAhmad%26aufirst%3DL.%2BJ.%26aulast%3DShaw%26aufirst%3DJ.%26aulast%3DThrelkeld%26aufirst%3DP.%2BG.%26aulast%3DWong%26aufirst%3DD.%2BT.%26aulast%3DTakeuchi%26aufirst%3DK.%26atitle%3DAdvances%2520toward%2520new%2520antidepressants%2520beyond%2520SSRIs%253A%25201-aryloxy-3-piperidinylpropan-2-ols%2520with%2520dual%25205-HT1A%2520receptor%2520antagonism%252FSSRI%2520activities.%2520Part%25204%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2653%26epage%3D2656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Atkinson, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bromidge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duxon, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaster, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadley, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">North, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rami, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vong, A. K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">3,4-Dihydro-2<i>H</i>-benzoxazinones are 5-HT<sub>1A</sub> receptor antagonists with potent 5-HT reuptake inhibitory activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=737-741&author=P.+J.+Atkinsonauthor=S.+M.+Bromidgeauthor=M.+S.+Duxonauthor=L.+M.+Gasterauthor=M.+S.+Hadleyauthor=B.+Hammondauthor=C.+N.+Johnsonauthor=D.+N.+Middlemissauthor=S.+E.+Northauthor=G.+W.+Priceauthor=H.+K.+Ramiauthor=G.+J.+Rileyauthor=C.+M.+Scottauthor=T.+E.+Shawauthor=K.+R.+Starrauthor=G.+Stempauthor=K.+M.+Thewlisauthor=D.+R.+Thomasauthor=M.+Thompsonauthor=A.+K.+K.+Vongauthor=J.+M.+Watson&title=3%2C4-Dihydro-2H-benzoxazinones+are+5-HT1A+receptor+antagonists+with+potent+5-HT+reuptake+inhibitory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAtkinson%26aufirst%3DP.%2BJ.%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26aulast%3DDuxon%26aufirst%3DM.%2BS.%26aulast%3DGaster%26aufirst%3DL.%2BM.%26aulast%3DHadley%26aufirst%3DM.%2BS.%26aulast%3DHammond%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DNorth%26aufirst%3DS.%2BE.%26aulast%3DPrice%26aufirst%3DG.%2BW.%26aulast%3DRami%26aufirst%3DH.%2BK.%26aulast%3DRiley%26aufirst%3DG.%2BJ.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DShaw%26aufirst%3DT.%2BE.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DStemp%26aufirst%3DG.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DThomas%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DM.%26aulast%3DVong%26aufirst%3DA.%2BK.%2BK.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3D3%252C4-Dihydro-2H-benzoxazinones%2520are%25205-HT1A%2520receptor%2520antagonists%2520with%2520potent%25205-HT%2520reuptake%2520inhibitory%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D737%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodacre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vong, A. K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">3,4-Dihydro-2<i>H</i>-benzoxazinones as dual-acting 5-HT<sub>1A</sub> receptor antagonists and serotonin reuptake inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1033</span><span class="NLM_x">–</span> <span class="NLM_lpage">1036</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1033-1036&author=P.+J.+Lovellauthor=F.+E.+Blaneyauthor=C.+J.+Goodacreauthor=C.+M.+Scottauthor=P.+W.+Smithauthor=K.+R.+Starrauthor=K.+M.+Thewlisauthor=A.+K.+K.+Vongauthor=S.+E.+Wardauthor=J.+M.+Watson&title=3%2C4-Dihydro-2H-benzoxazinones+as+dual-acting+5-HT1A+receptor+antagonists+and+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5k&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DBlaney%26aufirst%3DF.%2BE.%26aulast%3DGoodacre%26aufirst%3DC.%2BJ.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DVong%26aufirst%3DA.%2BK.%2BK.%26aulast%3DWard%26aufirst%3DS.%2BE.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3D3%252C4-Dihydro-2H-benzoxazinones%2520as%2520dual-acting%25205-HT1A%2520receptor%2520antagonists%2520and%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1033%26epage%3D1036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Moltzen, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkelsen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornholm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennum, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, C.</span><span> </span><span class="NLM_article-title">In vitro profile of LU 36−274: a compound with combined 5-HTT/5-HT<sub>1A</sub> activity and putative fast onset of antidepressant action</span> <span class="citation_source-journal">Soc. Neurosci. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">958.16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2003&pages=958.16&author=E.+K.+Moltzenauthor=I.+Mikkelsenauthor=B.+Bjornholmauthor=L.+T.+Brennumauthor=S.+Hoggauthor=C.+Sanchez&title=In+vitro+profile+of+LU+36%E2%88%92274%3A+a+compound+with+combined+5-HTT%2F5-HT1A+activity+and+putative+fast+onset+of+antidepressant+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5l&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoltzen%26aufirst%3DE.%2BK.%26aulast%3DMikkelsen%26aufirst%3DI.%26aulast%3DBjornholm%26aufirst%3DB.%26aulast%3DBrennum%26aufirst%3DL.%2BT.%26aulast%3DHogg%26aufirst%3DS.%26aulast%3DSanchez%26aufirst%3DC.%26atitle%3DIn%2520vitro%2520profile%2520of%2520LU%252036%25E2%2588%2592274%253A%2520a%2520compound%2520with%2520combined%25205-HTT%252F5-HT1A%2520activity%2520and%2520putative%2520fast%2520onset%2520of%2520antidepressant%2520action%26jtitle%3DSoc.%2520Neurosci.%2520Abstr.%26date%3D2003%26volume%3D29%26spage%3D958.16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Taber, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrente, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poss, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortolani, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yevich, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, R. J.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of BMS-296859, a novel serotonin reuptake inhibitor and serotonin 5-HT<sub>1A</sub> receptor antagonist</span> <span class="citation_source-journal">Soc. Neurosci. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">958.15</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2003&pages=958.15&author=M.+T.+Taberauthor=J.+R.+Torrenteauthor=J.+Palmerauthor=M.+A.+Possauthor=D.+R.+Tortolaniauthor=J.+P.+Yevichauthor=A.+D.+Starkauthor=R.+J.+Mattson&title=Pharmacological+characterization+of+BMS-296859%2C+a+novel+serotonin+reuptake+inhibitor+and+serotonin+5-HT1A+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaber%26aufirst%3DM.%2BT.%26aulast%3DTorrente%26aufirst%3DJ.%2BR.%26aulast%3DPalmer%26aufirst%3DJ.%26aulast%3DPoss%26aufirst%3DM.%2BA.%26aulast%3DTortolani%26aufirst%3DD.%2BR.%26aulast%3DYevich%26aufirst%3DJ.%2BP.%26aulast%3DStark%26aufirst%3DA.%2BD.%26aulast%3DMattson%26aufirst%3DR.%2BJ.%26atitle%3DPharmacological%2520characterization%2520of%2520BMS-296859%252C%2520a%2520novel%2520serotonin%2520reuptake%2520inhibitor%2520and%2520serotonin%25205-HT1A%2520receptor%2520antagonist%26jtitle%3DSoc.%2520Neurosci.%2520Abstr.%26date%3D2003%26volume%3D29%26spage%3D958.15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Roberts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span> </span><span class="NLM_article-title">Ligands for the investigation of 5-HT autoreceptor function</span> <span class="citation_source-journal">Brain Res. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm100714c&amp;key=10.1016%2FS0361-9230%2801%2900628-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm100714c&amp;key=11750791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptFylt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2001&pages=463-469&author=C.+Robertsauthor=G.+W.+Priceauthor=D.+N.+Middlemiss&title=Ligands+for+the+investigation+of+5-HT+autoreceptor+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Ligands for the investigation of 5-HT autoreceptor function</span></div><div class="casAuthors">Roberts, Claire; Price, Gary W.; Middlemiss, Derek N.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">463-469</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  The existence of multiple 5-HT autoreceptors in the central nervous system is now firmly established and they have been pharmacol. identified as belonging to the 5-HT1A, 5-HT1B, and 5-HT1D receptor subtypes.  In addn., 5-HT1F, 5-HT5A, and 5-HT7 receptors remain as potential candidates for addnl. autoreceptors.  The emergence of selective ligands, such as SB-224289 (5-HT1B receptor antagonist), BRL 15572 (5-HT1D receptor antagonist), GR 127935 (a mixed 5-HT1B/1D receptor antagonist), LY 334370 (5-HT1F receptor agonist), and SB-269970 (5-HT7 receptor antagonist), has aided the characterization of 5-HT autoreceptors and has highlighted the complexity of mechanisms which modulate the release of 5-HT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh3Lk0_xEYELVg90H21EOLACvtfcHk0lgbXuFpF9psAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptFylt7s%253D&md5=1b38f404662c50829d0f1d20bd313d84</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0361-9230%2801%2900628-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0361-9230%252801%252900628-1%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DC.%26aulast%3DPrice%26aufirst%3DG.%2BW.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26atitle%3DLigands%2520for%2520the%2520investigation%2520of%25205-HT%2520autoreceptor%2520function%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2001%26volume%3D56%26spage%3D463%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Davidson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, J. A.</span><span> </span><span class="NLM_article-title">Evidence that 5-hydroxytryptamine release in rat dorsal raphe nucleus is controlled by 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub> and 5-HT<sub>1D</sub> autoreceptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1109</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm100714c&amp;key=10.1111%2Fj.1476-5381.1995.tb13321.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm100714c&amp;key=7620698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A528%3ADyaK2MXksFyjtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=1995&pages=1107-1109&author=C.+Davidsonauthor=J.+A.+Stamford&title=Evidence+that+5-hydroxytryptamine+release+in+rat+dorsal+raphe+nucleus+is+controlled+by+5-HT1A%2C+5-HT1B+and+5-HT1D+autoreceptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence that 5-hydroxytryptamine release in rat dorsal raphe nucleus is controlled by 5-HT1A, 5-HT1B and 5-HT1D autoreceptors</span></div><div class="casAuthors">Davidson, Colin; Stamford, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1107-9</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">Elec. stimulated 5-HT release was monitored in slices of rat dorsal raphe nucleus (DRN) by fast cyclic voltammetry.  Pseudo-single pulse stimulations (5 pulses at 100 Hz) were used to enable the effect of various receptor agonists to be seen without competition from endogenously released transmitter.  The selective 5-HT1A receptor agonist, (+)-8-OH-DPAT (1.0 μM) decreased stimulated 5-HT release to 31% of controls.  This decrease was inhibited by the 5-HT1A receptor antagonists, (+)-WAY 100135 (1.0 μM) and WAY 100635 (0.1 μM) but not by the 5-HT1D/B antagonist, GR 127935 (0.05 μM).  The selective 5-HT1B receptor agonist, CP 93129 (0.3 μM) decreased stimulated 5-HT release to 61% of control.  This effect was antagonized by the 5-HT1B receptor antagonist, isamoltane (0.5 μM) but not by (+)-WAY 100135.  The 5-HT1D agonist, sumatriptan (0.5 μM) decreased stimulated 5-HT release to 52% of controls.  This decrease was blocked by GR 127935 but not by WAY 100635.  Apparently, 5-HT release in the rat DRN is under the control of 5-HT1A, 5-HT1B and 5-HT1D autoreceptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8kcNKxzVetLVg90H21EOLACvtfcHk0lidviwEbZn_HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXksFyjtrg%253D&md5=5b681d8d52622122cc580c60e9336dd7</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1995.tb13321.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1995.tb13321.x%26sid%3Dliteratum%253Aachs%26aulast%3DDavidson%26aufirst%3DC.%26aulast%3DStamford%26aufirst%3DJ.%2BA.%26atitle%3DEvidence%2520that%25205-hydroxytryptamine%2520release%2520in%2520rat%2520dorsal%2520raphe%2520nucleus%2520is%2520controlled%2520by%25205-HT1A%252C%25205-HT1B%2520and%25205-HT1D%2520autoreceptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D114%26spage%3D1107%26epage%3D1109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Davidson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, J. A.</span><span> </span><span class="NLM_article-title">Serotonin efflux in the rat ventral lateral geniculate nucleus assessed by fast cyclic voltammetry is modulated by 5-HT<sub>1B</sub> and 5-HT<sub>1D</sub> autoreceptors</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1627</span><span class="NLM_x">–</span> <span class="NLM_lpage">1634</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1996&pages=1627-1634&author=C.+Davidsonauthor=J.+A.+Stamford&title=Serotonin+efflux+in+the+rat+ventral+lateral+geniculate+nucleus+assessed+by+fast+cyclic+voltammetry+is+modulated+by+5-HT1B+and+5-HT1D+autoreceptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavidson%26aufirst%3DC.%26aulast%3DStamford%26aufirst%3DJ.%2BA.%26atitle%3DSerotonin%2520efflux%2520in%2520the%2520rat%2520ventral%2520lateral%2520geniculate%2520nucleus%2520assessed%2520by%2520fast%2520cyclic%2520voltammetry%2520is%2520modulated%2520by%25205-HT1B%2520and%25205-HT1D%2520autoreceptors%26jtitle%3DNeuropharmacology%26date%3D1996%26volume%3D35%26spage%3D1627%26epage%3D1634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Roberts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaster, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routledge, C.</span><span> </span><span class="NLM_article-title">Importance of h5-HT<sub>1B</sub> receptor selectivity for 5-HT terminal autoreceptor activity: an in vivo microdialysis study in the freely-moving guinea pig</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">549</span><span class="NLM_x">–</span> <span class="NLM_lpage">557</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=549-557&author=C.+Robertsauthor=G.+W.+Priceauthor=L.+Gasterauthor=B.+J.+Jonesauthor=D.+N.+Middlemissauthor=C.+Routledge&title=Importance+of+h5-HT1B+receptor+selectivity+for+5-HT+terminal+autoreceptor+activity%3A+an+in+vivo+microdialysis+study+in+the+freely-moving+guinea+pig"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DC.%26aulast%3DPrice%26aufirst%3DG.%2BW.%26aulast%3DGaster%26aufirst%3DL.%26aulast%3DJones%26aufirst%3DB.%2BJ.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DRoutledge%26aufirst%3DC.%26atitle%3DImportance%2520of%2520h5-HT1B%2520receptor%2520selectivity%2520for%25205-HT%2520terminal%2520autoreceptor%2520activity%253A%2520an%2520in%2520vivo%2520microdialysis%2520study%2520in%2520the%2520freely-moving%2520guinea%2520pig%26jtitle%3DNeuropharmacology%26date%3D1997%26volume%3D36%26spage%3D549%26epage%3D557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Roberts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. J.</span><span> </span><span class="NLM_article-title">The role of 5-HT<sub>1B/1D</sub> receptors in the modulation of 5-hydroxytryptamine levels in the frontal cortex of the conscious guinea pig</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Fjm100714c&amp;key=10.1016%2FS0014-2999%2897%2900156-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Fjm100714c&amp;key=9178651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A528%3ADyaK2sXjsVGhu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=1997&pages=23-30&author=C.+Robertsauthor=G.+W.+Priceauthor=B.+J.+Jones&title=The+role+of+5-HT1B%2F1D+receptors+in+the+modulation+of+5-hydroxytryptamine+levels+in+the+frontal+cortex+of+the+conscious+guinea+pig"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">The role of 5-HT1B/1D receptors in the modulation of 5-hydroxytryptamine levels in the frontal cortex of the conscious guinea pig</span></div><div class="casAuthors">Roberts, Claire; Price, Gary W.; Jones, Brian J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-30</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The role of 5-HT1B/1D receptors in modulating extracellular 5-hydroxytryptamine (5-HT) levels in the guinea pig was investigated with the nonselective 5-HT1B/1D receptor inverse agonist, methiothepin, and the selective 5-HT1B/1D receptor partial agonists, GR 127935 and GR 125743.  Extracellular 5-HT levels were measured using the technique of brain microdialysis, in the frontal cortex of the freely moving guinea pig.  Extracellular 5-HT was tetrodotoxin sensitive and calcium dependent, and increased when perfused with a high concn. of K+.  In addn., extracellular 5-HT levels were lowered by the 5-HT1B/1D receptor agonist, sumatriptan, and the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, while perfusion of the selective serotonin re-uptake inhibitor, paroxetine, increased 5-HT in a concn.-dependent manner.  Perfusion of methiothepin, GR 127935 and GR 125743 into the frontal cortex caused significant but transient increases of extracellular 5-HT.  However, systemic administration of methiothepin, GR 127935 and GR 125743, at 0.3 mg/kg i.p., produced significant decreases in extracellular 5-HT, to min. of 27%, 31% and 27% of basal, resp.  The increase of extracellular 5-HT, following 5-HT1B/1D receptor inverse and partial agonist perfusion into the frontal cortex, was probably a consequence of attenuation of an endogenous 5-HT tone at terminal 5-HT autoreceptors.  The unexpected decrease in 5-HT levels following systemic administration may be a result of addnl. attenuation of endogenous 5-HT tone at cell body autoreceptors in the raphe.  Such an increase in local 5-HT levels could then stimulate 5-HT1A receptors to inhibit cell firing and hence decrease 5-HT levels in the terminal regions.  This was confirmed when co-administration of the 5-HT1A receptor antagonist, WAY 100635, attenuated the GR 127935 decrease in 5-HT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroCdG0snkZCLVg90H21EOLACvtfcHk0lidviwEbZn_HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjsVGhu70%253D&md5=a89b3260998f97810b6862b604b03c95</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2897%2900156-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252897%252900156-8%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DC.%26aulast%3DPrice%26aufirst%3DG.%2BW.%26aulast%3DJones%26aufirst%3DB.%2BJ.%26atitle%3DThe%2520role%2520of%25205-HT1B%252F1D%2520receptors%2520in%2520the%2520modulation%2520of%25205-hydroxytryptamine%2520levels%2520in%2520the%2520frontal%2520cortex%2520of%2520the%2520conscious%2520guinea%2520pig%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D326%26spage%3D23%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hughes, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span> </span><span class="NLM_article-title">Differential autoreceptor control of extracellular 5-HT in guinea pig and rat: species and regional differences</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2004&pages=87-93&author=Z.+A.+Hughesauthor=L.+A.+Dawson&title=Differential+autoreceptor+control+of+extracellular+5-HT+in+guinea+pig+and+rat%3A+species+and+regional+differences"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DZ.%2BA.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26atitle%3DDifferential%2520autoreceptor%2520control%2520of%2520extracellular%25205-HT%2520in%2520guinea%2520pig%2520and%2520rat%253A%2520species%2520and%2520regional%2520differences%26jtitle%3DPsychopharmacology%26date%3D2004%26volume%3D172%26spage%3D87%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Stenfors, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallbus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S. B.</span><span> </span><span class="NLM_article-title">Synergism between 5-HT1B/1D and 5-HT1A receptor antagonists on turnover and release of 5-HT in guinea-pig brain in vivo</span> <span class="citation_source-journal">Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">359</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm100714c&amp;key=10.1007%2FPL00005329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm100714c&amp;key=10048595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A528%3ADyaK1MXkslymsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=1999&pages=110-116&author=C.+Stenforsauthor=T.+Magnussonauthor=L.+G.+Larssonauthor=H.+Yuauthor=M.+Hallbusauthor=O.+Magnussonauthor=S.+B.+Ross&title=Synergism+between+5-HT1B%2F1D+and+5-HT1A+receptor+antagonists+on+turnover+and+release+of+5-HT+in+guinea-pig+brain+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Synergism between 5-HT1B/1D and 5-HT1A receptor antagonists on turnover and release of 5-HT in guinea-pig brain in vivo</span></div><div class="casAuthors">Stenfors, C.; Magnusson, Teresa; Larsson, Lars-Gunnar; Yu, H.; Hallbus, Marie; Magnusson, O.; Ross, Svante B.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">359</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">110-116</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The effects on 5-HT turnover (5-HIAA/5-HT ratio) and extracellular 5-HT and 5-HIAA levels (in vivo microdialysis in freely moving animals) were analyzed in guinea-pig brains following the 5-HT1B receptor antagonist, GR 127935 {N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl) [1,1-biphenyl]-4-carboxamide}, or the 5-HT1A receptor antagonist, WAY-100635 (N-{2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl}-N-(2-pyridinyl) cyclohexanecarboxamide trihydrochloride), administered alone or in combination.  GR 127935, injected alone, increased 5-HT turnover with maximal effects approx. 50% above the control levels in the four brain regions examd. (hypothalamus, hippocampus, striatum and frontal cortex).  GR 127935 significantly increased extracellular concns. of 5-HT and 5-HIAA in frontal cortex (40%), whereas 5-HIAA, but not 5-HT, was elevated in striatum (20-30%).  WAY-100635 did not significantly change 5-HT turnover but caused a small significant increase in the extracellular 5-HT and 5-HIAA concns. in both striatum and frontal cortex.  The combined treatment with GR 127935 and WAY-100635 resulted in an increased 5-HT turnover reaching maximal effects of 70-90% above the control values in all brain regions tested and produced a significant elevation of striatal and frontal cortex extracellular 5-HT (40% and 60%, resp.) and 5-HIAA (60% and 70%, resp.) concns.  The synergistic effect of the two receptor antagonists on the 5-HT turnover and the terminal release of 5-HT indicate somatodendritic 5-HT release and stimulation of inhibitory 5-HT1A receptors at this level.  Extracellular 5-HIAA seems to be a better marker than 5-HT itself for the evoked 5-HT release when the reuptake mechanism is intact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroVi9rgL82jbVg90H21EOLACvtfcHk0ligZmY3ir97cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkslymsw%253D%253D&md5=61caf9559f99dc706b8587a8c5bf47fe</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1007%2FPL00005329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FPL00005329%26sid%3Dliteratum%253Aachs%26aulast%3DStenfors%26aufirst%3DC.%26aulast%3DMagnusson%26aufirst%3DT.%26aulast%3DLarsson%26aufirst%3DL.%2BG.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DHallbus%26aufirst%3DM.%26aulast%3DMagnusson%26aufirst%3DO.%26aulast%3DRoss%26aufirst%3DS.%2BB.%26atitle%3DSynergism%2520between%25205-HT1B%252F1D%2520and%25205-HT1A%2520receptor%2520antagonists%2520on%2520turnover%2520and%2520release%2520of%25205-HT%2520in%2520guinea-pig%2520brain%2520in%2520vivo%26jtitle%3DArch.%2520Pharmacol.%26date%3D1999%26volume%3D359%26spage%3D110%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Kling, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, U. E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakker, M. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drescher, K. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornberger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchins, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moeller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wicke, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schellhaas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, G.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of highly potent dual 5-HT<sub>1A</sub> and 5-HT<sub>1B</sub> antagonists as potential antidepressant drugs</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">5567</span><span class="NLM_x">–</span> <span class="NLM_lpage">5573</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5567-5573&author=A.+Klingauthor=U.+E.+W.+Langeauthor=H.+Mackauthor=M.+H.+M.+Bakkerauthor=K.+U.+Drescherauthor=W.+Hornbergerauthor=C.+W.+Hutchinsauthor=A.+Moellerauthor=R.+Muellerauthor=M.+Schmidtauthor=L.+Ungerauthor=K.+Wickeauthor=K.+Schellhaasauthor=G.+Steiner&title=Synthesis+and+SAR+of+highly+potent+dual+5-HT1A+and+5-HT1B+antagonists+as+potential+antidepressant+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKling%26aufirst%3DA.%26aulast%3DLange%26aufirst%3DU.%2BE.%2BW.%26aulast%3DMack%26aufirst%3DH.%26aulast%3DBakker%26aufirst%3DM.%2BH.%2BM.%26aulast%3DDrescher%26aufirst%3DK.%2BU.%26aulast%3DHornberger%26aufirst%3DW.%26aulast%3DHutchins%26aufirst%3DC.%2BW.%26aulast%3DMoeller%26aufirst%3DA.%26aulast%3DMueller%26aufirst%3DR.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DUnger%26aufirst%3DL.%26aulast%3DWicke%26aufirst%3DK.%26aulast%3DSchellhaas%26aufirst%3DK.%26aulast%3DSteiner%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520highly%2520potent%2520dual%25205-HT1A%2520and%25205-HT1B%2520antagonists%2520as%2520potential%2520antidepressant%2520drugs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D5567%26epage%3D5573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ward, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vong, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">Studies on a series of potent, orally bioavailable, 5-HT<sub>1</sub> receptor ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5214</span><span class="NLM_x">–</span> <span class="NLM_lpage">5217</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5214-5217&author=S.+E.+Wardauthor=C.+N.+Johnsonauthor=P.+J.+Lovellauthor=C.+M.+Scottauthor=P.+W.+Smithauthor=G.+Stempauthor=K.+M.+Thewlisauthor=A.+K.+Vongauthor=J.+M.+Watson&title=Studies+on+a+series+of+potent%2C+orally+bioavailable%2C+5-HT1+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DS.%2BE.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DStemp%26aufirst%3DG.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DVong%26aufirst%3DA.%2BK.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3DStudies%2520on%2520a%2520series%2520of%2520potent%252C%2520orally%2520bioavailable%252C%25205-HT1%2520receptor%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5214%26epage%3D5217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ward, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddershaw, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">Discovery of Potent, Orally Bioavailable, Selective 5-HT<sub>1A/B/D</sub> Receptor Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2887</span><span class="NLM_x">–</span> <span class="NLM_lpage">2890</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8001444" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2887-2890&author=S.+E.+Wardauthor=P.+J.+Eddershawauthor=C.+M.+Scottauthor=L.+J.+Gordonauthor=P.+J.+Lovellauthor=S.+H.+Mooreauthor=P.+W.+Smithauthor=K.+R.+Starrauthor=K.+M.+Thewlisauthor=J.+M.+Watson&title=Discovery+of+Potent%2C+Orally+Bioavailable%2C+Selective+5-HT1A%2FB%2FD+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fjm8001444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8001444%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DS.%2BE.%26aulast%3DEddershaw%26aufirst%3DP.%2BJ.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DGordon%26aufirst%3DL.%2BJ.%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DMoore%26aufirst%3DS.%2BH.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3DDiscovery%2520of%2520Potent%252C%2520Orally%2520Bioavailable%252C%2520Selective%25205-HT1A%252FB%252FD%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2887%26epage%3D2890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ward, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddershaw, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyman, P. A.</span><span> </span><span class="NLM_article-title">Studies on a series of potent, orally bioavailable, 5-HT<sub>1</sub> receptor ligands-Part II</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">428</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=428-432&author=S.+E.+Wardauthor=P.+J.+Eddershawauthor=S.+T.+Flynnauthor=L.+Gordonauthor=P.+J.+Lovellauthor=S.+H.+Mooreauthor=C.+M.+Scottauthor=P.+W.+Smithauthor=K.+M.+Thewlisauthor=P.+A.+Wyman&title=Studies+on+a+series+of+potent%2C+orally+bioavailable%2C+5-HT1+receptor+ligands-Part+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DS.%2BE.%26aulast%3DEddershaw%26aufirst%3DP.%2BJ.%26aulast%3DFlynn%26aufirst%3DS.%2BT.%26aulast%3DGordon%26aufirst%3DL.%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DMoore%26aufirst%3DS.%2BH.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DWyman%26aufirst%3DP.%2BA.%26atitle%3DStudies%2520on%2520a%2520series%2520of%2520potent%252C%2520orally%2520bioavailable%252C%25205-HT1%2520receptor%2520ligands-Part%2520II%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D428%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Atkinson, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bromidge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duxon, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaster, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadley, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">North, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rami, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vong, A. K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">3,4-Dihydro-2<i>H</i>-benzoxazinones are 5-HT<sub>1A</sub> receptor antagonists with potent 5-HT reuptake inhibitory activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=737-741&author=P.+J.+Atkinsonauthor=S.+M.+Bromidgeauthor=M.+S.+Duxonauthor=L.+M.+Gasterauthor=M.+S.+Hadleyauthor=B.+Hammondauthor=C.+N.+Johnsonauthor=D.+N.+Middlemissauthor=S.+E.+Northauthor=G.+W.+Priceauthor=H.+K.+Ramiauthor=G.+J.+Rileyauthor=C.+M.+Scottauthor=T.+E.+Shawauthor=K.+R.+Starrauthor=G.+Stempauthor=K.+M.+Thewlisauthor=D.+R.+Thomasauthor=M.+Thompsonauthor=A.+K.+K.+Vongauthor=J.+M.+Watson&title=3%2C4-Dihydro-2H-benzoxazinones+are+5-HT1A+receptor+antagonists+with+potent+5-HT+reuptake+inhibitory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAtkinson%26aufirst%3DP.%2BJ.%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26aulast%3DDuxon%26aufirst%3DM.%2BS.%26aulast%3DGaster%26aufirst%3DL.%2BM.%26aulast%3DHadley%26aufirst%3DM.%2BS.%26aulast%3DHammond%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DNorth%26aufirst%3DS.%2BE.%26aulast%3DPrice%26aufirst%3DG.%2BW.%26aulast%3DRami%26aufirst%3DH.%2BK.%26aulast%3DRiley%26aufirst%3DG.%2BJ.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DShaw%26aufirst%3DT.%2BE.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DStemp%26aufirst%3DG.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DThomas%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DM.%26aulast%3DVong%26aufirst%3DA.%2BK.%2BK.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3D3%252C4-Dihydro-2H-benzoxazinones%2520are%25205-HT1A%2520receptor%2520antagonists%2520with%2520potent%25205-HT%2520reuptake%2520inhibitory%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D737%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Serafinowska, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">Novel 5-HT<sub>1A/1B/1D</sub> receptors antagonists with potent 5-HT reuptake inhibitory activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5581</span><span class="NLM_x">–</span> <span class="NLM_lpage">5585</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5581-5585&author=H.+T.+Serafinowskaauthor=F.+E.+Blaneyauthor=P.+J.+Lovellauthor=G.+G.+Merloauthor=C.+M.+Scottauthor=P.+W.+Smithauthor=K.+R.+Starrauthor=J.+M.+Watson&title=Novel+5-HT1A%2F1B%2F1D+receptors+antagonists+with+potent+5-HT+reuptake+inhibitory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSerafinowska%26aufirst%3DH.%2BT.%26aulast%3DBlaney%26aufirst%3DF.%2BE.%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DMerlo%26aufirst%3DG.%2BG.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3DNovel%25205-HT1A%252F1B%252F1D%2520receptors%2520antagonists%2520with%2520potent%25205-HT%2520reuptake%2520inhibitory%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5581%26epage%3D5585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Bromidge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borriello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faedo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granci, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stasi, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zucchelli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo, G</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesentini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zonzini, L.</span><span> </span><span class="NLM_article-title">6-[2-(4-Aryl-1-piperazinyl)ethyl]-2<i>H</i>-1,4-benzoxazin-3(4<i>H</i>)-ones: Dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5653</span><span class="NLM_x">–</span> <span class="NLM_lpage">5656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5653-5656&author=S.+M.+Bromidgeauthor=B.+Bertaniauthor=M.+Borrielloauthor=S.+Faedoauthor=L.+J.+Gordonauthor=E.+Granciauthor=M.+Hillauthor=H.+R.+Marshallauthor=L.+P.+Stasiauthor=V.+Zucchelliauthor=G+Merloauthor=A.+Vesentiniauthor=J.+M.+Watsonauthor=L.+Zonzini&title=6-%5B2-%284-Aryl-1-piperazinyl%29ethyl%5D-2H-1%2C4-benzoxazin-3%284H%29-ones%3A+Dual-acting+5-HT1+receptor+antagonists+and+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26aulast%3DBertani%26aufirst%3DB.%26aulast%3DBorriello%26aufirst%3DM.%26aulast%3DFaedo%26aufirst%3DS.%26aulast%3DGordon%26aufirst%3DL.%2BJ.%26aulast%3DGranci%26aufirst%3DE.%26aulast%3DHill%26aufirst%3DM.%26aulast%3DMarshall%26aufirst%3DH.%2BR.%26aulast%3DStasi%26aufirst%3DL.%2BP.%26aulast%3DZucchelli%26aufirst%3DV.%26aulast%3DMerlo%26aufirst%3DG%26aulast%3DVesentini%26aufirst%3DA.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26aulast%3DZonzini%26aufirst%3DL.%26atitle%3D6-%255B2-%25284-Aryl-1-piperazinyl%2529ethyl%255D-2H-1%252C4-benzoxazin-3%25284H%2529-ones%253A%2520Dual-acting%25205-HT1%2520receptor%2520antagonists%2520and%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5653%26epage%3D5656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span>Enterprise Level Cheminformatics; <span class="NLM_publisher-name">Daylight Chemical Information Systems Inc.</span>: <span class="NLM_publisher-loc">Laguna Niguel, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span><a href="http://www.daylight.com" class="extLink">http://www.daylight.com</a>. (Accessed March, 2010).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Enterprise+Level+Cheminformatics%3B+Daylight+Chemical+Information+Systems+Inc.%3A+Laguna+Niguel%2C+CA%2C+2008%3B+http%3A%2F%2Fwww.daylight.com.+%28Accessed+March%2C+2010%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DEnterprise%2520Level%2520Cheminformatics%26pub%3DDaylight%2520Chemical%2520Information%2520Systems%2520Inc%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tristani-Firouzi, M.</span><span> </span><span class="NLM_article-title">hERG potassium channels and cardiac arrhythmia</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Fjm100714c&amp;key=10.1038%2Fnature04710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Fjm100714c&amp;key=16554806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Fjm100714c&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2006&pages=463-469&author=M.+C.+Sanguinettiauthor=M.+Tristani-Firouzi&title=hERG+potassium+channels+and+cardiac+arrhythmia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">hERG potassium channels and cardiac arrhythmia</span></div><div class="casAuthors">Sanguinetti, Michael C.; Tristani-Firouzi, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">440</span>
        (<span class="NLM_cas:issue">7083</span>),
    <span class="NLM_cas:pages">463-469</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  HERG potassium channels are essential for normal elec. activity in the heart.  Inherited mutations in the HERG gene cause long QT syndrome, a disorder that predisposes individuals to life-threatening arrhythmias.  Arrhythmia can also be induced by a blockage of hERG channels by a surprisingly diverse group of drugs.  This side effect is a common reason for drug failure in preclin. safety trials.  Insights gained from the crystal structures of other potassium channels have helped our understanding of the block of hERG channels and the mechanisms of gating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopS3WBEpuAUrVg90H21EOLACvtfcHk0lg63BwWRuVaIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D&md5=3f355dcd51da3488d73c7c91cbe8d3b8</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1038%2Fnature04710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04710%26sid%3Dliteratum%253Aachs%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DTristani-Firouzi%26aufirst%3DM.%26atitle%3DhERG%2520potassium%2520channels%2520and%2520cardiac%2520arrhythmia%26jtitle%3DNature%26date%3D2006%26volume%3D440%26spage%3D463%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mitcheson, J. S.</span><span> </span><span class="NLM_article-title">hERG Potassium Channels and the Structural Basis of Drug-Induced Arrhythmias</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx800035b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=1005-1010&author=J.+S.+Mitcheson&title=hERG+Potassium+Channels+and+the+Structural+Basis+of+Drug-Induced+Arrhythmias"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Ftx800035b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800035b%26sid%3Dliteratum%253Aachs%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26atitle%3DhERG%2520Potassium%2520Channels%2520and%2520the%2520Structural%2520Basis%2520of%2520Drug-Induced%2520Arrhythmias%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D1005%26epage%3D1010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="note"><p class="first last">All the work involving animals was carried out in accordance with European directive 86/609/EEC governing animal welfare and protection, which is acknowledged by Italian Legislative Decree no. 116, 27 January 1992, and according to internal review performed by the GlaxoSmithKline Committee on Animal Research & Ethics (CARE) and to the company Policy on the Care and Use of Laboratory Animals</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span>Cerep; <span class="NLM_publisher-name">Cerep</span>: <span class="NLM_publisher-loc">Paris</span>; <a href="http://www.cerep.fr" class="extLink">http://www.cerep.fr</a>. (Accessed March, 2010).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Cerep%3B+Cerep%3A+Paris%3B+http%3A%2F%2Fwww.cerep.fr.+%28Accessed+March%2C+2010%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DCerep%26pub%3DCerep" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Lazareno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birdsall, N. J. M.</span><span> </span><span class="NLM_article-title">Pharmacology characterization of guanine nucleotide exchange reactions in membranes from Cho cells stably transfected with human muscarinic receptors m1−m4</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">449</span><span class="NLM_x">–</span> <span class="NLM_lpage">456</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1993&pages=449-456&author=S.+Lazarenoauthor=N.+J.+M.+Birdsall&title=Pharmacology+characterization+of+guanine+nucleotide+exchange+reactions+in+membranes+from+Cho+cells+stably+transfected+with+human+muscarinic+receptors+m1%E2%88%92m4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLazareno%26aufirst%3DS.%26aulast%3DBirdsall%26aufirst%3DN.%2BJ.%2BM.%26atitle%3DPharmacology%2520characterization%2520of%2520guanine%2520nucleotide%2520exchange%2520reactions%2520in%2520membranes%2520from%2520Cho%2520cells%2520stably%2520transfected%2520with%2520human%2520muscarinic%2520receptors%2520m1%25E2%2588%2592m4%26jtitle%3DLife%2520Sci.%26date%3D1993%26volume%3D52%26spage%3D449%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm100714c&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm100714c%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-23" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm100714c" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                896KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991bbd3d5a22a8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
